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1 Introduction
1.1 The challenge of molecular interactions
Molecular interactions between proteins and different ligands control most biological func-
tions in organisms. These interactions are highly specific and thus permit an extremely
intricate regulation of cellular functions. The identification of molecules involved in these
specific interactions, as well as of molecules that might interfere with these complex cellu-
lar processes, forms the scientific basis of our understanding of differences between health
and disease on the molecular and cellular level and its translation into pharmaceutical
research.
Many different approaches have been developed to analyze the modes of interaction
and to identify or develop novel ligands that can interact in a desired fashion.
One approach, called “rational design”, uses computer-aided analysis and modeling of
molecular structures to predict modes of interaction and alterations in the amino acid
sequence of existing (known) molecules that might improve interactions (Shaikh et al.,
2007). This method has been used in numerous experiments (e.g. Pisabarro and Serrano,
1996; Russell, 1998); however, it requires intimate knowledge of the three dimensional
structures and the epitopes involved in the interaction in order to be able to predict
the effect of changes. While this knowledge is available for an increasing number of
macromolecules within bacterial and eukaryotic cells, the correlation of structure and
function is still largely unknown. This limits the applicability of the “rational design”
method.
A different approach, namely the empiric approach, sometimes ungenerously coined
“irrational design”, instead mimics the natural evolutionary process: In nature, all organ-
isms are believed to have evolved from numerous generations of diversification (mutation)
and selection of the ”fittest“ subjects, starting from a divergent “pool”.
Chemical and biological methods are now applying this principle on the molecular level
to evolve the function of molecules. Libraries that consist of up to 1010 different molecules
are subjected to a selection process in which the “best“ molecules are selectively enriched
on the basis of an experimental criterium and finally identified as “best candidates” or
”leads“ for further development.
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1.2 Biological libraries used for the identification of novel
ligands by affinity selection
Although selection from libraries is performed with many different target properties in
mind, e.g. for the directed evolution of enzymes to generate new variants, one of the
most common applications is the selection for ligands that bind to a given target with a
particularly high affinity. Identification of such novel high affinity ligands subsequently
allows their use as highly sensitive biological probes for the detection of their respec-
tive target molecules and the analysis of interaction modes including competition for or
blocking of receptor epitopes, thus being of high diagnostic and therapeutical interest.
Importantly, affinity selection allows the actual physical enrichment of ligands that
have bound to a target of interest. Competition elution with compounds that bind
to specific epitopes on the target molecule can therefore be used to characterize which
epitopes are being bound, e.g. different ligands binding to different epitopes, or, as is
often the case, can be used to select ligands binding to a specific desired epitope. This
method has been successfully used e.g. to select for ligands binding to a substrate binding
site or an allosteric activation site of an enzyme (see also Clackson and Wells, 1994).
1.2.1 Different presentation systems
During the screening process of biological libraries, the physical linkage of genotype —
the DNA sequence encoding a protein — and phenotype — the gene product — is always
required. As in Darwinian evolution, the potential benefits of an improved molecule
would be lost without the blue print — i.e. the encoding gene.
All systems for in vitro evolution must as well link genotype and phenotype in some
way, utilizing different methods of coupling the presented molecule(s) to the respective
gene(s) encoding them. A number of systems which have been developed and employed
for ”display“ screening/selection are described in the following sections.
1.2.1.1 Cell surface display
Cell-surface display is a method which uses living cells as a basis for the linkage of
phenotype and genotype. With this method, proteins of interest are usually fused to a
membrane protein so that they are presented on the cell surface (Lee et al., 2003; Olsen
et al., 2000). Various cells, including E. coli, yeast and insect cells, are used for this
purpose. This method has the advantage of being able to use the full cell arsenal of
chaperones to ensure complete correct folding of the target protein, and in the case of
eukaryotic cells also allows post-translational modifications (e.g. glycosylation).
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Cell surface display makes the use of fluorescence-activated cell sorting (FACS) as a
detection tool possible.
However, one has to deal with the complex system of a whole cell. This limits the
conditions under which the system can be applied. The number of different clones is
generally limited by the smaller size of the libraries.
Cell surface display is often used to present whole proteins and screen for protein func-
tion, although affinity selections with cell-surface based systems have also been used (e.g.
by selecting for binding of fluorescence-marked antigens to achieve antibody maturation,
see van den Beucken et al. (2003); Weaver-Feldhaus et al. (2004). Read Siegel (2009) for
further examples).
Figure 1: Cell surface display.
In cell-surface display, the proteins of interest are displayed on the surface of a living cell by
anchoring via integrated membrane proteins. The gene encoding the fusion protein of interest
and the anchor protein is encoded in a plasmid (from Matsuura and Yomo, 2006).
1.2.1.2 Ribosome display
In this method, a synthetic DNA library is expressed using an in vitro transcription+translation
system. The occurring ribosomal complexes of mRNA, ribosome and nascent translated
protein are stabilized to ensure a linkage of phenotype (the expressed peptide/protein)
and the encoding gene (mRNA) (Hanes and Plückthun, 1997).
This stabilized state results in a non-covalently-bound complex which is relatively
fragile and limits screening conditions to a narrow set of temperature and salt condi-
tions. Modified protocols aim to enhance the stability, e.g. by expressing a fused MS2
coat-protein that will bind to a specific binding motif, which was originated from the
bacteriophage MS2 (Sawata and Taira, 2003).
The main advantage of this method is that no DNA transformation step is required.
High complexities of up to 1012 could be generated, (see Gersuk et al., 1997; He and
Taussig, 2002; Mattheakis et al., 1994; Zhao et al., 2009).
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Figure 2: Ribosome display.
Ribosome display is based on the idea that ribosome complexes consisting of a nascent chain,
ribosome and mRNA can be generated, establishing a link between the protein and the encoding
gene (from Matsuura and Yomo, 2006).
1.2.1.3 mRNA display
In mRNA display, the mRNA and the encoded protein are linked covalently (in contrast
to the non-covalent complex of ribosome display) via puromycin. The linking is achieved
by having encoding mRNA that is bearing puromycin at its 3’ end, which mimics aminoa-
cyl tRNA. Puromycin will be covalently attached to the C-terminus of the protein once
it enters the ribosome (Nemoto et al., 1997; Roberts and Szostak, 1997).
The resulting fusion molecule can be screened under any conditions that leave the RNA
as well as the protein intact; reverse transcription of the RNA leads to a RNA/DNA
hybrid which is more stable (Takahashi and Roberts, 2009).
The advantage of this technique is the large possible number of variants that can be
obtained, since there is no limiting DNA transformation step; high complexities of up to
1012 could be generated (e.g. in the evolution of single-chain antibodies Fukuda et al.,
2006).
Figure 3: mRNA display.
mRNA display links the mRNA covalently to the encoded protein via puromycin, which is linked
to the mRNA at the 3’ end (from Matsuura and Yomo, 2006).
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1.2.1.4 In vitro-compartmentalization
In vitro compartmentalization uses emulsions of water-in-oil: The aqueous core of each
droplet holds a single gene encoding the protein of interest as well as an in vitro trans-
lation medium. The genotype-phenotype linkage occurs by encapsulating both the gene
and the resulting encoded proteins (Bertschinger and Neri, 2004; Tawfik and Griffiths,
1998).
Griffiths and Tawfik (2003) achieve the linkage of gene and translated protein by
embedding microbeads in the droplets, capturing DNA as well as protein via specific
tags.
A method to covalently bind the encoding sequence to the resulting protein uses the
M.hae III domain (Hae III DNA-methyltransferase of Haemophilus aegypticus) fused to
the proteins of interest. The M. hae III domain can react with a modified methylation
target DNA sequence to form a covalent bond (Chen et al., 1991). The DNA template
encoding the M. hae III domain and the fusion protein carries this DNA modification,
resulting in a DNA molecule “displaying” its covalently bound gene product.
After completed translation one can break up the compartments later and screen the
proteins directly (Bertschinger et al., 2007; Griffiths and Tawfik, 2003).
This method currently is the only way to do an in vitro selection of enzyme activity.
Figure 4: In vitro-compartmentalization.
In vitro compartmentalisation utilises the aqueous core of water-in-oil emulsions for in vitro
translation. Proteins are expressed inside this core, and could also be immobilized on microbeads
which the DNA could be fixed on. Expressed proteins are then immobilized on the same beads
via an anti-peptide tag antibody, which is also immobilized on the beads (from Matsuura and
Yomo, 2006).
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1.2.1.5 Phage display
Phage display is one of the most commonly used methods for evolutionary experiments.
Various types of phage are used, including the lambda phage, T7 phage, and filamentous
phage. The most widely used system is that using the M13 filamentous phage (Smith,
1985). With this system, the protein of interest is fused to a coat protein of the phage
and displayed on phage surface. The encoding gene is encapsulated inside the phage.
Phage display is typically used to select for binding interactions, such as from libraries
of antibodies, antibody fragments, proteins using other scaffolds or peptides.
This system will be explained in more depth in section 1.3.
Figure 5: Phage display.
In this system, a protein of interest is displayed as a fusion protein with a phage coat protein
on the surface of the phage, the gene encoding the protein is packaged inside the phage (from
Matsuura and Yomo, 2006).
1.2.2 Structural considerations
In libraries that are designed to yield ligands with high affinities to specific varied targets,
it has often been shown that ligands with more rigid structures show higher affinities. Be
it the use of antibody Fab fragments (Knappik et al., 2000) or also multivalent antibody
fragments (Plückthun and Pack, 1997), which possess a structure that nature has evolved
as a scaffold, or the use of constrained proteins/peptides, a rigid structure often exhibits
higher affinity than a more flexible chain of amino acids, due to the lower entropic price
of binding caused by larger potential interaction surface.
Structural stability of the bound conformation also affects the specificity of binding,
because of the inverse correlation between stability and the accessibility to alternative
binding conformations (Ladner, 1995).
This is the reason why a number of different structural elements are used for stabiliza-
tion. They are used to stabilize binding motifs as well as (and mainly) for the stabilization
of a supporting scaffold, on which the variable region of the library is displayed.
Many different scaffolds have been used and are in use in libraries where the designers
considered that reducing the entropy of the ligands will lead to higher affinities (other
than libraries made from natural antibodies). Examples of such library scaffolds are
8
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the following: The lipocalin derivatives that are used by the company Pieris (Skerra,
2000, 2001); libraries based on protease inhibitors (Roberts et al., 1992; Röttgen and
Collins, 1995); or “affibodies” (based on the α-helical bacterial receptor domain Z from
staphylococcal protein A) used by the company Affibody (Nord et al., 1997).
A limitation of these libraries often seems to be their specificity for a single target or a
family of similar targets, since one would need to create a custom library for each target
(e.g. anticalins that enclose small compounds as digoxigenin, but would not be suitable to
interact with larger proteins). It must also be considered that, by prejudicing a starting
structure, other, possibly more interesting ligands are removed from consideration.
In many cases where people want to create more general libraries, they do not go for
pre-planned scaffolds, but just introduce some form of rigidity. Smaller domains such as
zinc-finger domains (Bianchi et al., 1995), coiled-coil peptides or single helices (Houston
et al., 1996) were used to present conformationally uniform peptide libraries.
While uncommon to appear in short peptides of <10 aa length, the formation of α-
helices or β-sheets (for a review, see Binz and Plückthun, 2005) in a presented library
would add a more defined shape that can interact with a target protein more specifically.
The smallest feature used often to (intentionally) introduce limited rigidity is the use
of disulfide bridges between cysteines that constrain shorter or longer sequence motifs
(Karlsson et al., 2004; McLafferty et al., 1993). Nature uses cysteine-rich mini proteins
(for a look at the structure of knottins and short-chain scorpion toxins, see Combelles
et al., 2008) to provide structure as well, cysteine knots as scaffolds have been used
successfully (e.g. Christmann et al., 1999; Kimura et al., 2009), and the company Amunix
(California, USA) uses short proteins with high cysteine content to provide rigidity for
its display libraries.
1.3 Phage Display
The display of proteins and peptides on the surface of filamentous phage — phage display
— is an in vitro selection method that allows the selection of polypeptides with desired
properties from a large collection of variants. A gene encoding a peptide or protein of
interest is fused to the gene of a phage coat protein, and after production and packaging
of the phage particles, one gets phages that display the encoded protein and also contain
its gene, providing the link between phenotype and genotype.
This technique allows phage libraries to be subjected to a selection step (e.g. affinity
chromatography). Recovered clones can be identified by sequencing and re-grown for
further selection rounds.
Since the initial description of this method by Smith (1985), phage display has become
an established and well characterized method for the identification of polypeptides with
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novel properties — examples are the isolation of peptides that bind to the target receptors
for interleukin-1 (IL-1) (Yanofsky et al., 1996), thrombopoietin (Cwirla et al., 1997), or
erythropoietin (EPO) (Wrighton et al., 1996) with affinities in the low micromolar to
nanomolar range (see Clackson and Wells, 1994; Sidhu, 2000; Sidhu et al., 2000, for
reviews).
The following sections detail the biology of filamentous phages, the different ways to
present polypeptides via phage display, the considerations for selection processes utilizing
phage display and different applications where phage display is actually used.
1.3.1 Biology of filamentous phage
1.3.1.1 The phage particle
Filamentous phages and infect Gram-negative bacteria.
Filamentous phages constitute a large family of bacterial viruses, usually contain a
genome of single-stranded DNA, infecting a great variety of gram negative bacteria.
The best-characterized filamentous phages are those that infect E. coli, which are the
bacteriophages f1,M13 and fd. These phages are collectively referred to as Ff phages.
Their genomes are more than 98% identical and their gene products interchangeable
(Beck and Zink, 1981; van Wezenbeek et al., 1980). Unlike most other bacteriophages,
filamentous phages are temperate phages, they are produced and secreted from infected
bacteria continuously without lysing the cell (although a decrease in the rate of cell
growth is seen in the infected cells).
The Ff phage genome consists of about 6400-nucleotide ssDNA; it holds 9 genes en-
coding 11 proteins and a major non coding “intergenic region”, which contains the site of
origin for the synthesis of the viral and complementary DNA strands as well as a site of
initiation for phage particle assembly (packaging signal, PS ) (Webster, 1996).
The genes can be divided into three groups according to their function: The first
group encodes for DNA replication proteins (pII, pV, and pX), the second group encodes
capsid proteins (pIII, pVI, pVII, pVIII, and pIX), while the third group encodes proteins
that are required for the secretion of the phage proteins and the membrane associated
assembly process of the phage particles (pI, pIV, and pXI).
The phage genome is encapsidated into a long cylinder of about 6.5 nm and a length
of about 930 nm (depending on genome size, Specthrie et al. (1992)). The hollow tube
consists of several thousand copies of the pVIII major coat protein (about 2700 copies
per phage). On the “blunt” end of the phage, 3–5 copies each of pVII and pIX are located
(with pVII being less exposed, Endemann and Model, 1995), while the other end holds
about five copies of pIII and pVI (with pVI being less accessible).
The pIII protein (Figure 6) is vital for the infectivity of the phage, as well as for the
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assembly of the phage particle. Its three domains (D1, D2 and D3) are connected by
three glycine rich linkers. The domains D1 and D2 are important for the infectivity of
the phage, while D3 is buried within the phage. D3 is necessary and sufficient for pIII
to be incorporated into the phage and to mediate termination of phage assembly and
release of the phage from the host cell (Rakonjac et al., 1999).
Figure 6: Domain structure of the pIII protein in filamentous phages.
The domains D1, D2 and D3 are linked by glycine rich linker regions. D1 is necessary for E. coli
membrane penetration, while D2 is required for binding to the F-pilus of a host cell. D3 is
buried within the phage particle (here grey) and also important for the assembly of the virion
(see Figure 7)(Holliger and Riechmann, 1997).
The single-stranded DNA phage genome is oriented within the phage particle; its
orientation is determined by the packaging signal site (PS ) on the genome. The packaging
signal, forming a stable hairpin, is positioned at the pVII-pIX end of the phage and is
necessary and sufficient for the encapsidation of circular ssDNA into phage particles.
1.3.1.2 Infection of E. coli by Ff phages
Infection of E. coli by Ff phage normally begins when the D2 domain (see Figure 6) binds
to the tip of the F conjugative pilus of an E. coli cell.
Since pili normally assemble and disassemble continuously, possibly also stimulated by
phage binding, this brings the page close to the cell surface. Once the D2 domain binds
the F pilus, the D1 domain is released from its normal interaction with D2, making it
available to bind the host TolA protein. Three Tol proteins (Q, R and A), which are
all integral cytoplasmic membrane proteins, are absolutely required for phage infection
(Click and Webster, 1997). The exact mechanism of the phage penetration of the outer
cell membrane is not yet characterized.
Once the pVIII capsid proteins have integrated into the inner membrane, the phage
DNA (ssDNA, (+) strand, same polarity as mRNA) is released into the cytoplasm.
Upon entry of the viral single-stranded phage DNA, host RNA and DNA polymerases
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Figure 7: The life cycle of the Ff bacteriophage.
The phage enters the host cell through the F pilus, and the DNA (+ strand) is translocated
into the cytoplasm. The bacterial enzymes synthesize the complementary strand, creating the
replicative form (RF). The RF serves in a “rolling circle” reaction as template for the synthesis
of new ssDNA (+ strand), while also phage proteins are transcribed and translated from the
DNA. When pV concentration finally reaches a certain concentration, a complex of pV and the
ssDNA is formed. A complex of pV and the DNA as well as pVII and pIX forms in the cell
membrane, and in an translocation+elongation process through the membrane pV is replaced
by membrane embedded pVIII. The assembly is terminated by the addition of the membrane-
embedded complex of pIII-pVI, forming the end of the phage, upon which the complete phage
is released from the cell.
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and topoisomerases convert it into a double-stranded, super-coiled molecule that is called
the “Replicative Form” (RF ). The RF serves as template for phage gene expression. All
phage proteins are expressed simultaneously, although several mechanisms ensure that
each is produced at an appropriate rate.
The expression of pII particularly is necessary for further replication. pII, a site-specific
nicking-closing enzyme, nicks the + strand of RF at a specific site in the non-coding region
of the phage genome. The resulting 3’ end is used by the host enzymes as a primer in
order to synthesize a new (+) strand which is converted into a new RF DNA by bacterial
enzymes.
The more RF DNA is produced, the more phage proteins are produced also, and
proteins necessary for phage assembly get integrated into the cell membrane, while the
proteins required for replication remain in the cytoplasm.
1.3.1.3 Phage assembly
The assembly of the phage particle takes place in the cytoplasmic membrane of the host
cell; pI and pIX span the cytoplasmic membrane, while pIV forms a pore of about 8 nm ∅
in the outer membrane through which assembled phage particles are secreted (Marciano
et al., 2001).
The assembly is initiated by pV binding to the PS site of a newly synthesized circular
(+) phage ssDNA. Together with pVII and pIX, which are most probably interacting
with the PS, these proteins are assumed to create a complex in the membrane, forming
the “tip” of a new phage.
The elongation of the phage involves successive replacement of pV dimers that cover
the phage DNA by membrane-embedded pVIII and translocation of the DNA across the
cell membrane. This process continues until the end of the phage DNA has been coated
by pVIII.
The assembly is terminated by the addition of the membrane-embedded complex of
pIII-pVI, forming the end of the phage, upon which the complete phage is released from
the cell.
The phage production and assembly process is tolerated well by the cell, E. coli even
continues to divide and grow after infection. The first phages appear already 10min after
infection of the host cell (at 37 ○C), about 1000 phages are produced in the first hour.
Since cell growth continues, although significantly slower than uninfected cells, and
with a lower maximal growth, on a bacterial lawn turbid plaques can be observed that
contain infected cells and secreted phages (Model and Russel, 1988).
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1.3.2 Principles of phage display
1.3.2.1 Phage proteins used for phage display
All five capsid proteins (pIII, pVI, pVII, pVIII and pIX) have already been used to
display peptides or proteins, however, the by far most commonly used virion proteins for
phage display are pVIII and pIII.
• pVIII: pVIII, the major capsid coat protein, is present in several thousand copies
per phage particle (∼2700 per wildtype phage). Displayed peptides are usually
fused N-terminally, although one is usually limited to short peptides (6–8 amino
acids), since larger sizes prevent packaging and would therefore not produce viable
phages. The display of larger polypeptides requires the production of hybrid-pVIII
phages by the use of a phagemid vector (see section 1.3.2.2).
• pIII: pIII is present in five copies at the “end” of the virion. It is used for most
phage display fusions since it tolerates large insertions, and it can be used for mono-
valent presentation of a peptide/protein as well (see section 1.3.3.2). Fusions are
usually N-terminal to pIII, between the leader sequence and the pIII protein.
C-terminal fusions are rarely used, but would alleviate the requirement for in-frame
expression between the leader sequence (required for secretion) and the N-terminus
of pIII, which can help when cloning fragments of random length (e.g. cDNA).
Although larger fusions are tolerated, they can have a dramatic impact on infectiv-
ity due to the importance of pIII for the infectivity of the phage (see section 1.3.1.2).
This can also be alleviated by creating hybrid-pIII phages, where not all pIII pro-
teins are modified (see section 1.3.2.2).
1.3.2.2 Phage display systems
Peptides/proteins can be displayed using vectors based on the natural Ff phage sequence
— phage vectors — or using plasmid-based phagemid vectors that carry only the fusion
protein gene and no other phage genes (Lowman, 1997).
Phage-display systems can be classified according to the arrangement of the coat pro-
tein genes. This is illustrated for fusions to pVIII and pIII in Figure 8, in which gene
VIII is represented as a black block, gene III as a white block, the foreign DNA insert as
a red block, and the foreign peptide as a red circle. In a type 3 vector, there is a single
phage chromosome (genome) bearing a single gene III which accepts foreign DNA inserts
and encodes a single type of pIII molecule. The foreign peptide encoded by the insert is
theoretically displayed on all five pIII molecules on a virion. Type 8 is similar in regards
to the pVIII coat protein, which is present at ∼2700 copies per phage particle.
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In a type 33 vector, the phage genome bears two genes III, encoding two different
types of pIII molecule; one is recombinant (i.e., bears a foreign DNA insert) and the
other wild-type. The resulting virion is a mosaic, its coat comprised of both wild-type
and recombinant pIII molecules (the former usually predominating). This allows hybrid
pIII proteins with quite large foreign peptides to be displayed on the virion surface, even
though the hybrid protein by itself cannot support phage assembly. Type 88 has a similar
expression pattern, although the size of fusion peptides is limiting (section 1.3.2.1).
A type 3+3 system differs from a type 33 system in that the two genes III are on sep-
arate genomes. The phagemid genome encodes only for the modified pIII fusion protein,
while the so called “helper phage” provides the other phage proteins and also a wildtype
pIII protein. Monovalent display is achieved by having the fusion pIII from the phagemid
vector under control of a weak promotor, so that only a minority of the produced pIII in
the bacterial host cell is the modified fusion protein, leading to a statistical monovalent
presentation on the pIII protein of packaged phages.
The helper phage genome has a defective oriFf . This results in phagemid DNA being
packaged preferentially into the assembled phage particles, to the detriment of the helper
phage DNA (Russel et al., 2004); about 5–15% of the packaged particles usually contain
the helper phage genome, depending on the system used.
There have been also different systems developed that either modify or even replace
the helper phage, see section 1.3.3.2.
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Figure 8: Types of phage display systems.
The long vertical ovals represent phage virions, and the shorter vertical ovals represent phagemid
virions. The twisted line inside each virion represents the viral ssDNA, the segments encoding
coat proteins pVIII and pIII being designated by black and white boxes, respectively. The red
segments within these boxes represent foreign coding sequences spliced into a coat-protein gene,
and the red circles on the surface of the virions represent the foreign peptides specified by these
foreign coding sequences. The five white circles at one tip of the virions represent the N-terminal
domains of the five pIII molecules. In type 8 systems, the foreign peptide is displayed on all
copies of the major coat protein pVIII (2700 copies in wild-type virions), whereas in type 88 and
8+8 systems, only a minority of the pVIII copies display the foreign peptide (from Smith and
Petrenko, 1997).
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1.3.3 Screening of phage display libraries
Screening a phage display library consists of culling an initial population of phages pre-
senting peptides or proteins to obtain a subpopulation with increased “fitness” according
to a user-defined criterion , where affinity selection, screening the library for ligands that
bind to a target of choice, is the most common application.
In most cases, the input to the first round of selection is a very large initial library.
Typically 108-109 clones, each represented by 100–1000 particles on average, are applied
in this initial challenge, resulting in phage titers of > 108. This gives a concentration
for individual clones in the attomolar range, therefore binding in the first round will
be close to a first order reaction, driven mainly by target concentration. The selected
subpopulation is a relatively tiny fraction of the initial population (105-106 particles),
”fitter“ clones being over-represented due to favored enrichment.
This population can be ”amplified“ by infecting fresh bacterial host cells, so that each
individual phage in the subpopulation is represented by millions of copies in the am-
plified stock. The amplified population can be subjected to further rounds of selection
(perhaps accompanied by mutagenesis) to obtain an ever-fitter subset of the starting
peptides. Already in the second round of panning, each clone is at least 1000-fold higher
concentrated and more stringent washing conditions can be used.
1.3.3.1 The panning procedure
As mentioned, affinity selection for a target receptor is by far the most common selection
pressure imposed on phage-displayed libraries. This selection is accomplished by minor
modifications of standard affinity purification techniques that are commonly used in
biochemistry. An advantage of the phage display system is the inherent robustness of
phages that tolerate a wide range pH, are relatively temperature insensitive and resistant
to many chemicals (like organic solvents, chaotropic agents as guanidinium chloride and
many proteases), while still maintaining infectivity. This allows for a wide range of
different selection environments.
A phage library is usually incubated with an immobilized target, which has been either
covalently bound or just adsorbed to a treated surface. After the incubation, washing
steps remove the non-binding phage. The number of washing steps and the stringency
(e.g. salt concentration, detergents) determine how many phages remain bound to the
target. After washing, the binding phages are eluted from the immobilized target and
can be propagated. This cycle has to be repeated several times to enrich phage that bind
strongly, until a significant enrichment of the eluted phage is observed. At this stage,
individual clones are further analyzed by sequencing, and the clones are compared, with
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the aim of distinguishing a consensus sequence.
Phages bind, are washed and retained phages are afterwards eluted. This method is
also referred to as “sorting” or “(bio)panning” (Figure 9).
Figure 9: Affinity selection using phagemid libraries.
After the incubation of the target with the phage library, washing steps are performed
in order to wash away preferentially particles showing low affinity to the target, leaving
the strongly binding particles attached to the target.
For the elution of the retained phages, either specific or nonspecific conditions are
used:
• Nonspecific elution: Nonspecific elution conditions are intended to weaken the
target-peptide interactions without regard to their specificity. They exploit the
high resistance of filamentous phages to denaturation by acidic buffers with pH
down to 2.2 (Smith, 1985) or alkaline buffers such as 0.1M triethylamine (up to
pH 10.0 for 5–10 minutes) as reported by Harrison et al. (1996).
18
1 Introduction
• Specific elution: Specific elution seeks to release phages that are bound to the
target receptor’s binding site, or in general a domain of interest, without releasing
phages that are bound for some other reason, for example, by interaction with a
contaminant, or with the immobilization surface. In competitive elution, a known
soluble ligand for the receptor competes with phage for binding to the immobilized
target molecule (e.g. Dybwad et al., 1995; Sioud et al., 1994). This method has the
advantage of selecting for target and target-site specific phages.
One can also use specific elution during the challenge to select for ligands that
are binding to a different binding site (from personal communication with John
Collins).
In the absence of knowledge about an appropriate method for elution, one can also
just add E. coli host cells to the immobilized target-phage complexes directly after the
washing steps (from personal communication with John Collins).
1.3.3.2 Considerations for screening of phage display libraries
Other than the general design of peptide libraries presented via phage display, as it is
mentioned in section 1.4, there are also factors specific for phage display which must be
kept in mind:
• Library quality: The quality of the encoded library is of crucial importance for
the chances of isolating phages with desired properties. Developing a good strategy
for the peptide design is important, but it must be validated later that the encoded
peptides are still representative for that strategy. The steps of DNA modification,
amplification and transformation can create a sequence bias that must be taken
into account. Not only can bias arise through these steps, but also non-functional
presentation, e.g. by insertion of stop codons in the DNA sequence of the fusion
protein, leading to premature termination of translation.
• Library complexity: The transformation of DNA into cells before packaging into
phage particles is a limiting step in phage display. Having a certain complexity in
a library per design, even discounting sequence/codon bias, in order to cover the
whole complexity with a 99% probability, the number of clones in a library would
have to be about 5× higher than the theoretical complexity of a library (Collins,
1997).
• Valency of presentation: The effect of either mono- or multivalent presentation
(see section 1.3.2.2) on the enrichment of clones is also of great importance. While
multivalent presentation usually yields more phage particles after a panning, it is
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not as selective for high affinity ligands as a monovalent display system. This is
due to avidity effects, which can make weaker binding effects appear stronger, even
though the selection ought to be based on the affinity of a single presented molecule
(Lowman et al., 1991).
In general, monovalent display is considered to enrich ligands with higher affinities;
however, there are several protocols developed that consider a multivalent presen-
tation in at least the first panning round as beneficial (due to the relatively low
representation of each clone in the first round of panning, and thus the chance to
lose promising candidates early on).
In order to be able to ”switch“ the mode of presentation, different approaches have
been taken: By using an inducible promoter for the fusion protein used for presen-
tation, leading to a higher fusion-protein to wildtype-protein ratio, by developing
helper phages that do not encode a wildtype-protein themselves (e.g. Rondot et al.,
2001), or even by eliminating the use of helper phage completely and using cells
for phage packaging that carry different phage gene encoding plasmids, allowing
control over the valency of presentation (Chasteen et al., 2006).
1.4 Peptide libraries as source for ligands
Most libraries used today for the isolation of high affinity ligands consists of recom-
binant/engineered proteins or antibodies/antibody fragments (like single-chain variable
fragments, scFv); these libraries are screened for binding certain targets with high affini-
ties and specificities and have become powerful tools for therapy, in vivo and in vitro
diagnostics, drug target analysis and laboratory research (Binz and Plückthun, 2005).
However, proteins or antibodies are rather large molecules, a fact that can make pro-
duction/expression of the ligands problematic. The cheaper process of complete chemical
synthesis of interesting ligands usually is impossible or very difficult for larger molecules,
which leaves researchers dependent on recombinant production, as there is no alternative
path of validating results. Ligands that can be synthesized chemically are also desirable
for potential pharmaceutic application so that no micro organisms would be required for
production (Ladner et al., 2004).
Random peptide libraries have been used for many years to discover novel peptide
reagents that have affinity for molecular targets. Phage libraries encoding six (Cwirla
et al., 1990; Scott and Smith, 1990), seven (Scott et al., 1992), eight (Oldenburg et al.,
1992) and fifteen (Devlin et al., 1990) random amino acids were used in screenings for
high affinity ligands already more than 15 years ago.
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Since then, libraries of small peptides have been mainly used for epitope mapping of
antibodies, although the peptides themselves obtained from those experiments usually
yielded only affinities at best in the low micromolar range, mostly due to binding motifs
of only three or four amino acids length (noteworthy exceptions are high affinity ligands
like HPQ for binding to streptavidin (Devlin et al., 1990) or the RGD motif for integrin
binding (Ruoslahti, 1996)).
One reason to stop using of small peptide libraries was the potential complexity of a
complete random library — a library of heptamers, using all 20 available amino acids,
would already have a potential complexity of 207= ca. 1.28×109. A library of this size is
already at the limit of what can be transformed into E. coli. Libraries with even longer
peptides would not cover such a (potential) complexity completely.
Thus, since libraries of short peptides (< 10 aa) have already been used extensively, and
libraries containing longer peptides sequences could not cover the potential complexity,
researchers have not been using peptide libraries in searching for high affinity ligands in
the last years.
However, there have also been ideas to use libraries containing longer peptides (e.g.
Kay et al., 1993), due to the following ideas:
• Within long sequences, there are multiple short sequences because of a sliding
window — e.g., within a 36-mer there are 31 different, adjacent hexamers.
• The peptides might be long enough to provide multiple contact sites necessary for
a particular peptide-target interaction.
• The inserts might be large enough to assume a structure independent of the ma-
trix/partner that is used to present the peptide — while short peptides are known
to interact with the matrix quite often (e.g. with the phage surface in phage display
systems).
Even though the complexities of libraries containing peptides of such length could not
be covered in a library, these ideas have been applied to identify longer peptides binding
specifically, as e.g. Dedman et al. (1993) with a library of 15mers, Sparks et al. (1994)
with random 22mers, Adey and Kay (1996) with 26mers and Kay et al. (1993) with a
library of random 38mers.
21
1 Introduction
1.4.1 Increasing the diversity of a library
Having a large diversity is obviously a desirable property for a library. It increases
the chances of there being a candidate with the desired properties in the library. This
diversity can be achieved either by design in the original library (high sequence variety for
libraries whose DNA template is synthesized; large variety of sources for library material
obtained otherwise), or by increasing the diversity of a primary library later on (Gallop
et al., 1994). The latter can be achieved by using methods that utilize mutation and, as
is emphasized in the present investigations, recombination.
Error-prone PCR While the error-prone nature of the polymerase chain reaction (PCR)
has been an issue almost since its original development, even the Taq polymerase with
its relatively low fidelity is too accurate to be useful for the mutation of DNA libraries
under standard reaction conditions.
Increases in error rates can be obtained by different ways — the most straightforward
and popular method is the combination of introducing a small amount of Mn2+ (in place
of the natural Mg2+ cofactor in PCR reactions) and using biased concentrations of dNTPs
(Cirino et al., 2003).
A related method involves the synthesis of mixtures of small DNA molecules and is
usually based on the incorporation of partially randomized synthetic small DNA cassettes
into genes via PCR, directing the mutation to specific positions within the DNA template.
Mutator strains Low et al. (1996) developed a method that uses bacterial strains having
a proof-reading-negative DNA polymerase III (E. coli mutator strain mutD5). Other
strains have been developed that bear defects in one or several DNA repair pathways,
leading to a higher mutation rate as well.
Genetic material passing through cells of these strains accumulates mutations at a
vastly higher rate than usual. This is an effective and straightforward way of introducing
mutations throughout a DNA construct.
The process of mutagenesis using mutator strains can be quite slow as the level of
mutagenesis is controlled by the length of time the DNA spends in the strain (for a review
of mutator strains, see Nguyen and Daugherty, 2003). In general, the rate of mutation
is considered low, and since mutation is not limited to a library insert, a recloning of the
library would be necessary to avoid mutations in the bacterium itself.
PCR based recombination of DNA sequences In contrast to the insertion of random
mutations, natural evolution also exploits recombination to bring together advantageous
mutations and separate out mutations that are less advantageous.
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A number of different techniques of PCR based recombination utilizing partial ho-
mologies in DNA sequences is used:
The original technique of DNA shuﬄing (Stemmer, 1994a) is still one of the most
popular tools in many optimization strategies. It allows to recombine a range of similar
genes from various sources, or to combine selected point mutations in new combinations.
A number of other techniques have become available as well, each with own characteris-
tics and uses, such as the staggered extension process (StEP), random chimeragenesis on
transient templates (RACHITT) and different techniques based on iterative truncation
for the creation of hybrid proteins (ITCHY) (all reviewed in Neylon, 2004).
Figure 10: Homology based methods for recombining DNA sequences using PCR.
DNA shuﬄing uses randomly cleaved parental DNA as at template in a self-priming PCR reac-
tion; in StEP the DNA is not fragmented, but small segments are added to the end of a growing
DNA strand in a series of very short extension steps. In RACHITT one parental DNA is used as
a template where one strand in this template containing dUTP is generated. Fragments of the
opposite strand of the other parental DNAs are then produced and annealed to the template.
Non-annealed gaps are removed by exonuclease and filled using a DNA polymerase. These frag-
ments are then ligated together and the template strand removed by endonuclease V digestion.
The single strand is then converted to double-stranded DNA for further manipulations (from
Neylon, 2004).
1.4.2 Cosmix-plexing
Cosmix-plexing was designed as a method to use recombination in DNA libraries without
requiring large stretches of homologous regions. It allows the reassorting of hypervariable
DNA regions, requiring only a minimum of two bases homology at a recombination site
thus (Collins et al., 2001). This is compared to the previous PCR-based methods which
require >70% sequence homology on the DNA level to obtain efficient recombination.
Using this method, the potential diversity of the library is no longer limited to the
complexity of the initial library. A Cosmix-plexing library contains one or more re-
combination sites for type IIs restriction enzymes between hypervariable DNA sequence
cassettes (see Figure 11). These recombination sites allow the formation of novel com-
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binations of cassettes to the left and to the right of the recombination site. Due to two
defined base pairs without mirror symmetry at the recombination site, the cassettes will
remain in the same order and orientation before and after the recombination. This is a
highly efficient recombination process, in contrast to other methods that allow mutation
or recombination. This is important for the resulting library quality in that no “junk” is
produced from e.g. inverted sequences.
This technique can be used to increase the complexity of an initial library just by
recombining the cassettes that already exist in the library (as shown in Figure 11),
accessing new combinations of cassettes every time.
Figure 11: Principle of Cosmix Plexing. Peptide encoding DNA cassettes can be recombined
using type IIs restriction enzymes, requiring only small fixed positions for ordered recombination
instead of long homologous sequence stretches. Recombining a whole library this way gives
access to new combinations every time (figure kindly provided by Prof. John Collins, Technical
University Braunschweig, Germany).
One can also use Cosmix Plexing to recombine the DNA sequences of preselected clones
from an early step in a screening (say, after 1–2 rounds of panning), thus recombining
sequences that have already shown to be successfully enriched during the panning (Fig-
ure 12a). The method can also be used to “backcross” enriched clones with a library to
increase the variety in defined cassettes, while keeping the enriched sequences of the re-
maining cassettes (Figure 12b). This way, it is possible to screen the library for sequences
that are synergistic to the sequences in the kept cassettes. It can also be analyzed which
cassette(s) of an enriched peptide are contributing most to enrichment by replacing either
one or another sequence part. The Cosmix Plexing method will be explained in further
detail in section 3.2.2.5.
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(a)
(b)
Figure 12: Further recombination possibilities offered by Cosmix Plexing:(a) Prese-
lected sequences (blue, red, green, orange) can be recombined between each other to assemble
new alternative variants. Recombination of sequences which have already been selected due to
e.g. weak to medium affinities should offer a good probability of yielding sequences which pos-
sess even higher affinities to the selection target. (b) Preselected sequences (blue, red, green,
orange) can be recombined with a whole library (yellow). Screening the obtained new library
allows to evaluate the impact that the preselected cassette sequences have on affinity; it also
allows to screen the recombination library (yellow) for motifs that have synergistic effects to the
preselected motifs.
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1.5 Aim of the work
Libraries utilizing phage display have been used for twenty years now; phage display
libraries presenting peptides have been largely abandoned for other purposes than initial
screenings. This is due to the fact that most will have an intrinsically low affinity to
other small target ligands, but can be bind strongly to larger molecules having specific
binding pockets (including antibodies). Their size however, in general limits potential
interaction surface and the formation of secondary structures. Recent experiments show
that library diversity increases probabilities of isolating high affinity ligands, which calls
for structural diversity as well and is usually not obtained from short peptide libraries.
The advantages of peptide libraries include the easier chemical synthesis of interesting
candidates and thus the possibility to generate peptides from D-amino acids (after a
panning of L-peptides on a synthetic D-amino acid target molecule). The latter offers
the chance of increased stability against proteolytic degradation and has already been
used in the development of a gp41-targeting D-peptide (Eckert et al., 1999) and for
identification of a cyclic D-peptide that interacts with cSRC SH3 domain (Schumacher
et al., 1996).
The smaller size of peptides compared to antibodies makes direct application in cell
penetration or generally as leads for research easier as well.
Mature protein domains that fold into stable secondary and tertiary structures have
been found to consist of about 50–55 amino acids in average (Cunningham and Wells,
1997; Fung et al., 2008). There are also protein domains of smaller size, as the zinc
finger domains (25–30 aa — Berg, 1988) or even the Trp-cage structure of 20 aa size
(Neidigh et al., 2002, 2001). As a compromise between peptide length and the potential
for secondary structures, the decision was made to use a polypeptide of 33 aa length (+
linker) in our library.
Recombination should allow for increase of diversity at every time of work with the
library — at first in the beginning to increase the diversity of the primary library that
is screened, or secondly later in the screening process where one could recombine clones
that have been enriched due to their affinity to the target or just recombine high affinity
clones with the primary library to vary/modify them.
The potential for recombination is vital to access the potential complexity of a peptide
library of this length by backcrossing with either the primary library or a sublibrary of
choice, and it offers also a tool for evolution or epitope screening of enriched candidates.
The recombination uses the technique of Cosmix Plexing (see section 1.4.2) to allow
for ordered recombination. This reduces the amount of out-of-frame products which are
a major disadvantage encountered using other recombination methods.
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In this thesis the following steps are described which were used in building and evalu-
ating the library:
• library design
• synthesis and cloning of the library, including composition analysis on DNA level
and recombination functionality
• evaluation of peptide display
• evaluation of the library on different targets
The results are interpreted at each step. This is followed by a recapitulation of the
whole work and major conclusions drawn with reference to the initial expectations and
actual performance of this novel Cosmix Plexing technology in the Conclusions chapter.
Finally projections are made as to how the project could be extended towards drug
development.
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2.1 Materials
2.1.1 Chemicals
If not mentioned otherwise, all chemicals used in the context of this thesis were of ana-
lytical quality. Aqueous solutions were prepared with double deionized (Milli Q) water.
2.1.2 Software
Graphical and annotation work with plasmids was done using the program pDRAW32
V1.1.97. Analysis of sequencing data was done with Chromas Lite V2.01, alignment and
sequence editing work was done with BioEdit v7.0.9.
This thesis was written in and typeset with LATEX2ε, from the MikTex 2.7 distribution
(www.miktex.org), using the editor WinEdt.
2.1.3 Bacteria, bacteriophages and plasmids
2.1.3.1 Bacteria
The following strains were used in the work for this thesis:
• Escherichia coli Top10F’ (Invitrogen) (Top10F’)
genotype: F´{lacIq, Tn10(TetR)} mcrA ∆(mrr -hsdRMS-mcrBC) φ80lacZ ∆M15
∆lacX74 recA1 araD139 ∆(ara leu)7697 galU galK rpsL (StrR) endA1 nupG
• Top10F’λ (λ lysogen Top10F’ strain) kindly provided by Prof. John Collins, Tech-
nical University Braunschweig, Germany
2.1.3.2 Bacteriophages
• Helper-phage M13K07 (New England Biolabs)
2.1.3.3 Plasmids
• Phagemid vector pROCOS4/7, constructed by Peter Röttgen, kindly provided by
Cosmix GmbH, Braunschweig, Germany
28
2 Materials and Methods
2.1.4 Media and antibiotics for cultivation of bacteria
The following media and antibiotics were used for the cultivation of bacteria, :
2×YT medium (2YT)
Tryptone 16.0 g
Yeast extract 5.0 g
NaCl 5.0 g
Agar (for solid medium only) 20.0 g
ddH2O fill up to 1000mL
adjust pH to 7.0 if necessary, then autoclave
M9 salt solution (10×)
Na2HPO4*2H2O 74.1 g
KH2PO4 30 g
NaCl 5.0 g
NH4Cl 10.0 g
Agar (for solid medium only) 20.0 g
ddH2O fill up to 1000mL
autoclave
M9 minimal medium
M9 salt solution (10×) 100mL
Glucose (40% w/v) 12.5mL
CaCl (1M) 100µl
MgSO4 (1M) 1mL
FeCl3 (1mM) 0.5mL
Thiamin (10mg/mL) 100µl
ddH2O fill up to 1000mL
The used solutions were autoclaved separately or
filtered (0.2µm) for sterilization (Thiamin).
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Antibiotics
Ampicillin stock solution (50mg/mL)
Ampicillin (sodium salt) 2.5 g
Ethanol (70% in ddH2O ) 50mL
The final concentration in either liquid or solid medium
to select for ampicillin resistance was 100 µg/mL.
Tetracycline stock solution (12.5mg/mL)
Tetracycline 0.625 g
Ethanol (70% in ddH2O ) 50mL
The final concentration to select for tetracycline
resistance in liquid medium was 10 µg/mL and
12.5 µg/mL in solid medium.
Kanamycin stock solution (50mg/mL)
Kanamycin 2.5 g
ddH2O 50mL
The solution was filtered (0.2µm) for sterilization
The final concentration in either liquid or solid medium
to select for kanamycin resistance was 30 µg/mL.
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2.1.5 Oligonucleotides
2.1.5.1 Oligonucleotides for library generation (section 3.2.2.2)
CPL19YS-2 BAS (132 bp):
5’- TTA CAT AGA GCT CGG ACG GCN TNH TNH TNH TNT SNV TNV TNV TNV
TTM CNH TNH TNY TCA TTG CNH TNH TNH THM YNV TNV TNV TNC CNH
TNH TNH TNH TNH CTC CAG CCC AGG TAC CCC GGA TAT CAT GGC -3’
JCOSTART3B-3 (18 bp):
5’-GCC ATG ATA TCC GGG GTA -3’
2.1.5.2 Primers used for mutagenesis PCR (section 3.2.1.1)
For the removal of the BceAI recognition site at pos. 489 of pROCOS4/7:
BCE-FX-1 (forward, 33 bp):
5’- CCC TCT CGA TGG CAC TTA TCC GCC TGG TAC TGA -3’
BCE-X-1 (reverse, 38 bp):
5’- GGC GGA TAA GTG CCA TCG AGA GGG TTG ATA TAA GTA TA -3’
For the removal of the BceAI recognition site at pos. 1906 of pROCOS4/7:
BCE-FX-2 (forward, 22 bp):
5’- GTG CTT TAC GAC ACC TCG ACC C -3’
BCE-X-2 (reverse, 26 bp):
5’- CGA GGT GTC GTA AAG CAC TAA ATC GG -3’
For the removal of the BceAI recognition site at pos. 2758 of pROCOS4/7:
BCE-FX-3 (forward, 28 bp):
5’- GGC CTA ACT ACG ACT ACA CTA GAA GGA C -3’
BCE-X-3 (reverse, 27 bp):
5’- GTG TAG TCG TAG TTA GGC CAC CAC TTC -3’
For the removal of the BceAI recognition site at pos. 4075 of pROCOS4/7:
BCE-FX-4 (forward, 30 bp):
5’- GGC AGC AGT GAC GTC GAT AGT ATG CAA TTG -3’
BCE-X-4 (reverse, 30 bp):
5’- CTA TCG ACG TCA CTG CTG CCA GAT AAC ACC -3’
For the removal of the BsrDI recognition site at pos. 3210 of pROCOS4/7:
ABSRD-1FX (forward, 22 bp):
5’- GGC CCC AGT GCT GCG ATG ATA C -3’
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ABSRD-1 (reverse, 22 bp):
5’- CTC GCG GTA TCA TCG CAG CAC T -3’
For the removal of the BsrDI recognition site at pos. 3384 of pROCOS4/7:
ABSRD-2F (forward, 29 bp):
5’- GTT GCC ATA GCT GCA GGC ATC GTG GTG TC -3’
ABSRD-2Z (reverse, 23 bp):
5’- TGC CTG CAG CTA TGG CAA CAA CG -3’
For the removal of the BsrDI recognition site at pos. 4012 of pROCOS4/7:
ABSRD-3FX (forward, 28 bp):
5’- TTT ATC TTG TGC AAC GTA ACA TCA GAG A -3’
ABSRD-3X (reverse, 27 bp):
5’- CTG ATG TTA CGT TGC ACA AGA TAA AAA -3’
For the removal of the BsrDI recognition site at pos. 4109 of pROCOS4/7:
BSRDCURE-F (forward, 40 bp):
5’- GTC GAT AGT ATG CAA TTG ATA ATT ATT ATC ATT TGC GGG T -3’
BSRDCURE-R2 (reverse, 38 bp):
5’- CAA ATG ATA ATA ATT ATC AAT TGC ATA CTA TCG ACG TC -3’
2.1.5.3 Primers used for sequencing of the library insert in pEPO8
JCOFSQ (binding at pos. of 4634 of pEPO8,forward, 20 bp):
5’- TTC TAC AAC TTG CTT GGA TT -3’
JCORSQ (binding at pos. of 237 of pEPO8,reverse, 20 bp):
5’- TCC AGA CGT TAG TAA ATG AA -3’
2.1.5.4 Primers used for detection of λ prophage integration into the E. coli
genome (section 2.2.2.4)
Primer Lambda1 (forward, 22 bp):
5’- GAG GTA GCA GCG CGG TTT GAT C -3’
Primer Lambda2 (reverse, 18 bp):
5’- ACT CGT CGC GAA CCG CMC- -3’
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2.1.5.5 Various primers used for plasmid sequencing and PCR synthesis of DNA
fragments for PCR mutagenesis
ABPUE3-1 (binding at pos. 540 of pROCOS4/7 - forward, 24 bp):
5’- AAT CCT TCT CTT GAA GAG TCT CAG -3’
ABPUE3-2 (binding at pos. 631 of pROCOS4/7 - forward, 26 bp):
5’- TAC GGG CAC TGT TAC GCA AGG CAC TG -3’
ABPUE3-3 (binding at pos. 1145 of pROCOS4/7 - forward, 24 bp):
5’- TTC CCA AAT GGC CCA AGT CGG TGA -3’
ABPUE4 (binding at pos. 2375 of pROCOS4/7 - forward, 27 bp):
5’- ACA AAA ATC GAC GCV CAA GTC AGA GGT -3’
ABPUE5 (binding at pos. 2640 of pROCOS4/7 - forward, 25 bp):
5’- ACT ATC GTC TTA AGT CCA ACC CGG T -3’
ABPUE7 (binding at pos. 3763 of pROCOS4/7 - reverse, 23 bp):
5’- GCG GTA AGA TCC TCG AGA GTT TT -3’
BPUE-66 (binding at pos. 2885 of pROCOS4/7 - reverse, 36 bp):
5’- GAT CAA AGG ATC TTC TTG GGA TCC TTT TTT TCT GCG -3’
XMN1171FOR (binding at pos. 1190 of pROCOS4/7 - forward, 32 bp):
5’- CCT TTA ATG AAT AAT TTC CGT CAA TAT TTA CC -3’
NEW1170RVP (binding at pos. 1159 of pROCOS4/7 - reverse, 24 bp):
5’- TTG ACG GAA ATT ATT CAT TAA AGG -3’
SEQ3606 (binding at pos. 3628 of pROCOS4/7 - forward, 23 bp):
5’- GAT GCT TTT CTG TGA CTG GTG AG -3’
RSEQ4306 (binding at pos. 4285 of pROCOS4/7 - reverse, 22 bp):
5’- GGC CAA AAA GCT CGC TTT CAG C -3’
F133 (binding at pos. 151 of pROCOS4/7 - forward, 19 bp):
5’- CCC GGG TAC CCC GAT ATC A -3’
R1084 (binding at pos. 1064 of pROCOS4/7 - reverse, 21 bp):
5’- TAG CAA GGC CGG AAA CGT CAC -3’
33
2 Materials and Methods
F1335 (binding at pos. 1358 of pROCOS4/7 - forward, 24 bp):
5’- TTC TAC GTT TGC TAA CAT ACT GCG -3’
R1986 (binding at pos. 1967 of pROCOS4/7 - reverse, 20 bp):
5’- GGA CTC CAA CGT CAA AGG GC -3’
F2548 (binding at pos. 2565 of pROCOS4/7 - forward, 18 bp):
5’- CGT TCG CTC CAA GCT GGG -3’
R3398 (binding at pos. 3380 of pROCOS4/7 - reverse, 19 bp):
5’- TGC CTG CAG CAA TGG CAA C -3’
F4027 (binding at pos. 4046 of pROCOS4/7 - forward, 20 bp):
5’- GAG ACA CAA CAG ATC TGG CC -3’
R4648 (binding at pos. 4626 of pROCOS4/7 - reverse, 23 bp):
5’- TCT AGA CCT CCT TGG TCG ACT TC -3’
2.1.6 Common buffers and solutions
Phosphate buffered saline (PBS), 10× stock
KCl 2 g
KH2PO4 2.4 g
Na2HPO4 × 2H2O 14.4 g
NaCl 80 g
ddH2O fill up to 1000mL
adjust pH to 7.4 if necessary
(using either HCl or NaOH), then autoclave.
Dilute with sterile distilled water to 1× to use.
PEG/NaCl (16,7%/3M)
PEG 8000 167 g
NaCl 0.2 g
ddH2O fill up to 1000mL
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2.2 Methods
2.2.1 Work with bacteria
2.2.1.1 Cultivation of bacteria
For liquid culture, E. coli cells were cultivated in baﬄed Erlenmeyer flasks filled up to
1/4th of the nominal volume with 2YT medium. When required, respective antibiotics
were added. Incubation was done at 37 ○C under shaking (160 rpm).
For cultivation on agar plates E. coli cells were grown on 2YT agar, containing appro-
priate antibiotics. Incubation was done at 37 ○C.
2.2.1.2 Preparation of electrocompetent cells
The preparation of electrocompetent E. coli cells is following the protocol of Dower et al.
(1988).
Bacteria from the strain to be made competent were streaked out on M9 minimal agar
plates with appropriate antibiotics. A single colony was picked as inoculatum for an
overnight culture in 2YT medium with selective antibiotics.
With 10mL from this overnight culture, 1 L of prewarmed (37 ○C) 2YT medium (with
strain specific antibiotics) was inoculated and grown at 37 ○C, 160 rpm, until an OD600
of 0,4–0,6 was reached. The flasks were finally cooled on crushed ice directly for 15min.
The cell suspension was centrifuged using a pre-cooled GS3 rotor at 4,000× g for 15min.
After careful decanting of the supernatant, the cells were resuspended in 1L of precooled
ddH2O (0 ○C), and recentrifuged using GS3 rotor centrifuge tubes at 4,000× g for 15min.
The supernatant was decanted again and the cell pellet suspended in 500mL of precooled
ddH2O (0 ○C). This was followed by another centrifugation step (GS3 rotor, 4,000× g,
15min). The cell pellet remaining after decanting the supernatant was taken up in
20mL of pre-cooled 10% glycerol (0 ○C) and then spun down in SS34 centrifuge tubes
(precooled SS34 rotor, 4,000× g, 15min). After carefully discarding the supernatant, the
pellet was suspended in 2mL of pre-cooled 10% glycerol, aliquoted in 50µL aliquots and
then deepfrozen in liquid nitrogen, followed by storage at -70 ○C.
2.2.1.3 Storage of bacteria
For short term storage of up to two weeks, bacteria were stored on agar plates sealed
with parafilm at 4–8 ○C.
For longer term storage, 1mL of bacterial cells (either from a fresh overnight culture
or a cultivation up to a OD600 of 0.5–1) were mixed with 0.5mL of sterile 87% glycerol,
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deep frozen in liquid nitrogen and then stored at -70 ○C. Under those conditions, strains
could be stored almost indefinitely.
2.2.2 Work with DNA
2.2.2.1 Isolation of plasmid DNA
For the isolation of plasmid DNA, preparational kits from Qiagen were used, either
QIAprep Spin Miniprep Kit for small-scale preparations (1–5µg plasmid DNA from 1–
2mL overnight cultures in 2YT medium), or QIAGEN Plasmid Maxi Kit for larger-scale
preparations (>50µg plasmid DNA from 50–200mL overnight cultures in 2YT medium).
The plasmid DNA isolation was performed according to the manufacturer’s instructions.
2.2.2.2 Determination of DNA concentration
DNA concentration was determined by measuring the absorption of monochromatic light
of a wavelength of 260 nm (A260) in Hellma quartz glass cuvettes.
Background absorption was measured in a quartz cuvette filled with either ddH2O or
an appropriate buffer. DNA was then added to the solution used as background and the
absorption was measured. The DNA concentration was calculated by multiplying the
absorption with the dilution factor and the factor 50 ng/µL.
DNA concentration[ng/µL] = A260 × dilution factor × 50ng/µL.
2.2.2.3 Polymerase Chain Reaction (PCR)
The PCR method was used to amplify DNA fragments and insert mutations by using
selected oligonucleotides as primers. For the reactions, the Phusion PCR kit (Finnzymes,
Finland) was used, using a high-fidelity DNA polymerase. The thermocycler used was a
Primus Thermocycler Evolution 96 (Clemens GmbH, Germany).
If not mentioned otherwise, the following PCR reaction mix and protocol were used.
The amount of DNA template used for the reaction was always «100 ng of DNA. For a
negative control, 1µL ddH2O was added instead of the template DNA.
2.2.2.4 Detection of phage λ prophage integration into the E. coli genome
The Top 10F’λ strain was provided with the phage Lambda already integrated into the
bacterial genome (lysogenic state). This integration was only assumed, though, so an
insertion into the genome had to be proven before further work (the test was also used
later on to check and differentiate between Top 10F’ and Top 10F’λ strains).
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PCR reaction mix
Phusion HF 5×buffer 10µL
Forward primer (10µM) 2µL
Reverse primer (10µM) 2µL
dNTP solution (2mM each) 2µl
DNA template 1µl
Phusion polymerase 0.5µl
ddH2O 32.5µl
Final volume 50 µl
PCR program
Step Temperature Duration
pre-denaturation 98 ○C 2:00min
denaturation 98 ○C 1:00min
annealing primer dependent 0:40min
elongation 72 ○C 1:00min
postelongation 72 ○C 3:00min
The steps “denaturation” to “elongation” were repeated as
cycles, dependent on the reaction yield, between 10 and 25 times.
In order to integrate into the bacterial genome to reach the lysogenic state, phage
Lambda encodes an integrase enzyme that mediates recombination between a short se-
quence of phage DNA (see Groth and Calos, 2004), the phage attachment site, attP, and
a short sequence of bacterial DNA, the bacterial attachment site, attB. An integrated
phage is flanked by two hybrid sites, attL and attR, each consisting of half attP sequence
and half attB sequence (Figure 13).
The integration of lambda DNA can be detected by using PCR primers that are specific
to the DNA sequence left of the E. coli attB site (Lambda1) and to the Lambda phage int
gene right to the attB site after integration (Lambda2); this is illustrated in Figure 14.
A PCR reaction utilizing those primers will only give a PCR amplicon when the
prophage is integrated. The expected product size (calculated from the two genome
sequences, E. coli and phage Lambda) is 501 bp, so presence of this band after gel elec-
trophoresis of a PCR reaction using genomic E. coli DNA as template could be seen as
confirmation of Lambda prophage integration, absence of the band meant no Lambda
prophage integration.
The PCR reaction was performed at an annealing temperature of 58 ○C for 15 cycles.
As DNA template, some bacterial cell material was used, diluted in water and boiled at
100 ○C for 5minutes. From this solution, 1µL was used for a 50µL PCR reaction.
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Primer Lambda1 (forward, 22 bp):
5’- GAG GTA GCA GCG CGG TTT GAT C -3’
Primer Lambda2 (reverse, 18 bp):
5’- ACT CGT CGC GAA CCG CMC- -3’
Figure 13: Phage genome integration/excision. The bold circle represents the phage
genome, with the phage attachment site attP. The larger circle represents the bacterial genome,
with the bacterial attachment site attB. In order to enter the lysogenic state, the integration
reaction proceeds, resulting in the phage genome integrated into the bacterial chromosome,
flanked by two hybrid att sites, attL and attR. Once the phage becomes lytic again, the reverse
reaction occurs. The phage genome is excised from the bacterial chromosome, resulting in a
phage genome with attP and a bacterial genome with attB(from Groth and Calos, 2004).
Figure 14: Detection of lambda prophage integration by PCR. The diagram shows
the different att sites occurring in the genome of a λ nonlysogen E. coli (top) and λ lysogenic
E. coli (bottom). Lines depict bacterial DNA (solid) and lambda DNA (hatched), with att sites
represented by boxes. The respective locations and orientations for hybridization of PCR primers
numbered 1 (primer Lambda1) and 2 (primer Lambda2) are indicated by arrow heads above and
below the DNA lines. The fragment size of 501 bp produced by productive priming is noted in
case of λ prophage integrated into the bacterial genome (from Powell et al., 1994).
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2.2.2.5 DNA agarose gel electrophoresis
For the DNA separation in agarose gels, gel chambers from Biometra (Germany) were
used — the Horizon 58 model for analytical, the Horizon 11.14 model for preparative
gels. As running buffers, TAE and TBE were used. TAE was used for analytical and
preparative gel runs, while TBE was only used for the high resolution separation of very
small DNA fragments (below 150 bp).
The agarose gels (concentrations 0.8%–3% agarose w/v) were prepared by dissolving
standard agarose (Agarose GTQ, Carl Roth, Germany) in the appropriate buffer by
heating. After cooling to about 50 ○C the gel was cast in the gel running chamber that
contained pocket forming combs.
The DNA loading buffer used was 6X DNA Loading Dye from Fermentas, Canada,
DNA markers used were GeneRuler DNA ladders of different fragment sizes obtained
from Fermentas, Canada.
DNA agarose gels were run at voltages between 60V and 150V, depending on gel
chamber system and experimental factors. The power supply used was a PowerPack P25
(Biometra, Germany).
Staining of DNA in agarose gels after gel run was performed by mildly shaking the gel
in an ethidium-bromide solution (10mg/L) for 10min, then washing out background in
ddH2O for 5min.
The DNA was then detected using the Intas Gel Jet Imager gel documentation system
(Intas, Germany), based on UV illumination and a filter for a wavelength of 312 nm, a
digital video camera and computer image capturing.
TAE buffer 50×
Tris base 242 g
Acetic acid 57.1mL
0.5M EDTA 100mL
ddH2O fill up to 1000mL
dilute with ddH2O to get 1×
TBE buffer 50×
Tris base 54 g
Boric acid 27.5 g
0.5M EDTA, pH8.0 20mL
ddH2O fill up to 1000mL
dilute with ddH2O to get 1×
2.2.2.6 DNA polyacrylamide gel electrophoresis — (PAGE)
For the DNA separation of very small fragments (below 150 bp and resolution of length
differences below 5 bp) polyacrylamide gels were used (12% concentration). The gel
chamber used was the Mini Protean 3 system from Biorad, California. The running
buffer was TBE 1x, ladders and sample buffers used were the same as for agarose elec-
trophoresis (see section 2.2.2.5).
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The ingredients for the acrylamide gel were mixed in a small beaker with a magnetic
stirrer. Immediately before casting the gel, APS and TEMED were added and mixed
thoroughly for 20 seconds. After casting the gel between the glass plates, the gel was
allowed to settle for >1 hour at room temperature.
Prepared gels could be kept between the glass plates, covered in foil, overnight in the
refrigerator before running them the next day.
The gel separation was performed at a voltage of ∼18V/cm. Staining and detection
was the same as with agarose electrophoresis.
12% acrylamide gel
for DNA electrophoresis
acrylamide solution 40%, 4,5mL
19:1 acrylamide:bis-acrylamide
TBE 5× 3mL
ddH2O 7,5mL
immediately before casting,
add 95µl 10% APS and 9.5µl TEMED
2.2.2.7 DNA gel extraction from agarose gels
DNA Bands of interest were cut out from the agarose gels in non-symmetric shapes (only
gels run with TAE buffer, not TBE). Only flanking DNA bands had been stained with
ethidium bromide so that the bands of interest were never in contact with ethidium
bromide which could cause reduced efficiencies in further working steps.
The DNA was then extracted using the Nucleospin Extract II kit from Macherey-
Nagel, Germany, according to the manufacturer’s instructions. The method is based on
denaturation of the agarose by a chaotropic salt (guanidine thiocyanate) and selective
binding of DNA to a silica membrane.
2.2.2.8 DNA restriction
For the enzymatic digestion of DNA, different enzymes from New England Biolabs, USA
were used. A reaction mix containing DNA solution, 1/10 of 10× corresponding NEB
buffer and an experimentally determined amount of restriction enzyme was set up. The
final volume was set as low as possible, depending on the volume of DNA solution, but not
lower than 20µl in order to avoid evaporation effects. The mixture was then incubated
at the optimum enzyme temperature.
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In case of digestions with more than one enzyme, the corresponding buffer was deter-
mined through enzyme buffer compatibility charts available from the manufacturer.
Each DNA restriction was verified by gel electrophoresis. Depending on further utiliza-
tion of the DNA, either gel extractions were performed to isolate the DNA fragments,
or a cleanup procedure was used to remove enzymes, salt and potentially small DNA
fragments (using Nucleospin Extract II kit from Macherey-Nagel, Germany).
2.2.2.9 DNA ligation
DNA fragments were ligated with the Quick Ligation Kit from New England Biolabs,
USA, following the manufacturer’s instructions. Volumes were kept as low as possible
in order to aim for final DNA concentrations of ∼10 ng/µl. Different Vector DNA and
insert DNA molar ratios were used to determine the optimal conditions (usually in the
range of ratios from 3:1 to 1:3).
In the course of this thesis, only DNA ligations with overhanging 5’ or 3’ ends were
done, and the 5’-ends were phosphorylated, the 3’-ends had hydroxyl groups. For those
ligations, the ligation time varied between 15min and 2 hr and the ligations were done
at 16 ○C.
After ligation, DNA was purified with the Nucleospin Extract II kit from Macherey-
Nagel, Germany to remove salts and PEG from the ligation kit and prepare the DNA
for electroporation.
2.2.2.10 Electroporation of DNA into E. coli cells
DNA used for electroporation of cells had to be prepared to avoid traces of salt in the
transformation mix, which could cause a short circuit during the transformation, with the
resulting heat destroying the cells. The Nucleospin Extract II kit from Macherey-Nagel,
Germany was used for that purpose.
40µl of electrocompetent cells were mixed with 1–3µl of DNA (various concentrations,
between 1 and 500 ng), all the time kept cool on ice. The mix was incubated for 1min.
Then the suspension was pipetted into an ice-cooled 2mm electroporation cuvette (Eu-
rogentec, Belgium) and electroporated in an Easyject electroporation device (EquiBio
Ltd., USA) , which uses the parameters of 2500V, 25µF and 200Ohm. “Successful”
electroporation (low deviation from the ideal pulse time of 5ms) was monitored by the
device and communicated by an acoustic signal.
Immediately after the electroporation, 1mL of prewarmed (37 ○C) SOC medium was
added to the cells, and the cell suspension was thereafter transferred into a sterile 15mL
conical tube. Cells were incubated at 37○C, 160 rpm shaking for 60min.
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This protocol follows the principles of Dower et al. (1988), who optimized parameters
for electroporation for a number of bacterial and eukaryotic cells.
In order to determine the number of transformants, dilution series were made and
plated out on antibiotic selective agar, while the rest of the cell suspension was plated
out on large selective antibiotic agar plates.
SOC medium
Tryptone 20.0 g
Yeast extract 5.0 g
NaCl 0.5 g
0.25M KCl 10mL
2M MgCl2 10mL
1M glucose 20mL
ddH2O fill up to 1000mL
adjust pH to 7.0 if necessary, then autoclave
2.2.2.11 Generation of a dsDNA fragment from a ssDNA oligonucleotide
While the oligo-primed complementary strand synthesis of ssDNA DNA and following
amplification by PCR is well known and established, in the course of this work any bias
by amplification (Iannolo et al., 1997) was undesired. Thus, only a fill-out reaction (from
ssDNA to dsDNA) was utilized. A combination of the heat-stable enzyme Phusion DNA
polymerase (as in the PCR reactions [see chapter 2.2.2.3], a DNA polymerase with 5’-3’
proof-reading activity) and T4 DNA polymerase (New England Biolabs) was used. The
reaction mix also contained the four nucleotide triphosphates.
The mix for the first step was prepared and the incubated at 98 ○C for 60 sec, 53 ○C for
4min and finally at 72 ○C for 1.5min. The DNA was then purified using the Nucleospin
Extract II kit from Macherey-Nagel, Germany, eluted in 50µl finally.
The purified DNA from the first step was then used in the second step to fill-out the
remaining single stranded “ends” that had shown not be completely filled up in the first
step alone. The ingredients were pipetted together and incubated at 12 ○C for 60min.
After another purification with the Nucleospin Extract II kit (for each 150µl, one column
of the kit was used) and elution in 2×50µl, the dsDNA DNA was prepared for validation
by gel electrophoresis (preferably PAGE, s. chapter 2.2.2.6).
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1st step dsDNA DNA fill-out
5×HF Phusion buffer 10µl
dNTP solution (2mM each) 2µl
50mM MgCl2 1µl
DMSO 1.5µl
Phusion polymerase 2µl
Template (10µM) 5µl
Primer (10µM) 15µl
H2O 13.5µl
2nd step dsDNA DNA fill-out
Elution 1st step 100µl
dNTP (2mM each) 20µl
NEB 10×restriction buffer “2” 30µl
T4 DNA polymerase 8µl
(=24 u)
H2O 142µl
2.2.2.12 DNA sequencing
In order to sequence plasmid DNA, 10mL test tubes were filled with 2mL 2YT (+
respective antibiotics for plasmid/cell type selection) and inoculated by using sterile
toothpicks that had been stabbed into isolated colonies. The test tubes were incubated
over night at 37 ○C, 200 rpm, next day a mini-prep plasmid isolation was done from those
cultures (s. chapter 2.2.2.1).
Alternatively, 96well deep-well plates filled with the same medium were used for culti-
vation later to allow for a higher throughput. Plasmid isolation was then kindly provided
by Tschong-Hun Im from the department Genome Analysis at the Helmholtz Centre for
Infection Research. The protocol and materials used there were similar to the ones used
in commercial kits like the “QIAprep 96 Turbo Miniprep Kit” (Qiagen).
The plasmid DNA was sequenced by the department Genome Analysis, using appro-
priate primers that were provided. The DNA sequence data was then provided in .abi
file format (Applied Biosystems sequencing data file).
2.2.3 Work with proteins
2.2.3.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
For the separation of proteins obtained from phage preparations, SDS poly-acrylamide
gel electrophoresis (SDS-PAGE) was performed.
The gel chamber system used was the Mini Protean 3 system (Biorad, California)
with glass plates creating 8 cm × 8 cm gels of 0.75mm thickness. The gel used was a
discontinuous SDS gel (Laemmli, 1970) consisting of a stacking gel and a separation gel.
The separation gel was cast first, until ca. 1.5 cm below the pocket forming comb.
It was overlayed with isopropanol and given 30min to solidify. The isopropanol was
removed then and the stacking gel poured into the glass cassette, sealing with the pocket
forming comb.
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Protein samples were precipitated with acetone before a gel run in order to remove
salt from the sample: 1 volume of acetone was added to the protein solution (here:
phage preparation, ∼5×1010 phage particles, also diluted, depending on experiment) in
an Eppendorf tube, mixed and cooled at -20 ○C for at least 1 hr. The sample was then
centrifuged in a lab centrifuge for 15min at 13.000 rpm, the supernatant removed and
the pellet suspended in a 1:4 mixture of 5×protein sample buffer and ddH2O .
The proteins in sample buffer were heated to 95 ○C for 5min in order to denature the
proteins and loaded into the gel pockets after a short cooldown. The molecular weight
standard used was PageRuler Prestained Protein Ladder (Fermentas, Canada).
The gel was run at constant 10mA until the bromophenol-blue dye front reached
the top of the separating gel, then the current was changed to a constant 20mA until
sufficient separation was achieved.
Separation gel (10%)
acrylamide solution 40%, 2.5mL
19:1 acrylamide:bis-
acrylamide
1M Tris-HCl pH8.8 2.5mL
10% SDS 0.1mL
ddH2O 4.8mL
right before casting, add
80µl 10% APS and 8µl TEMED
Stacking gel (4.5%)
acrylamide solution 40%, 550µL
19:1 acrylamide:bis-
acrylamide
1M Tris-HCl pH6.8 625µL
10% SDS 50µL
ddH2O 3.75mL
right before casting, add
40µl 10% APS and 4µl TEMED
Gel buffer 5 ×
Tris base 15 g
Glycine 72 g
SDS 5 g
ddH2O fill up to 1000mL
Protein sample buffer 5 ×
1M Tris-HCl pH6.8 0.5mL
Glycerol 1.6mL
10% SDS 1.6mL
Bromophenol-blue 400µL
solution 0.05% (w/v)
β-mercaptoethanol 400µL
ddH2O 5.5mL
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2.2.3.2 Western blotting
For western blot protein transfer, the Mini Trans-Blot system (Biorad, California) was
used. It is made for the electro-transfer of proteins from the 8 cm × 8 cm gels used in the
Mini Protean 3 system (s. section 2.2.3.1).
A sandwich was prepared, starting with a fiber pad, then a layer of Whatman 3mm
paper (Whatman, England), followed by a nitrocellulose membrane (Invitrogen) and the
acrylamide gel. The next layer was Whatman 3mm paper and another fiber pad. The
whole sandwich was soaked in blotting buffer, and potential bubbles were pressed out to
the sides. The sandwich was put into the blotting cassette which was then inserted into
the blotting chamber, then the chamber was filled with 1× blotting buffer.
The electro-transfer was performed for 1 hr at a constant current of 200mA.
After the transfer, the membrane was rinsed with water, then fixed (and temporary
stained) with a solution of 0.2% Ponceau red in 3% TCA (Trichloroacetic acid). A
photo of the temporary staining could be taken, then the Ponceau red was washed out
thoroughly with water first, then PBS. After those steps, the membrane could be used
for an immunostaining with specific enzyme coupled antibodies.
Blotting buffer 10×
Tris base 30.3 g
Glycine 144 g
ddH2O fill up to 1000mL
for 1×blotting buffer, mix 100mL
10×blotting buffer with 50mL
methanol and 850mL ddH2O
2.2.3.3 Immunological detection of proteins on Western blots
The nitrocellulose membrane with the blotted proteins was blocked with blocking solution
for at least 2 h or over night. The blocking was followed by an incubation with an
appropriately diluted primary antibody (in blocking solution) for the detection of the
proteins of interest for 1.5 h. The membrane was washed three times for five minutes
each with T-PBS, then incubated with an appropriate horseradish peroxidase labeled
secondary antibody (diluted in T-PBS) for 1.5 h. The membrane was washed then three
times for five minutes with T-PBS, then three times with distilled water.
For the detection of the bound antibodies, the membrane was dried for a short time
by putting its edge onto a tissue paper. The membrane was put into a 50mL tube, then
the freshly prepared ECL solution was added. The tube was slowly rotated for 1min,
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then the membrane was taken out and dried shortly again. The blot was put between
two sheets of plastic foil and put into a closed cassette.
In a darkroom a sensitive film was exposed to the chemiluminescence emitted by the
reaction and then developed and fixed to get an image.
Blocking solution
Skimmed milk powder 10.0 g
PBS buffer fill up to 200mL
T(0.02%)-PBS
Tween-20 100µl
PBS buffer 500mL
ECL solution
1.5M Tris ph 8.8 333µl
p-Coumaric acid 11µl
Luminol (Fluka 09253 ) 25µl
H2O2 1.5µl
2.2.4 Preparation and handling of bacteriophages
2.2.4.1 Preparation of M13K07 helper-phage stock
A fresh overnight culture in 2YT was inoculated from a single Top 10F’ colony grown
on M9 minimal agar. This overnight culture was used to inoculate a 20mL 2YT culture
which was grown at 37 ○C, 160 rpm up to an OD600 of 0.5. The temperature of 37 ○C is
crucial for the induction of F-pili formation in the cells (Novotny and Lavin, 1971); these
pili are necessary for an efficient infection of the E. coli cells by the filamentous phage
M13.
500µl of that culture were infected with 1µl of several dilutions of M13K07 bacterio-
phage (1×1011 pfu, New England Biolabs, USA) and incubated at 37 ○C for 15min.
3mL of premelted 2YT Top Agar (as 2YT agar, just 0.6% agar, premelted and kept
at 50 ○C) were added to each 501µl of cells, mixed briefly and then immediately poured
onto a 2YT agar plate (containing tetracycline).
After hardening of the Top Agar, the plates were incubated overnight at 37 ○C.
From a plate that showed easily distinguishable, yet separate phage plaques, a single
plaque was picked using a sterile plastic pipette tip stabbing through the agar. Note:
Very small or very large plaques were avoided in order not to pick phages that might
have developed mutations.
This piece of agar was used to inoculate 20mL 2YT (containing tetracycline and
kanamycin) and grown for 6 h at 37 ○C, 160 rpm. From this culture, 1 L 2YT (containing
tetracycline and kanamycin) was inoculated and grown overnight at 37 ○C, 160 rpm.
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Next day, the cells were centrifuged (15min at 8000 rpm, 4 ○C, GS3 rotor). The super-
natant was carefully decanted and centrifuged a second time in order to remove remaining
bacterial cells. The supernatant was then mixed with 0.15 volume of PEG/NaCl and put
on ice for at least 2 h. The phage were precipitated by centrifugation (90min, 8000 rpm,
4 ○C, GS3 rotor). The supernatant was decanted and remaining liquid removed after a
second short centrifugation (5min, 8000 rpm, 4 ○C, GS3 rotor).
The pellet was taken up in 10mL PBS and cleared by 15min centrifugation at 11000×g
in a lab centrifuge. NaN3 was added to the supernatant to a final concentration of 0.02%
NaN3.
The phage titer had to be determined, it was usually in the range of 1–5×1012.
2.2.4.2 Determination of bacteriophage titers
To determine bacteriophage titers, a 20mL culture (2YT, tetracycline) was inoculated
with 200µl of Top 10F’ overnight culture and grown at 37 ○C, 160 rpm until an OD600 of
0.5 was reached.
The phage solution to be titered was diluted in PBS (100-1010-fold), and 100µl of each
dilution were mixed with 100µl of the growing culture in a well on a microtiter plate.
The plate was incubated at 37 ○C for 60min, then 20µl from each sample were spotted
on 2YT agar plates containing appropriate antibiotics (tetracycline and kanamycin to
determine M13K07 titers, tetracycline and ampicillin to determine phagemid titers).
The agar plates were incubated overnight at 37 ○C, then the colonies in each spot were
counted and multiplied with the respective dilution factors in order to calculate the cfu.
2.2.4.3 Packaging of phagemid DNA libraries into bacteriophage particles
After DNA modification work on the library, either during the creation of the library or
after modifications of the library later on, a large number of competent Top 10F’λ cells
were transformed with the phagemid DNA by electroporation (see section 2.2.2.10)
After electroporation, the cells resuspended in 1mL SOC medium were plated out
on 2YT agar plates (containing tetracycline and ampicillin) to harvest the phagemid
clones. 10mL 2YT medium (containing tetracycline and ampicillin) was pipetted onto
every plate, then the plates were left resting for 30min. The cells were scraped off from
he plates using a Drigalski spatula, mixing them thoroughly in this process, then 3mL
from each plate of the same transformation experiment was pipetted into a 50mL tube.
The cell suspension in the tube was mixed by inverting the tube several times, and
2.5mL were uses to inoculate 250mL 2YT medium (containing tetracycline and ampi-
cillin). From the rest of the cell suspension, several glycerol stocks were prepared by
mixing 1mL of cell suspension with 0.5mL of sterile glycerol.
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The 250mL culture was grown at 37 ○C, 160 rpm until an OD600 of 0.5 was reached.
2.5×1011 cfu of M13K07 were added to the culture, then the culture was incubated
at 37 ○C for 30min without agitation to allow for the phage to infect the cells after
regeneration of F’ pili on the cells. The culture was then grown for six more hours at
37 ○C, 160 rpm.
The cells were centrifuged (15min at 8000 rpm, 4 ○C, GS3 rotor). The supernatant was
carefully decanted and centrifuged a second time in order to remove remaining bacterial
cells. The supernatant was then mixed with 0.15 volume of PEG/NaCl and put on ice
for at least 1 h. The phage were precipitated by centrifugation (90min, 8000 rpm, 4 ○C,
GS3 rotor). The supernatant was decanted and remaining liquid removed after a second
short centrifugation (5min, 8000 rpm, 4 ○C, GS3 rotor).
The pellet was taken up in 2mL PBS and cleared by 15min centrifugation at 13000 rpm
in a bench top centrifuge. NaN3 was added to the supernatant to a final concentration
of 0.02%.
The helper phage as well as the phagemid titer was determined by cfu dilution plating
with Top 10F’ λ cells (see section 2.2.4.2).
Cells obtained from individual electroporations were initially kept separately. Pooling
was only carried out after appropriate quality control checks.
2.2.5 Affinity selection from phagemid libraries
2.2.5.1 Panning procedure
A standard protocols was used to enrich candidate clones with a specific affinity to an
immobilized target from a (sub-)library of phagemid particles.
The target was immobilized and incubated with the phagemid library. This was fol-
lowed by washing steps to remove unspecific binding, and afterwards bound phagemid
particles were eluted. Those remaining phagemid particles were used to reinfect Top 10F‘
or Top 10F‘λ cells, which, after superinfection with M13K07 helper-phage, produced new
phage that could be subjected to another round of panning.
Affinity selections were performed either in reaction tubes containing magnetic beads
that bind the target, or on microtiter plates where the target is adsorbed to the specially
treated surface of the microtiter wells.
For immobilization on magnetic beads, protein A dynabeads (Dynabeads Protein A,
Invitrogen, California) or streptavidin dynabeads (Dynabeads M-280 Streptavidin, In-
vitrogen, California) were used. The protein A, which is covalently bound on the bead
surface, allows the immobilization of antibody Fc fragments of many different IgG anti-
bodies, while the streptavidin allows immobilization of biotinylated molecules. The beads
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present a considerably larger surface area than the wells of microtiter plates, which are
often used in similar experiments. When the beads should be held back from a solution,
the reaction tube was put into a magnetic stand (Dynal MPC, Invitrogen).
In order to prepare protein A beads for a panning experiment, the following procedure
was used: 40µl of Dynabeads suspension per 5µg of IgG antibody/IgG antibody fusion
protein to be immobilized were pipetted into a reaction tube. After putting the tube into
the magnetic rack, the supernatant was removed. The beads were washed twice with a
500µl 0.1M Na-phosphate pH8. The supernatant was discarded every time.
The washed beads were resuspended in a volume of 0.1M Na-phosphate pH8 so that
together with the target protein solution the original volume of the Dynabeads was
reached. The target protein solution was then added (between 1 and 50µg of target).
The tube was incubated at RT for 30min under continuous slow inversion to avoid settling
of the beads. After this capturing process, the tube was put into the magnetic rack and
the supernatant was removed. The beads were then resuspended and washed with a
volume of 500µl 0.1M Na-phosphate pH8 three times.
Using streptavidin beads for a panning experiment, the following procedure was used:
100µl of Dynabeads suspension per 5µg of biotinylated IgG antibody fusion protein
to be immobilized were pipetted into a reaction tube. After putting the tube into the
magnetic rack, the supernatant was removed. The beads were washed twice with a 500µl
PBS. The supernatant was discarded every time.
The washed beads were resuspended in a volume of PBS so that together with the
target protein solution the original volume of the Dynabeads was reached. The target
protein solution was then added (between 1 and 10µg of target). The tube was incubated
at RT for 30min under continuous slow inversion to avoid settling of the beads. After
this capturing process, the tube was put into the magnetic rack and the supernatant was
removed. The beads were then resuspended and washed with a volume of 500µl PBS
three times.
For the panning, the prepared beads were incubated with 500µl blocking buffer for
30min under slow rocking. This pre-blocked the tube walls as well as the protein beads
and reduced unspecific binding of the phage particles later.
In parallel, 250µl of phagemid library solution were mixed with 750µl blocking so-
lution (this was for a first round of panning, in following rounds, always 50µl phage
solution were mixed with 450µl of blocking buffer), and also incubated for 30min at
room temperature.
After the 30min, the beads were washed 3×with 500µl T-PBS, then the phage-
blocking-buffer-mix was added to the beads and they were incubated for 2 h at RT under
gentle shaking.
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The supernatant was removed from the beads, then the beads were washed several
times with T-PBS and blocking solution — 10min T-PBS, 10min blocking solution,
5min T-PBS, 5min blocking solution, 5min T-PBS, 5min blocking solution. Finally,
the beads were suspended in 200µl elution buffer and shaken at RT for 15min. Then
the supernatant, containing the eluted phages (that had not been washed away, but were
now eluted, was pipetted out of the tube and mixed with 40µl neutralization buffer.
Those 240µl now contained the eluted phages.
T(0.05%)-PBS (T-PBS)
Tween-20 500µl
PBS buffer 1000mL
Blocking buffer (2% MP)
T(0.05%)-PBS (T-PBS) 100mL
Skimmed Milk Powder 2 g
Elution buffer (0.1M Glycine)
Glycine 35.4 g
ddH2O ad 200mL
adjust pH to 2.2
Neutralization buffer (2M Tris)
Tris base 24.2 g
ddH2O ad 200mL
2.2.5.2 Reinfection of E. coli cells with eluted phages
20µl of the elution solution were used to determine the titer of the phages after elution,
the remaining amount was used to infect 15mL of a freshly grown OD600=0.5 culture of
Top 10F’λ in 2YT medium. The cells were mixed with the phage thoroughly and then
incubated at 37 ○C for 60min. The cells were then pelleted by centrifugation (10min,
5000×g) and resuspended in 400µl 2YT (containing ampicillin and tetracycline). This
suspension was plated out on a 125mm∅ 2YT agar plate (containing ampicillin and
tetracycline) and incubated overnight at 37 ○C.
2.2.5.3 Packaging of phagemid particles from reinfected cells
10mL 2YT medium (containing tetracycline and ampicillin) was pipetted onto every
plate on which the reinfected cells had been grown, then the plates were left resting for
30min. The cells were scraped off from he plates using a spatula, mixing them thoroughly
in this process.
2mL of that cell suspension were used to inoculate 200mL 2YT medium (containing
tetracycline and ampicillin). From the rest of the cell suspension, several glycerol stocks
were prepared by mixing 1mL of cell suspension with 0.5mL of sterile glycerol.
The 200mL culture was grown at 37 ○C, 160 rpm until an OD600 of 0.5 was reached.
2×1011 cfu of M13K07 were added to the culture, then the culture was incubated at 37 ○C
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for 30min without agitation to allow for the phage to infect the cells after regeneration
of F’ pili on the cells. The culture was then grown for six more hours at 37 ○C, 160 rpm.
The cells were centrifuged (15min at 8000 rpm, 4 ○C, GS3 rotor). The supernatant was
carefully decanted and centrifuged a second time in order to remove remaining bacterial
cells. The supernatant was then mixed with 0.15 volume of PEG/NaCl and put on ice for
at least 1 h. The phage precipitate was harvested by centrifugation (90min, 8000 rpm,
4 ○C, GS3 rotor). The supernatant was decanted and remaining liquid removed after a
second short centrifugation (5min, 8000 rpm, 4 ○C, GS3 rotor).
The pellet was taken up in 200µl PBS and cleared by 15min centrifugation at 13000 rpm
in a bench top centrifuge. NaN3 was added to the supernatant to a final concentration
of 0.02% NaN3.
The helper phage as well as the phagemid titer was determined afterwards, the phage
solution could be used now for another round of panning. After the second round of
selection, single clones were picked from the overnight plates for characterization by
DNA sequencing of the library sequence containing the variable cassettes.
2.2.5.4 Characterization of selected single clones after reinfection
When packaging phagemid particles as in chapter 2.2.5.3, the phage titer was determined
as well. Single colonies from those titer determination agar plates were picked and
cultivated as in chapter 2.2.2.12, so that the DNA sequence of eluted phagemid particles
could be determined.
2.2.5.5 Biacore affinity measurements
The Biacore system is based on a surface plasmon resonance (SPR) to monitor the
adsorption of molecules on a sensor chip. This optical technique measures changes in the
refractive index of the medium very close to a metal surface. Such changes are directly
proportional to the amount and molecular weight of the macromolecules bound to the
surface at any time.
This system is designed for functional real-time characterization of the interaction of
protein-protein, ligand-receptor and the interaction of low molecular weight molecules
in general. While all the interactions are dynamic processes, the ability to measure the
kinetic parameters of association and dissociation (kon and koff ) precisely allows the
understanding of biological processes as well as the determination of affinity values (KD)
of molecules for targets of interest.
The Biacore system consists of a sensor chip on which the ligand can be immobilized on
a matrix composed of flexible dextran, a miniaturized fluidics cartridge for the transport
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of analytes and reagents to the sensor chip, and a SPR detector (Jönsson et al., 1991;
Malmqvist, 1993).
A laser source emits plane-polarized light which is aimed through a prism, onto a
metal covered sensor chip (usually gold or silver) on which the targets of interest are
immobilized. When the analyte binds to this target, the beam angle is altered, which
can be measured so that the intensity of the interaction can be determined. These
measurements are performed continuously so that a real time plot (sensorgram) of the
beam angle difference, in arbitrary resonance units (RU), versus time can be obtained
(Panayotou et al., 1993).
From this data, using different mathematic fitting algorithms, the association and
dissociation values of the studied interaction can be determined.
The measurements were done at the university of Kassel, Germany, in the department
of Biochemistry. Sonja Schweinsberg (University of Kassel, Germany) performed the
experiments.
The instrument used for the interaction studies was a Biacore 3000 (BIAcore, Uppsala,
Sweden).
The biotinylated ligands (peptides with a biotin molecule covalently coupled to the
C-terminus), solved in PBS buffer (concentration: 5µg/mL), were immobilized on strep-
tavidin SA chips from Biacore, which have streptavidin coupled covalently to the dextran
layer on the chip surface.
Before immobilization of the ligands, the four flow cells of the chip were rinsed three
times with 1M NaCl/50mM NaOH for 1min at a flow rate of 1µL/min.
The ligand peptides were then immobilized at flow rates of 10µL/min up to 130–
250RU each.
The analyte studied in regards to its interaction with the immobilized peptides was
a recombinant chimera protein of the extracellular domain of human CD28 (amino acid
residues 1–152, Aruffo and Seed, 1987) fused carboxy-terminally to the Fc region of
human IgG1 via a polypeptide linker (source: R&D systems, USA), suspended in PBS.
The kinetic measurements with the analyte were performed at a flow rate of 30µL/min
with an association phase of 120 s.
Regeneration of the chip surface after addition of the analyte was attempted by rinsing
the flow cells twice for one minute each at a flow rate of 30µL/min, using 1.5M NaCl,
3M NaCl and 10mM glycine (pH3).
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2.2.5.6 Phage ELISA
T(0.05%)-PBS (T-PBS)
Tween-20 500µl
PBS buffer 1000mL
Blocking buffer (2% MP)
T(0.05%)-PBS (T-PBS) 100mL
Skimmed Milk Powder 2 g
0.05M Citric Acid
Citrate monohydrate 1.05 g
ddH2O 100mL
Adjust pH to 4.0 with 10N NaOH
and filter (0.2µm) for sterilization
1 ×ABTS stock solution
ABTS diammonium salt 22mg
(2’,2’-azino-bis (3-ethylbenz-
thiazoline-6-sulphonic acid))
0.05M Citric Acid solution 100mL
Filter (0.2µm) for sterilization
ABTS substrate solution
H2O2, 30% 36µL
1×ABTS stock solution 21mL
Prepare just immediately before use
In order to compare the interaction between enriched clones and the target (relative
affinity ranking of clones), phagemid particles were packaged from cultures cultivated
from single colonies. These phagemid particles were submitted to a phage ELISA (En-
zyme Linked Immuno Sorbent Assay) experiment.
The target protein of interest was coated on Nunc-MaxiSorp microtiter plates (Nunc/Thermo
Fisher Scientific, Roskilde, Denmark) by incubating wells with each 100µL of protein
solution (10µg/mL) overnight at 4 ○C in a humidified container.
The target immobilized in the microtiter wells was a recombinant chimera protein of
the extracellular domain of human CD28 (amino acid residues 1–152, Aruffo and Seed,
1987) fused carboxy-terminally to the Fc region of human IgG1 via a polypeptide linker
(source: R&D systems, USA), suspended in PBS.
The supernatant was removed from the wells, which were washed then with
T(0.05%)-PBS. After the washing, the wells were filled in with the blocking buffer and
incubated at room temperature for 1 hr. Uncoated wells were blocked as well to serve as
background controls.
In separate Eppendorf tubes, phagemid particles were diluted in blocking buffer to a
final concentration of 5× 1010 particles/mL and incubated for 30min to block any non-
specific protein-protein interactions that may occur between phagemid particles and sur-
rounding proteins.
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After removal of the blocking buffer from the microtiter plate, 200µL of the phagemid
solution was added to the wells and incubated at room temperature for 2 hours.
After incubation with the phagemid particles, the wells were washed twice with T(0.05%)-
PBS and then incubated for 1 hr with 200µL HRP conjugated anti-M13 antibody (article
code 27-9421-011, GE Healthcare, United Kingdom), diluted 1:5000 in blocking buffer.
The microtiter plate wells were then washed three times with T(0.05%)-PBS, and
200µL ABTS substrate solution were added to the wells. After 5 to 30min, depending
on the development of the green color, the absorbance at 410 nm was measured in a
Tecan Sunrise ELISA-plate reader (Tecan, Männedorf, Switzerland).
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3.1 Library design
The CPL19YS-2 library was designed with several considerations in mind (see Figure 16):
• Peptide length: Overall length of 33 amino acids, with as many positions vari-
able as possible. This length should give potential for the formation of secondary
structures that increase the molecule’s internal stability (internal β-sheet struc-
tures) or the ability to interact with target domains (in the case of α-helices or
loop formation), thus increasing the potential to bind target domains specifically
and with higher affinity. This is discussed in more detail in 1.4.
• Four cassettes: The library comprises four cassettes as so called “building blocks”.
These building blocks can be recombined by Cosmix-plexing as described in chapter
1.4.2 during every stage of work with the library.
• Potential for disulphide bridged loops: In order to support the forming of
stabilizing loops, a certain potential for the occurrence of multiple cysteine amino
acids at defined positions was implemented.
The CPL19YS-2 library was designed to be cloned into the pEPO8 phagemid vector
(see section 3.2.1.4). This fuses a leader peptide sequence to the library’s N-terminus,
providing secretion out of the bacterial cell after cleavage of the leader peptide. Addi-
tionally, a full-size pIII protein from M13 is fused to the library’s C-terminus, leading to
the presentation of the library encoded peptide when incorporated into a phage particle
(see Figure 15).
3.1.1 Peptide length and amino acid composition
Most peptide libraries consist of 6 to 12mers. The reason for this is that such a peptide
library can actually cover nearly completely its whole potential complexity.
A library of 7mers, using all 20 available amino acids, would already have a potential
complexity of 207= ca. 1.28×109. The phage libraries with the highest complexity,
produced on an industrial scale, are in the ∼1010-range (see Vaughan et al., 1996)).
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Figure 15: Schematic structure of the fusion protein encoded in the CPL19YS-2
library.
To the N-terminus of the library encoded peptide a leader peptide sequence is fused, providing
secretion out of the E.coli cell while having the leader peptide cleaved off during secretion
(Szardenings and Collins, 1990). The pIII protein of M13 is fused to the C-terminus of the
library peptide via a linker sequence.
Although there are examples of short peptides possessing secondary structures, chances
for structural features other than just extended linear or randomly coiled peptides are
much higher with increased length (s. chapter 1.4).
As illustrated by the DNA sequence for peptides encoded in the CPL19YS-2 library
in Figure 16, not every possible amino acid is available at each position (which would
require NNB [with B=G,T or C] or NNK [with K=G or T] codons), but the repertoire
at each position is limited. The reasons for this restriction were:
• avoidance of stop codons: the codons TAG, TAA and TGA were not supposed
to exist in the CPL19YS-2 library at all, in order to prevent premature termination
of translation even in the absence of suppressor tRNAs.
• avoidance of additional restriction enzyme recognition sites:
The Cosmix-Plexing method used for recombination in the CPL19YS-2 library uses
certain type II s DNA restriction enzymes to cut the library on distinct positions
that will be used for later re-ligation as well. Therefore it is essential for an efficient
recombination process that all restriction enzymes used for the Cosmix-Plexing do
recognize only one site per plasmid (a site inside the library region) so that an
enzymatical digestion leads only to a liberalization of the plasmid rather than a
fragmentation. It also helps in the last step of Cosmix-Plexing, where linear DNA
fragments are re-constituted to circularized plasmids (see section 3.2.2.5), as re-
circularization of plasmids is one of the most efficient ligation reactions (compared
to the ligation of separate DNA fragments into a circular plasmid).
The DNA triplets were chosen in a way that ensures that none of the restriction
enzymes used (BceAI, BsrDI and BpmI) will recognize positions inside the library
other than the single predefined sites.
• avoidance of the HPQ motif (histidine-proline-glutamine: HPQ is an
amino acid motif that is binding to streptavidin with a high affinity (Devlin et al.,
1990). Streptavidin-coated surfaces or beads are often used to immobilize targets
for use in a panning experiment, so it is undesirable to have the library peptides
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binding strongly to the immobilization material rather than the target material.
This measure reduces the background binding in the library that is often a problem
in panning processes where streptavidin is used (Menendez and Scott, 2005).
• avoidance of the RGD motif (arginine-glycine-aspartic acid: RGD is a
common motif present in many proteins that interact with integrins found on eu-
karyotic cells (Ruoslahti, 1996). Because it is such a small amino acid motif, the
RGD site can be found in many random peptides, promoting cell adhesion. Analo-
gous to the HPQ motif, a library not containing RGD could be used for screening
targets presented on cell surfaces without enriching sequences that have an arti-
ficial RGD-based affinity to integrins on the cell surface without actually binding
specifically to a presented target molecule. (Menendez and Scott, 2005).
• absence of tryptophan in the library: while tryptophan is an amino acid that
can have a strong impact on a potential peptide structure, it is also very hydropho-
bic. In small peptides, a massed occurrence of tryptophan cannot be “shielded”
by sequestering these hydrophobic residues in a ”cage“ of more hydrophilic amino
acids. This can often lead to insoluble products (Riechmann and Winter, 2000),
which are obviously undesirable for panning conditions in aqueous solutions. An-
other factor is that in many panning experiments, tryptophan-rich sequences were
often preferentially enriched —- apparently not due to specific interactions with
the target, but just due to hydrophobic “sticking” to the panning container (Adey
et al., 1995); long aliphatic arms of arginine had also been noted in association
with the same phenomenon. This target-unspecific binding should be reduced by
removing tryptophan from the library.
• restriction to just one of the acidic amino acids (aspartic and glutamic
acid): since those two amino acids have a rather similar structure and both con-
tribute the negative charge of the COOH group, codons were selected in a way that
only allows aspartic acid to occur within peptides of the CPL19YS-2 library.
• absence of lysine and low frequency of arginine: in order to avoid any
additional recognition sites for the restriction enzymes used for recombination (see
above), the sequence variety is limited. Due to this restriction, no lysine is encoded
in the library sequence, and arginine is allowed only in 8 out of 25 positions.
This contributes to positively charged amino acid residues being slightly under-
represented in the library and needs to be taken into account when analyzing
enriched sequences.
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• coverage of variant combinations after recombination of selected vari-
ants: even with the above mentioned limitations, the complexity of each of the
four cassettes would still have been much higher than what would be possible to
cover in the process of library creation (assuming that the library should cover at
least most of its potential complexity per cassette). Therefore, as also common
in other libraries (e.g. Dennis et al., 2002), the complexity of each cassette was
adjusted to be below 1×108 by appropriate choice of degenerate codons.
Even the complexities used in this design approach might still be too high, following
what Clackson and Wells (1994) stated in their review. According to the authors,
the actual number of clones required to ensure that all possible variants are present
at least once in the primary library with a probability of 99% is at least 5×greater
than the potential complexity of a library (in our case, per DNA cassette).
The necessary number of clones in the CPL19YS-2 library might be even higher,
considering the potential bias in base composition of the synthetic oligonucleotides
used for library creation (for the actual deviation from ideal distribution, see Ta-
ble 2, p.70) and statistical variation (see Collins, 1997).
Discounting sequence/codon bias, in order to cover the whole complexity within
each cassette with a 99% probability, the number of clones in a library would have
to be approximately five times higher than the theoretical complexity, meaning a
minimum of 2.75×108 clones — based on the complexity of 5.5×107 in the 3rd
cassette).
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3.1.2 Cassette structure
While most of the sequence is degenerate (8 different types of degenerate codons were
used), there are certain fixed positions in the library. Among those are the recognition
sites for the three different type IIs restriction enzymes mentioned above (see e.g Szybalski
et al., 1991, for a review of type IIs restriction enzymes).
Type IIs restriction enzymes cleave at a fixed distance adjacent to their recognition
sequence. They recognize a sequence that is continuous and asymmetric. This feature
makes it possible to position the (fixed) recognition sequence outside of the library en-
coding sequence, while still being able to cleave at a fixed position within the library
sequence.
The positions at which the restriction enzymes cleave (highlighted in green in Fig-
ure 16) were chosen in such a way that, after a cleavage, the sticky-ends are non-
palindromic. This ensures that during subsequent ligation of the cleavage products
only an ordered recombination is possible (as required for Cosmix-plexing, section 1.4.2),
rather than head-to-head/tail-to-tail ligations. All the cohesive-end sites are also specific
to allow for a correctly ordered directed ligation-mediated recombination even if cleavage
is carried out simultaneously with a combination of type IIs restriction enzymes.
3.1.3 Disulfide bridges
It has been shown that constrained sequences or peptides often possess advantages in
affinity selections over linear peptides (see Binz and Plückthun, 2005).
One method to achieve this is to bracket a peptide sequence by a pair of flanking
cysteines, which, when oxidized to a disulfide linkage, result in the displayed peptide
being presented to the target as a looped structure. This method has been found to
yield positive results (e.g. by McLafferty et al., 1993), and is commonly used, even in
commercial libraries, such as the Ph.D.-C7C phage display library from New England
Biolabs (presenting random heptamers, flanked by cysteines), or the versabody libraries
from Amunix (California, USA), which consist of 15–60mers possessing additional rigid-
ity due to multiple disulfide bridges (>15% overall cysteine content).
The CPL19YS-2 library was designed to offer a multitude of a least partially con-
strained, highly variable three-dimensional structures, rather than being restricted to
restrained peptides of fixed architecture. This was achieved by allowing for the occur-
rence of multiple cysteines within one peptide (positions with potential for presence of
cysteine are marked by a red bar in Figure 16). This design element has been used in
several other libraries before, for example by McConnell et al. (1996).
Whereas the central cysteine is fixed, the NVT codons to the left and to the right
of the central cysteine have the potential to code for a cysteine. Assuming a Poisson
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distribution, the probability for the occurrence of a peptide with just one cysteine (the
central one) are 54.4%, while the probability for one additional cysteine (thus having
two cysteines and the chance to form disulfide bridges) is 38.8%. The remaining 6.8%
represent the chance to have three or more cysteines in a peptide.
3.2 Library creation
3.2.1 The phagemid vector
The library was created by inserting synthetic, highly variable DNA fragments into a new
DNA vector pEPO8, based on the pROCOS4/7 phagemid vector (provided by Cosmix
GmbH, Braunschweig, Germany), which is derived from the pSKAN8 vector (Röttgen
and Collins, 1995).
The pROCOS4/7 vector contained a library (15mer peptide library pCPL3, unpub-
lished data, Michael Mersmann, John Collins), fused N-terminally to the full-length
minor coat protein pIII of the M13 bacteriophage and fused C-terminally to a secretion-
providing leader peptide. The pCPL3 library was replaced with the library created in
the course of this thesis.
The properties of the pROCOS4/7 vector are largely identical to the modified pEPO8
phagemid vector, and are explained in detail in section 3.2.1.4.
3.2.1.1 Removal of restriction sites
In a first step, the pROCOS4/7 vector had to be modified since it contained several
restriction sites which were required to be unique in the final vector in order to allow
recombination using selected type IIs restriction enzymes.
The DNA type IIs restriction enzymes used for recombination of the CPL19YS-2 li-
brary are BceAI, BsrDI and BpmI. The original pROCOS4/7 vector contained seven
recognition sites for these restriction enzymes (see Figure 18).
The restriction sites were removed by mutagenesis PCR (see Figure 19) to generate
a modified DNA fragment (no longer containing the unwanted restriction site) that was
then cloned into the pROCOS4/7 vector replacing the original part with the unwanted
type IIs restriction site.
For every site to be mutated, plasmid DNA from the pROCOS4/7 vector was used
as a template for two separate PCR reactions. Hereby, two DNA fragments (of 200 -
800 bp length) were generated; one containing the sequence upstream of the site to be
mutated, ranging up to a position of a DNA restriction site utilizable for cloning, the
other fragment covering the DNA sequence downstream of the mutation site, including
a restriction site suitable for cloning as well.
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Figure 18: Phagemid plasmid vector pROCOS4/7 with seven (unwanted) restriction enzyme
recognition sites and their positions given as distance in base pairs relative to base pair position
1. There is no unwanted recognition site for BpmI.
Both fragments overlapped (20–25 bp) in the sequence region containing the restriction
site to be mutated; the primers used to mediate amplification in this region contained a
point mutation that removed the restriction site in both PCR DNA fragments.
After a cleanup step (excision of the amplification product bands and subsequent ex-
traction after agarose gel electrophoresis, in order to remove the last traces of remaining
vector DNA), both separate PCR products were mixed together and used as template
DNA for a further PCR. The flanking primers for this second round of PCR were specif-
ically designed to yield a larger PCR amplicon containing the desired mutation, thus
removing the original unwanted restriction site. Due to the choice of flanking primers,
this PCR amplicon contained restriction enzyme recognition sites on both ends that
allowed cloning into the pROCOS4/7 vector.
These “corrected” fragments where subsequently cloned into the pROCOS4/7 vector,
using appropriate restriction enzymes and restriction sites as close to the site of mutation
as possible, in order to minimize undesired mutations in other regions. In principle, it
is not unlikely that such mutations occur during PCR amplification (ca. 1 base change
per 1000 bp). The resulting vector was therefore always checked for successful mutation
by digestion with the DNA restriction enzyme whose recognition site had been mutated.
Only after verification of the successful restriction site modification, the vector was used
as starting material for the next round of PCR-mediated site-specific mutation.
This strategy was used to eliminate the seven unwanted recognition sites shown in
Figure 18. Unfortunately, during the final quality control it became apparent that an-
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Figure 19: PCR mutagenesis.
Introduction of a mutation into a DNA sequence using two subsequent PCR reactions with
specifically designed primers.
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other recognition site for BsrDI had been accidently introduced at position 4109 (most
probably in the process of eliminating the BceAI recognition site at position 4075). This
site was therefore re-mutated into the original sequence of the pROCOS4/7 vector, and
this final product was designated pEPO8.
3.2.1.2 Preparation of the library insertion site
The pEPO8 vector contained a sequence of 76 bp length between the restriction sites
chosen for library insertion (enzymes Sac I and EcoRV — see Figure 20).
Figure 20: library insertion site for pEPO8
Thus, a digestion with those two enzymes would result in two fragments (4587 bp and
76 bp) that could not easily be distinguished from fragments that would results from only
partial digestion — 4587 bp vs. 4663 bp.
It was, however, highly desirable to ensure that the completely double-digested vector
would be clearly separated and easily distinguishable from the uncleaved and partially
cleaved DNA during subsequent clean up gel electrophoresis. In order to achieve this,
in an intermediate step a ”stuffer“ fragment was introduced between the SacI and the
EcoRV site of pEPO8.
A stuffer fragment (1745 bp in size, obtained from Lambda DNA SacI and EcoRV
digestion) was cloned between the Sac I and EcoRV sites of pEPO8. The resulting vector
was then designated pEPO8-stuffer. A digestion of this vector with the two restriction
enzymes SacI and EcoRV now resulted in easily separatable bands (4587 bp + 1745 bp
for correct double digestion vs. 6408 bp for partial cleavage products).
65
3 Results and discussion
3.2.1.3 Validating the vector sequence
After the introduction of the stuffer fragment, plasmid DNA from pEPO8-stuffer was
digested with BceAI and BsrDI to check if any unwanted restriction sites had been
introduced or arisen by mutation. Since no further unwanted restriction sites outside of
the stuffer fragment were found, the plasmid pEPO8-stuffer was sequenced using various
different primers in order to cover the whole sequence. Additionally, a large part of the
vector DNA was sequenced forward and backward to reduce sequencing errors as much
as possible. A few deviations from the sequence of the pROCOS vector, provided by the
Cosmix GmbH (Braunschweig, Germany), were found during sequencing and noted in a
corrected vector map.
These sequence deviations did not confer any functional alterations to the plasmid
vector with respect to packaging, antibiotic resistance, promoters or DNA replication.
All these factors were checked extensively to ensure full for functionality of the final
library vector.
3.2.1.4 The pEPO8 phagemid vector
The final form of the pEPO8 phagemid vector is shown in Figure 21.
The leader peptide sequence OmpL of the “outer membrane”-protein OmpA is fused
to the first amino acid of the CPL19YS-2 library, thereby ensuring production, secretion
and correct cleavage of the leader peptide (Szardenings and Collins, 1990). This in turn
results in secretion of the fusion protein, while the leader peptide sequence (MKKTA-
IAIAVALAGFATVAQA), which is fused N-terminally to the library insert, is cleaved
off.
Within the pEPO8 phagemid vector, the pIII-CPL19YS-2(library) fusion protein is
expressed under the control of the pL promoter from the bacteriophage Lambda. This
promoter is strongly repressed by the λ cI protein that is produced in λ lysogenic E. coli
strains. By using this promoter, it is ensured that the ratio of hybrid to wild type pIII
in the phagemid particles (every particle presenting five copies of pIII) produced upon
superinfection with the helper-phage M13K07 is approximately 1:10, i.e. one hybrid
protein per two phagemid particles (Röttgen and Collins, 1995). This leads mainly to
the desired monovalent presentation which is advantageous during selection for high
affinity ligands (Lowman et al., 1991).
The pEPO8 vector contains an ampicillin resistance gene (bla, β-lactamase) to al-
low selection for plasmid uptake, an Col E1 origin of replication responsible for plasmid
replication in E. coli (ensuring a multicopy plasmid by relaxed replication) and the M13
phage replication/packaging origin ori fd.
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Figure 21: Phagemid plasmid vector pEPO8, with inserted library CPL19YS-2 (sec-
tion 3.2.2)
The following abbreviations are used: λ PL: major leftward promoter of phage λ; ompL: leader
peptide signal sequence derived from the E. coli outer membrane protein OmpA; pIII: gene
encoding the minor coat protein pIII of the bacteriophage M13K07; bla: β-lactamase gene,
conferring ampicillin resistance; ori fd: origin of replication for single stranded DNA of the bac-
teriophage fd; ori E: origin of replication from the plasmid Col E1. A library DNA sequence,
including a linker sequence, has been inserted in front of the pIII coding region.
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3.2.2 Generation of the library
3.2.2.1 Preparation of linearized vector DNA
Large amounts of pEPO8 stuffer plasmid DNA were isolated and enzymatically digested
with Sac I and EcoRV. The DNA was separated on an agarose gel until good single band
separation was achieved. Only the linearized, desired vector fragment of 4587 bp size
(without the stuffer fragment of 1745 bp, see 3.2.1.2) was extracted from the agarose gel.
3.2.2.2 Generation of library dsDNA
The library encoding DNA oligonucleotides were ordered from the company Biospring
(Frankfurt am Main, Germany). The single stranded DNA was filled up to dsDNA by
using the method described in chapter 2.2.2.11, and afterwards enzymatically digested
with Sac I and EcoRV in preparation for the primary library preparation (see Figure 22).
The ssDNA oligonucleotide used as “backbone” was designated CPL19YS-2 BAS, the
oligonucleotide used for the fill-out reaction was JCOSTART3B-3 (see section 2.1.5.1).
Figure 22: Preparation of the synthetic DNA library insert
3.2.2.3 Ligation of vector and library DNA
After validation of correct fragment sizes, the library dsDNA fragment and the large
Sac I-EcoRV pEPO8 vector fragment were ligated (see section 2.2.2.9) and subsequently
transformed into Top 10F’ cells (see section 2.2.2.10). The amount of DNA used for
electroporation was as high as 1–2µg of DNA per electroporation step sometimes in order
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to generate a high number of transformants (up to 1×107 transformants), compared to
the recommended amount of 50 ng DNA/20µl for optimal efficiency. There were about
thirty transformations made, resulting in ca. 1.8×108 transformants total, which is also
assumed to be the total complexity of the primary library.
Further work in our lab, conducted by Simone Nieswandt, increased the complexity of
the primary library from 1.8×108 to about 4.2×108, using the Cosmix Plexing technique
described in section 3.2.2.5 and the recombination sites BpmI and BsrDI.
This latter library was used in panning experiments conducted on the target CD28
(section 3.3.3) and the NS 3-4A + NS2-3 serin proteases of the hepatitis C virus. Subse-
quently the library has also been used for panning on various antibodies.
3.2.2.4 Evaluation of primary library constitution
After each separate electroporation batch, single clones containing the plasmid (indicated
by growth on ampicillin antibiotic agar) were picked and sequenced (s. chapter 2.2.2.12).
The first part of the analysis was to confirm that each clone contained a single li-
brary insert, in correct orientation and open reading frame without additional mutations
(insertions, deletions, frame shifts). The percentage of clones not conforming to these
criteria was determined.
The second part of the analysis addressed was the statistical frequency of each single
nucleotide at each position in reference to the expected values.
From DNA sequencing using the primers JCOFSQ (TTC TAC AAC TTG CTT GGA
TT, binding 5’ of the library sequence at vector position 4575, reading downstream)
and JCORSQ (TCC AGA CGT TAG TAA ATG AA, binding behind (3’ to) the library
sequence at vector position 218, reading upstream) it was concluded that 10 from 132
sequenced clones did not meet the desired criteria. In 2 of them no insert was detected,
the rest had various insertions or deletions. This corresponded to there being some 7.6%
“defective” clones in the library. The other 122 clones were of the correct sequence type
and could be analyzed in their nucleotide composition. This frequency distribution was
compared to the expected nucleotide sequence according to the library design (fig. 16,
chapter 3.1).
As can be seen in Table 2, the deviations from the statistically expected nucleotide
distributions were similar for each nucleotide, rather than deviating maybe dependent
on codon usage. If the latter had been the case, one could assume selective pressure
due to expression of the encoded peptides, but since the variations almost always had
the same tendencies, it can be concluded that these differences originate in the synthesis
process of the template DNA oligonucleotides, e.g. efficiency of chemical conjugation
during oligonucleotide template synthesis.
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In summary, the frequency of adenine is much less frequent than expected (ca. be-
tween 1/3 and 1/2 lower), while guanine is found with about 1/3–1/2 higher frequency
than expected. Cytosine frequency deviation is statistically insignificant and inside the
expectation range, while thymine frequency is slightly over-represented.
Averaging the frequency deviations in Table 2 and considering the design in section 3.1,
the distribution of amino acids for the most common DNA triplets NYT and NVT (the
most common triplets, on 19 of 25 variable positions) would result in reduction to ∼40%
of the original value for threonine, to ∼60% for histidine, to ∼50% for isoleucine and to∼30% for asparagine. The frequencies of occurrence for other amino acids were increased,
as for alanine (increased to ∼140%), cysteine (increased to ∼185%, but only in the seven
NVT triplets), phenylalanine (increased to ∼140%), valine (increased to ∼150%), glycine
(increased to ∼200%) and arginine (increased to ∼125%).
In summary, this deviation would result in more hydrophobic peptides than originally
devised. This has to be considered when analyzing enriched peptides.
The increase in cysteine frequency also increases the chances of more than one cysteine
per encoded peptide. While the original design predicted 54.4% of the clones with just
the central cysteine, 38.8% with two cysteines and 6.8% of the clones with more than two
cysteines, the 122 sequenced clones showed 33 sequences with just one cysteine (27.0%),
59 clones with two cysteines (48.4%) and 30 clones with three or four cysteines (24.6%).
This needs to be taken into account when analyzing peptides, as clones with two or more
cysteines are much more frequent than originally intended.
Table 2: Nucleotide distribution for each position in 122 clones sequenced from
the CPL19YS-2 library. The first % value for each nucleotide gives the frequency with
which the respective nucleotide actually occurs at a certain position, the second value gives the
deviation in percentage points by which the distribution in the library at the given position
actually deviates from the “ideal” frequency. A blue number indicates a higher frequency than
statistically expected, a red number a lower frequency.
Position A deviation G deviation C deviation T deviation
1 0% 0% 0% 0% 100% 0% 0% 0%
2 7% -18% 39% 14% 18% -7% 35% 10%
3 0% 0% 0% 0% 0% 0% 100% 0%
4 14% -11% 35% 10% 19% -6% 30% 5%
5 27% -6% 0% 0% 30% -3% 42% 9%
6 0% 0% 0% 0% 0% 0% 100% 0%
7 14% -11% 29% 4% 22% -3% 33% 8%
8 22% -11% 0% 0% 38% 5% 38% 5%
9 0% 0% 0% 0% 0% 0% 100% 0%
10 9% -16% 38% 13% 20% -5% 31% 6%
continued on next page
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Position A deviation G deviation C deviation T deviation
11 23% -10% 0% 0% 31% -2% 44% 11%
12 0% 0% 0% 0% 0% 0% 100% 0%
13 7% -18% 34% 9% 18% -7% 39% 14%
14 0% 0% 0% 0% 0% 0% 100% 0%
15 0% 0% 60% 10% 39% -11% 0% 0%
16 8% -17% 34% 9% 20% -5% 36% 11%
17 27% -6% 40% 7% 31% -2% 0% 0%
18 0% 0% 0% 0% 0% 0% 100% 0%
19 14% -11% 34% 9% 13% -12% 36% 11%
20 21% -12% 52% 19% 26% -7% 0% 0%
21 0% 0% 0% 0% 0% 0% 100% 0%
22 16% -9% 38% 13% 13% -12% 31% 6%
23 17% -16% 63% 30% 19% -14% 0% 0%
24 0% 0% 0% 0% 0% 0% 100% 0%
25 13% -12% 36% 11% 13% -12% 36% 11%
26 17% -16% 59% 26% 23% -10% 0% 0%
27 0% 0% 0% 0% 0% 0% 100% 0%
28 0% 0% 0% 0% 0% 0% 100% 0%
29 45% -5% 0% 0% 55% 5% 0% 0%
30 0% 0% 0% 0% 100% 0% 0% 0%
31 13% -12% 40% 15% 13% -12% 32% 7%
32 20% -13% 0% 0% 29% -4% 50% 17%
33 0% 0% 0% 0% 0% 0% 100% 0%
34 8% -17% 38% 13% 23% -2% 29% 4%
35 17% -16% 0% 0% 28% -5% 54% 21%
36 0% 0% 0% 0% 0% 0% 100% 0%
37 10% -15% 47% 22% 18% -7% 22% -3%
38 0% 0% 0% 0% 34% -16% 65% 15%
39 0% 0% 0% 0% 0% 0% 100% 0%
40 0% 0% 0% 0% 100% 0% 0% 0%
41 100% 0% 0% 0% 0% 0% 0% 0%
42 0% 0% 0% 0% 0% 0% 100% 0%
43 0% 0% 0% 0% 0% 0% 100% 0%
44 0% 0% 100% 0% 0% 0% 0% 0%
45 0% 0% 0% 0% 100% 0% 0% 0%
46 9% -16% 39% 14% 22% -3% 28% 3%
47 18% -15% 0% 0% 42% 9% 38% 5%
48 0% 0% 0% 0% 0% 0% 100% 0%
49 11% -14% 42% 17% 17% -8% 28% 3%
continued on next page
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Position A deviation G deviation C deviation T deviation
50 22% -11% 0% 0% 35% 2% 42% 9%
51 0% 0% 0% 0% 0% 0% 100% 0%
52 11% -14% 39% 14% 18% -7% 31% 6%
53 27% -6% 0% 0% 23% -10% 49% 16%
54 0% 0% 0% 0% 0% 0% 100% 0%
55 14% -19% 0% 0% 31% -2% 53% 20%
56 36% -14% 0% 0% 63% 13% 0% 0%
57 0% 0% 0% 0% 29% -21% 70% 20%
58 14% -11% 38% 13% 16% -9% 30% 5%
59 19% -14% 48% 15% 31% -2% 0% 0%
60 0% 0% 0% 0% 0% 0% 100% 0%
61 9% -16% 37% 12% 16% -9% 36% 11%
62 18% -15% 47% 14% 34% 1% 0% 0%
63 0% 0% 0% 0% 0% 0% 100% 0%
64 12% -13% 39% 14% 22% -3% 25% 0%
65 20% -13% 51% 18% 27% -6% 0% 0%
66 0% 0% 0% 0% 0% 0% 100% 0%
67 10% -15% 39% 14% 26% 1% 23% -2%
68 0% 0% 0% 0% 100% 0% 0% 0%
69 0% 0% 0% 0% 100% 0% 0% 0%
70 13% -12% 37% 12% 19% -6% 29% 4%
71 25% -8% 0% 0% 35% 2% 39% 6%
72 0% 0% 0% 0% 0% 0% 100% 0%
73 10% -15% 45% 20% 15% -10% 27% 2%
74 20% -13% 0% 0% 27% -6% 51% 18%
75 0% 0% 0% 0% 0% 0% 100% 0%
76 10% -15% 37% 12% 21% -4% 30% 5%
77 15% -18% 0% 0% 32% -1% 51% 18%
78 0% 0% 0% 0% 0% 0% 100% 0%
79 9% -16% 40% 15% 17% -8% 31% 6%
80 21% -12% 0% 0% 29% -4% 49% 16%
81 0% 0% 0% 0% 0% 0% 100% 0%
82 9% -16% 38% 13% 25% 0% 26% 1%
83 18% -15% 0% 0% 31% -2% 50% 17%
84 0% 0% 0% 0% 100% 0% 0% 0%
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3.2.2.5 Evaluation of the Cosmix-plexing principle
With the primary library being cloned, the Cosmix-plexing feature had to be evaluated in
function. Using this method, it is possible to increase the variety of the primary library
by an ordered recombination between the cassettes. This recombination can generate
new sequences every time, since the number of all possible cassette combinations in the
CPL19YS-2 library is 1.6×1025.
It is also possible to recombine selected sub-populations of clones either with them-
selves, another sub-population or the complete library. This can help to analyze the effect
of certain sequence motifs on the panning process if those sequences are either kept or
replaced by sequences from other cassettes. One can also use Cosmix-Plexing to generate
new sequence parts “around” or in addition to an motif of interest. While a motif could
have been enriched due to a positive effect on affinity, the neighboring sequences could
still have potential for improvement, which could be possibly assessed by replacing the
flanking cassettes with cassettes from the original library, adding variety that can be
screened again.
The CPL19YS-2 library was designed to allow for the Cosmix-Plexing method of
recombination, therefore it needed to be shown that the recombination of the library
cassettes was possible and the procedure working without any bias which could affect
screening experiments.
For reasons of verifiability, a limited repertoire of just four different clones from the
library was selected for the recombination experiments. Recombination within such a
limited repertoire allows to check if the expected combinations can be obtained in equal
frequencies.
Using the restriction enzyme BsrDI, the library region was cut in the middle and then
recombined as shown schematically (Figure 23).
Figure 23: Principle of recombination and generation of variety from a limited reper-
toire of variants
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Cosmix-plexing was performed using plasmid DNA isolated from the four different
clones. DNA from the four variants was mixed in equal amounts. The principle of
recombination can be seen in Figure 24.
The plasmid DNA mixture could be digested using any one of the three possible
type IIs restriction enzymes, as shown in Figure 16 (here BsrDI was used, cutting in the
middle position between cassettes 2 and 3). After purification, the linearized vectors were
ligated at DNA concentrations as high as possible (>200µg/mL), forming concatemers.
The specific nucleotides forming the “sticky ends” allowed only oriented ligation, no
formation of head-to-head ligations.
The DNA concatemers were digested with a second restriction enzyme (BglI, cutting
only once in the vector sequence) to generate linearized vector fragments that combined
two different library cassettes now.
After digestion, the DNA was diluted to a low DNA concentration (<20 µg/mL) and
ligated to make an internal ring closure the most frequent ligation product. The library
was transformed into Top 10F’λ cells by electroporation and could also be packaged into
phagemid format.
24 clones from the transformation were picked and sequenced (s. Figure 25). One of
them had a frame shift mutation (meaning 4.2% mutated variants, well below the level
of degeneration in the library found before).
The 23 remaining sequenced clones showed an even distribution of the different library
DNA fragment from the four original clones, which confirmed that there was no bias in
the process of recombination. 14 different sequences were obtained from the 23 clones
picked, which was a good yield considering that 16 different combinations of the original
four sequences were possible. Sequencing of more clones would have shown the remaining
two combinations in all likelihood.
The recombination process was shown to be reliable, without introducing any bias,
degenerating library quality and allowed for an ordered recombination of cassettes. Re-
combination was also verified as working utilizing the other two restriction/recombination
sites (BceAI and BpmI, data not shown here).
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Figure 24: General method of Cosmix-plexing
The starting material consists of pEPO8 phagemids carrying the library insert. These phagemids
can either be from the original primary CPL19YS-2 library, or from eluted phage that have
already been subjected to panning.
The phagemids are linearized using one of the three type IIs restriction enzymes cutting inside the
library cassette region (BceAI, BsrDI and BpmI) and then religated at high DNA concentration
to form concatemers. The concatemers are resolved as single vectors by digestion with BglI,
and ligated at low DNA concentration to achieve ring closure as monomers. The recombined
phagemid vectors can be electroporated, packaged, and used for panning.
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3.3 Evaluation of the CPL19YS-2 library
3.3.1 Evaluation of peptide display
With the DNA sequence quality of the phagemid in plasmid format validated, it was still
necessary to validate the display of the fusion peptide on the phage surface itself. As
mentioned already in chapter 1.3, there are different modes of expression if the peptide
is fused to the pIII phage protein. Using the pSKAN8 expression vector from which
the plasmid pEPO8 is derived, a ratio of about 1:10 for hybrid protein to wildtype pIII
protein had been found in the past (Röttgen and Collins, 1995). This ratio had been
determined by western blotting phage preparations and immunofluorescence staining of
the pIII protein. The size difference between the native pIII and the fusion protein (fusion
protein + pIII) was used to separate those two proteins and allowed a comparison of the
band intensities.
Attempts to do so with the CPL19YS-2 library had been unsuccessful, it had not been
possible to visually identify a band differing in size from the native pIII protein. How-
ever, successful enrichment during panning was demonstrated possible. It was therefore
concluded that just the size difference between the native pIII (running in a gel at about
an apparent size of 60 kDa) and the fusion protein (60 kDa + [114Da (average aa mass)×33= ∼3.7 kDa]= about 63–64 kDa) was not large enough, or other structural factors
made a separation impossible.
In order to remedy this effect, in our lab a partial deletion mutant of pIII was created
(John Collins, unpublished). Following ideas from Holliger and Riechmann (1997), a
deletion of the domains D1 and D2 of pIII (see Figure 26; see section 1.3.1.1 for expla-
nation of the domains’ functions) in the library vector was created in our lab by Simone
Nieswandt and Gökhan Haslak. This fd-D3 mutant was used to display a peptide from
the CPL19YS-2 library. Due to the reduction in size (D3 domain: ∼24 kDa + (peptide
mass: 114Da ×33 = ∼3.7 kDa) = ∼28 kDa) compared to the wild type pIII (∼60 kDa
apparent size), a second band would be easier to separate on a Western blot.
PEG/NaCl precipitated phagemid particles from either full-length pIII fusion protein
(type fd-D123 – packaged phagemid pEPO8-Do1-19)) or partially deleted pIII fusion pro-
tein (type fd-D3 – packaged phagemid pEPO8-Do1-19-D3) were examined in a Western
blot with monoclonal anti-pIII antibody (MobiTec, Göttingen, Germany). The antibody
binds to the -ATDYGAAIDGF- epitope that lies in the D3 domain of pIII and can
therefore be used to detect the truncated pIII protein as well. Figure 27 shows additional
bands around 26 kDa in the fd-D3 type that could not be found in the fd-D123 phagemid
preparation. While the bands between 34 and 43 kDa only appeared at high protein
concentrations (also in the fd-D3 preparation), the 26 kDa bands were only detected
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in the fd-D3 phagemid alone. From this, it can be concluded that those bands show
the truncated pIII fusion protein. The multiple bands were assumed to be degradation
products.
Concluding from the serial dilutions in Figure 27 the ratio of truncated pIII fusion
protein to wildtype pIII in the fd-D3 type was determined to be ∼5–15% (confirmed by
two more experiments, also with a type fd-D23 construct, data not shown here). These
ca. 10% were also expected from the data in Röttgen and Collins (1995) and were
confirmed to be valid with the modified phagemid vector pEPO8.
These data show both that the display of the fusion protein on the phage coat protein
was taking place and gives in addition information about the valency of the fusion protein
per phage particle.
With ∼10% of the pIII proteins being fusion proteins, there would be about one fusion
protein per ten wildtype pIII proteins (meaning one fusion protein per two phagemid
particles, with each particle presenting five pIII proteins). This would result in most
phagemid particles presenting either none or just one fusion protein (assuming a Poisson
distribution and 10% probability of the fusion protein: 0 hybrid molecules – 60.7%;
monovalent – 30.4%; divalent – 7.5%; trivalent – 1.25%; 4 hybrids – 0.156%; 5 hybrids –
0.016%; i.e., ca. 39.3% of the phage particles are presenting the fusion protein, according
to Röttgen and Collins, 1995). This leads to prevalently monovalent display which is
important for the selection of high affinity ligands from a library.
Figure 26: Schematic representation of the gene3 protein (pIII) in phage fd constructs. Boxes
indicate the presence of the domains g3p-D1, g3p- D2, and/or g3p-D3. Lines indicate the glycine-
rich linkers between g3p-D1, g3p-D2, and g3p-D3 and the C-terminal membrane anchor, respec-
tively.
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Figure 27: Western blot of phage preparations showing pIII and pIII- fusion pro-
teins. Lanes: 1, pEPO8-Do1-19 phagemid (wildtype pIII and pIII fusion protein); 2, threefold
amount of phagemid as in lane 1; 3–7, pEPO8-Do1-19-D3 phagemid (wildtype pIII and trun-
cated pIII+fusion protein) in serial 2-fold dilutions from 3 to 7.
Phagemid was packaged from E. coli Top 10F’λ cells using M13K07 helper-phage.
Phagemid particles were precipitated by PEG/NaCl precipitation. The protein separation was
performed in a discontinuous SDS gel (4.5% stacking gel, 10% separation gel, after Laemmli,
1970), followed by a western blot transfer onto nitrocellulose. Protein pIII was detected by a
monoclonal anti-pIII antibody, for staining a secondary peroxidase-labeled antibody was used.
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3.3.2 Evaluation panning of the CPL19YS-2 library on the model target
anti-p53 Ab-6 (Clone Do-1)
The antibody anti-p53 Ab-6 (Clone Do-1 – source: Labvision, USA) was selected as a
model target to determine appropriate panning conditions for the CPL19YS-2 library
and to validate that library peptides are being displayed. The antibody is a monoclonal
mouse antibody targeting the p53 tumor suppressor protein. The p53 protein is expressed
in a wide variety of tissue types and regulates the cell cycle.
The binding specificity of the antibody had been well studied in the past (for example
Stephen et al., 1995), with affinity having been shown for the motif
(F/Y)SDLx(R/K)(L/M), with x being no specific amino acid.
It was expected that similar motifs would be enriched during panning the
CPL19YS-2 library on this antibody if the peptides were being efficiently presented on
the surface of the phagemid.
3.3.2.1 Panning conditions
The panning was performed as described in chapter 2.2.5.1, the panning/washing con-
ditions (and thus the panning stringency) were not changed over the different rounds of
panning due to the monitored enrichment. The amount of target immobilized for each
panning was 5µg of p53 Ab-6 in the first three rounds of panning, reduced to 2.5µg in
the 4th round and to 1.25µg in the fifth round.
There were two independent pannings done in parallel (P#1 and P#2), as well as a
background control panning with no antibody immobilized on the protein A beads (PB).
The background control panning was stopped after the third round because all isolated
clones were found to be mutants, containing stop codons or deletions.
3.3.2.2 Enrichment of eluted phages
If an affinity selection panning is successful, over the course of several rounds the recov-
ered clones will possess improved binding properties. This results usually in an increased
ratio of phage recovered after the panning (phage output) in relation to the number
of phage incubated with the target (phage input) should go up. This increase in the
ratio can usually be seen as a positive indication for a successful panning process, i.e.
enrichment of higher affinity ligands.
An enrichment in this panning experiment was only detectable in the fifth round in
one of the two separate panning experiments (P#2), as can be seen in Table 3. While
the output:input ratio often goes down in the first few rounds of a panning experiment,
which was also the case here, the number of eluted phage goes up only in the case of P#2
in the 5th panning round (see also Figure 28). The very high amount of recovered phage
in the first round of panning on the background (PB) seems to be due to a mistake in
the experimental work, since it could not be reproduced later under similar conditions.
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P #1 P #2 PB
1R phage input 2.5 x 1011 2.5 x 1011 2.5 x 1011
1R phage output 4 x 106 4 x 106 4 x 107
1R output:input 1.6 x 10−5 1.6 x 10−5 1.6 x 10−4
2R phage input 2.5 x 1010 3 x 1010 2 x 1010
2R phage output 5 x 105 5 x 105 1.6 x 103
2R output:input 2 x 10−5 1.7 x 10−5 8 x 10−8
3R phage input 2 x 1010 3 x 1010 1.2 x 1010
3R phage output 2 x 104 2 x 104 1 x 104
3R output:input 1 x 10−6 6.7 x 10−7 8.3 x 10−7
4R phage input 2.5 x 1010 3 x 1010
4R phage output 8.3 x 104 1.3 x 104
4R output:input 3.3 x 10−6 4.3 x 10−7
5R phage input 3 x 1010 2.5 x 1010
5R phage output 4 x 104 4 x 106
5R output:input 1.3 x 10−6 1.6 x 10−4
Table 3: Development of phage titer over five rounds on panning the CPL19YS-2
library on p53 Ab-6.
P#1 and P#2 are the two separate pannings with p53 Ab-6 as target, PB is a panning on just
the beads used for immobilization to check the background enrichment. 1R to 5R indicates the
round of panning, input gives the number of phage incubated with the target protein, while
output shows the amount of eluted phage after washing steps.
An increase of the output:input ratio from one round to another usually indicates a successful
enrichment of clones presenting ligands with high affinities.
Figure 28: Output:Input ratio for different rounds of panning the CPL19YS-2 library
on the p53 Ab-6 target
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3.3.2.3 Analysis of isolated phages
In addition to measuring the output:input ratio of eluted phage after each round of
panning, single clones were also picked from each population of eluted clones. For the
background (PB), there were only clones from the 3rd round analyzed (6 total), while
for the two parallel pannings (P#1 and P#2) clones from the 4th and the 5th round
were sequenced (6 clones for each round and panning).
While the DNA sequences from the PB clones showed 4 stop codon mutations and 2
mutations where no library insert was detectable at all (thus, 100% of the clones were
defective), the 24 sequenced clones from the two pannings gave just one single stop codon
mutation (4.2% mutations).
Figure 29: Sequences of single clones isolated after 4/5 rounds of panning on p53
Ab-6, panning P#1
The variable part is flanked by the aa sequence ELGR to the left and by SSPG to the right.
HC in the middle is also invariable. 4R indicates 4th panning round, 5R means 5th panning
round. 1 out of 6 clones in the 5th round was a mutant (only five sequences therefore after the
5th round). Even after five rounds of panning, there was no enrichment of a specific clone or
consensus sequence detected.
Figure 30: Sequences of single clones isolated after 4/5 rounds of panning on p53
Ab-6, panning P#2
The variable part is flanked by the aa sequence ELGR to the left and by SSPG to the right. HC
in the middle is also invariable. 4R indicates 4th panning round, 5R means 5th panning round.
Already after four rounds of panning, a dominant sequence appeared, after five panning rounds
there is only one enriched specific sequence left in all six sequenced clones.
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The sequences from panning P#1 in Figure 29 showed no detectable enrichment of
sequences similar in the variable part of the library. In the second panning, P#2 (see
Figure 30), however, a specifically enriched sequence could be detected. Since there were
no different sequences, but just one single recurring sequence, no consensus sequence
could be concluded. But the similarity between the sequence element YSDLFHL with
the expected sequence (F/Y)SDLx(R/K)(L/M) is obvious:
The only difference between the result and the expectation is thus the histidine instead
of the arginine/lysine. This can be explained by the non-availability of R or K at this
position in the library (see chapter 3.1), and taking into consideration that histidine
can be seen as similar to those amino acids in hydrophilicity and under the pH of the
panning buffer having a positive charge. Histidine can thus be considered an acceptable
substitution for arginine or lysine.
3.3.2.4 Conclusions from panning on the model target anti-p53 Ab-6
The most important conclusion to be drawn from this panning experiment was that the
panning & selection process worked — a proof of principle. While a negative result would
have given no enriched clones, or only clones containing non-displaying mutations as was
found in the negative control panning, a successful enrichment was achieved, confirmed
by comparison with an already known sequence.
Presentation of the fusion protein was confirmed independently by antibody mediated
detection of the fusion protein (chapter 3.3.1), it was still necessary to confirm the actual
process of panning to be working.
It is noted that only a single clone had been found to be enriched as opposed to an
enrichment of clones with a similar or identical binding sequence (consensus motif) with
different flanking sequences (=variants with a consensus motif). This expected “richness”
of clones would result from panning a library of sufficient complexity, i.e., which would
hold a range of sequences containing such sequences. This result came along with the
observation that only in one of two experiments an enrichment was observed at all.
There are three possible explanations for this result — either the complexity of the
library was much lower than expected, or the washing conditions in the first rounds of
panning were too stringent, so that not all the ligands showing affinity to the target were
retained and eluted. The last explanation would be that there were too few panning
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rounds to bring out other clones and that there were not enough clones sequenced to
determine that no other clones have been enriched.
Since there were no other indications of a much lower library complexity than expected,
and one panning did not yield any enrichment at all, it was more likely that there were
limitations in how many of the ligands expressing higher affinities were kept after the
first round of panning.
The first round of panning usually is the most important one with regard to accessing
the whole complexity of a library, since clones from a complex library usually appear only
in a low number of (<104) copies (see section 1.3.3). If the washing conditions are too
stringent, coupled with a low number of copies per clone, it can happen that only a few
of the high affinity ligands are actually retained and could be eluted for the consequent
panning rounds, resulting in less or no high affinity ligands enriched in the process, even
though those ligands appeared in the original library.
Considering that only a single clone, no variations of it, had been isolated, and that
only one of two experiments yielded an enriched clone, it seems highly improbable that
the general complexity of the library was too low. If a low library complexity would be the
reason for the absence of variations on the expected binding sequence, both experiments
should have yielded the same resulting clone — which was not the case. This supports
the hypothesis that the results were originating from too stringent washing in the first
round. It was also confirmed by further work with the CPL19YS-2 library conducted
in our laboratory by Juliane Lindner and Jonas Kügler (Helmholtz Centre for Infection
Research, see section 3.3.5).
As a consequence, in the later pannings the washing times were shortened only for the
first panning round, the other parameters remaining constant as in the general guide-
lines in chapter 2.2.5.1. The conditions used are given in the respective experimental
description.
3.3.3 Test evaluation panning on CD28
CD28 is a member of the immunoglobulin superfamily of molecules (IgSF). It is a homo-
dimer of two polypeptides containing a single V-like domain with short transmembrane
and cytoplasmic regions. It serves as a co-signalling molecule for T cell activation through
binding to its cognate counter-receptors B7.1 (CD80) and B7.2 (CD86), expressed on
antigen presenting cells. The costimulation is important for the proliferation of T cells
and induction of an antigen specific immune response Linsley and Ledbetter (1993).
There are bacterial superantigens which trigger an excessive Th1-cytokine response
leading to toxic shock. These superantigens (e.g. Staphylococcal Enterotoxin B, SEB,
produced by Staphylococcus aureus), are indicated (Arad et al., 2009, submitted) to inter-
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act directly with CD28. Rather than interacting indirectly via the CD80/B70 receptors
expressed on antigen presenting cells, they lead to massive induction of Th1 cytokines
(Arad et al., 2001) which include interleukin-2 (IL-2), interferon-gamma (IFN-γ), and
tumor necrosis factor β (TNF-β or LT-α)(see Hackett and Stevens, 1993).
Due to this indicated direct interaction of superantigens with CD28, the interaction
sites of CD28 are of interest to characterize, since blocking of CD28-superantigen inter-
action sites could help to alleviate the symptoms of a toxic shock.
In the screening of the CPL19YS-2 library, no specific domain of CD28 was targeted,
the library was screened for any clones that exhibit affinity to CD28.
The CD28 molecule used as a target in the panning experiments was from two different
sources to allow two different modes of immobilization:
• A recombinant chimera of the extracellular domain of human CD28 (amino acid
residues 1–152, Aruffo and Seed, 1987) fused carboxy-terminally to the Fc region
of human IgG1 via a polypeptide linker. Source: R&D systems, USA
• A recombinant fusion protein of human CD28 (extracellular domain of CD28, amino
acid residues 1–134, Aruffo and Seed, 1987) and the Fc portion of mouse IgG2a (232
aa), which was biotinylated after expression and purification.
Source: Ancell, USA
3.3.3.1 Panning conditions
The panning was performed as described in chapter 2.2.5.1, with the exception that the
washing stringency in the first round was reduced in order to retain more phage (following
the conclusions in chapter 3.3.2.4). Therefore, in the first panning round the washing
steps consisted of rocking incubation for 10min T-PBS, 10min blocking solution and
5min T-PBS before doing the elution. In the following rounds, the complete washing
procedure was used and not changed over the course of the panning experiments.
The panning/washing conditions (and thus the panning stringency) were not changed
over the different rounds of panning (rounds 2 to 4) due to the monitored enrichment.
The amount of target immobilized was reduced for each round of panning, as shown
in Figure 31. After the second round of panning, the amplified phages were not just
panned further on the proteinA immobilized CD28, but a fraction was panned against
the streptavidin bound biotinylated CD28. This alternation of the material used as
immobilization surface should prevent any enrichment of clones which specifically bind
to either streptavidin or proteinA.
This has previously been recognized as a problem (Menendez and Scott, 2005), where
for instance HPQ-containing sequences had been enriched on streptavidin. It should
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further be noted that the motif HPQ should not occur in the variable region of the
CPL19YS-2 library.
Two independent pannings were performed (P#1 and P#2), as well as two background
control pannings with no target/antibody immobilized on the protein A beads (PB#1
and PB#2).
Figure 31: Layout for CD28 panning experiments.
After panning and elution, the remaining phages were amplified and subjected to another round
of panning (indicated by the arrows).
After the second round of panning, the amplified phages were screened under two different
conditions (two different methods of immobilization) rather than only screening on protein A
bead mediated immobilization. The amount of CD28 target shown was the amount used per
individual panning experiment.
3.3.3.2 Enrichment of eluted phages
Enrichment was detectable in this panning experiment after the 4th panning round,
independent from the immobilization method used – see Table 4. While the output:input
ratio finally went up in the experiments with CD28 immobilized, it did not change at all
for the background panning experiments (PB#1 and PB#2).
The increase in the output:input ratio for the pannings with CD28 as target is shown
in Figure 32. The background panning was left out of this graph.
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Figure 32: Output:Input ratio for different rounds of panning the CPL19YS-2 library
on the CD28 target
3.3.3.3 Analysis of isolated phages
There were two independent panning experiments (P#1 with PB#1 as background con-
trol as well as P#2 with PB#2). Single clones were picked and sequenced from each
population of isolated clones.
Defective clones were defined to contain mutations that cause either frame shifts or
stop codons in the library region. In a few cases, there was no detectable library insert at
all. Frequency of these mutations did not show any increase or variation during selection
and was in the range of the rates determined at the time the CPL19YS-2 library was
created (7.6% defective clones):
1st panning experiment (4 rounds):
• panning on target: 72/80 clones were correct (10% defective clones)
• panning on background: 15/16 correct (6.3% defective clones)
2nd panning experiment (4 rounds):
• panning on target: 68/72 clones were correct (5.5% defective clones)
• panning on background: 22/24 correct (8.3% defective clones)
In both panning experiments, enriched sequences were identified (Figure 34b for P#1,
and Figure 35b for P#2). A preferential enrichment for certain clones could be observed
in round 4 compared to round 3.
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It is worth noting that the change of the immobilization procedure seems to have
caused a change in the preferred enrichment conditions — while all 3rd rounds of panning
were run with the same phagemid population obtained from the 2nd round of panning,
different clones were subsequently enriched. This can be concluded from comparing the
clones isolated already after three panning rounds, i.e. one must summarized that some
clones had been specifically enriched for affinity to the protein A matrix material in
combination with the immobilized antibody.
The sequencing of the clones obtained from the “background” panning (panning CPL19YS-
2 against protein A beads, without any target captured) showed no specific enrichment
of single clones or similar consensus sequences (Figure 34a for PB#1, and Figure 35a for
PB#2), this result fits the lack of increase in the output:input ratio of phage during the
consecutive panning rounds (Figure 32).
A comparison of the enriched sequences does not show obvious similarities or consensus
sequences of more than one or two amino acids and therefore no definite motifs (see
Figure 33). The exception is a rather small common sequence of VYAD that comes up
in the clones #1 and #4. It seems worth noting that neither clone #1 or clone #4
were enriched in the pannings where proteinA as immobilization matrix was replaced by
streptavidin, as mentioned above.
Looking at the potential for the formation of disulfide bridges, 6 of 7 enriched sequences
possess an even number of cysteines (1×single cysteine, 5×double cysteine, 1×four cys-
teines). As mentioned by McConnell et al. (1996) and Kay et al. (1993), due to lack of
further data it can not be concluded if this is due to preferential enrichment for clones
that can form an intramolecular disulfide loop (”rigidifying“ the peptide) or just a selec-
tion against clones which possess an unpaired cysteine, potentially forming inappropriate
disulfide linkages between the displayed peptide and other cysteine residues. The clones
enriched in the evaluation panning on anti-p53 Ab-6 (section 3.3.2) did not show this
preference, as did the original CPL19YS-2 library, indicating that the preference for
paired cysteines are specific to the panning on the CD28 target.
Figure 33: Overview of sequences enriched in two independent experiments of pan-
ning the CPL19YS-2 library on the extracellular domain of CD28 (after four rounds
of panning each)
Numbers #1–#7 refer to the numbering of clones enriched after the final round in the two sep-
arate panning experiments. Clones #1–#4 were enriched in panning P#1, the clones #5–#7
were isolated in panning P#2. The frequency gives the number of clones isolated in the fourth
panning round. See Figures 34 and 35 for detailed panning results.
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(a)
(b)
Figure 34: First panning experiment on CD28:(a) Sequences of single clones isolated after
3/4 rounds of panning on protein A beads (background for CD28 panning), panning PB#1.
3R indicates 3rd panning round, 4R means 4th panning round. No single clone or a consensus
sequence of different clones could be detected.
(b)Sequences of single clones isolated after 3/4 rounds of panning the CPL19YS-2 library on
CD28, panning P#1. Numbers #1–#4 indicate clones that appear more than once and thus are
considered to be enriched rather than just being picked coincidentally. Sequences isolated more
than once are shown with their frequencies of isolation.
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(a)
(b)
Figure 35: Second panning experiment on CD28:(a) Sequences of single clones isolated
after 2/3 rounds of panning on protein A beads (background for CD28 panning), panning PB#2.
2R indicates 2nd panning round, 3R means 3th panning round. No single clone or a consensus
sequence of different clones could be detected.
(b)Sequences of single clones isolated after 3/4 rounds of panning the CPL19YS-2 library on
CD28, panning P#2. Numbers #1–#4 indicate clones that appear more than once and thus are
considered to be enriched rather than just being picked coincidentally. Sequences isolated more
than once are shown with their frequencies of isolation.
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3.3.3.4 Recombination experiment
After the enrichment and identification of several clones from panning the CPL19YS-
2 library on the CD28 target, the cassette structure of the library should be used to
examine closer which part of the sequences was contributing most to the enrichment in
the panning and therefore probably was also contributing most to the peptide’s affinity
to the CD28 target.
By ”backcrossing“ the enriched clones with the original library and panning the result-
ing new library on CD28 again, clones should be preferentially enriched that contain the
sequence parts contributing most to affinity.
In order to achieve this, either the first two or the latter two of the four cassettes from
the enriched clones from the P#1 panning on CD28 (clones #1 62, #2 75, #3 83, #4 61
from Figure 33) were replaced with the highly varied cassettes from the original library.
The principle is explained in Figure 36.
Figure 36: Principle used for recombination of four selected DNA sequences with
the sequence variety in the whole CPL19YS-2 library.
The colors blue, red, green and orange represent specific DNA sequences from specifically isolated
clones #1–#4. The yellow bar represents the whole complexity of variable DNA sequences
existing in the CPL19YS-2 library. A recombination between each left sequence parts of one
pool with the right sequence parts of the other pool results in new DNA sequences which possess
one half consisting of just four different sequence parts, with the other half consisting of various
different sequence parts from the library.
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In order to carry out this recombination procedure (see Figure 37 for an overview),
plasmid DNA was isolated from Top10F’λ carrying the CPL19YS-2 library in plasmid
format as well as from Top10F’λ cultures carrying the clones #1 62, #2 75, #3 83 and
#4 61. DNA concentration of all plasmid preparations was determined and the single
clone plasmid preparations were pooled to get a 1:1:1:1 molar mix ratio of the clones
#1–#4.
Plasmid DNA from the library mix as well as the plasmid DNA from the four clones
was digested with two different pairs of restriction enzymes, either BsrDI+BglI or
BsrDI+DraIII. Digestion with the first pair of enzymes resulted in two DNA fragments
(1514 bp and 3188 bp size), digestion with the second pair also gave two DNA fragments
(1855 bp and 2847 bp size).
From the library plasmid digestions, the larger fragments (3188 bp respective 2847 bp)
were purified by agar gel electrophoresis and following extraction from the gel. From the
clone mix plasmid digestions, the smaller DNA fragments (1515 bp respective 1855 bp)
were separated and purified in the same way.
The purified fragments were then ligated in the following combination:
• The large library fragment and the small clone mixture fragment from the BsrDI+BglI
digestion (3188 bp + 1515 bp)
• and the large library fragment and the small clone mixture fragment from the
BsrDI+DraIII digestion (2847 bp + 1855 bp)
After a cleanup procedure, the DNA was transformed into Top 10F’λ cells by electro-
poration. The final number of clones obtained in this way was
• 2×107 for the BsrDI+BglI recombination (right sequence part varied, left
part from just the four clones — further designation for the resulting library:
CPL19YS-2-CD28B), and
• 7×106 for the BsrDI+DraIII recombination (left sequence part varied, right
part from just the four clones — further designation for the resulting library:
CPL19YS-2-CD28D).
Both populations were amplified and packaged into phagemid format in order to get
two new libraries that could be used for panning experiments.
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Figure 37: Digestion and ligation scheme used for recombination of library cassettes
from distinct clones with variable cassettes from the whole CPL19YS-2 library.
The violet color represents the DNA cassettes from the four isolated clones #1–#4, the yellow
cassettes represent the variable DNA sequences present in the entire CPL19YS-2 library. Unique
recognition sites for restriction enzymes are indicated.
Phagemids, either pooled from plasmid DNA preparations of four previously isolated clones
(upper part) or from plasmid DNA preparations of the CPL19YS-2 library (lower part) were
digested using two different sets of restriction enzymes. Either the small or the large resulting
fragments were isolated and then the respective fragments from both experiments were ligated
to create recombined phagemids that contain a noted combination of library cassettes.
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Panning conditions for panning the recombined libraries on CD28 The panning con-
ditions used to pan the new libraries [designated CPL19YS-2-CD28B and CPL19YS-2-
CD28D] on the CD28 target were the same as in section 3.3.3.1.
A background control panning was carried out to detect unspecific binding, this was
the panning PB#2 from section 3.3.3.1.
Enrichment of eluted phages Enrichment was detectable in this panning experiment
already the 3rd panning round, independent from the immobilization method used —
see Table 5. Compared to the other two pannings on CD28 using the original CPL19YS-
2 library (see section 3.3.3.2), this enrichment occurred earlier. The final output:input
ratio was about the same in the 3rd and 4th round of panning, which implies that the
most affine ligands had already been enriched.
The increase in the output:input ratio for the pannings with CD28 as target is shown
in Figure 38.
Figure 38: Output:Input ratio for different rounds of panning either the CPL19YS-2
library (P#1 and P#2) or the recombined CPL19YS-2-B/-D libraries on the CD28
target
The ratios for the pannings of the CPL19YS-2 library on CD28 (green and red/orange bars) do
all show more or less the same development, while the panning experiments of the recombined
CPL19YS-2-B/-D libraries show an earlier increase in the output:input ratio (already in the 3rd
panning round, compared to the 4th round for the CPL19YS-2 pannings).
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Analysis of isolated phages In this panning experiment, single clones were picked and
sequenced for their library DNA sequence starting after the 2nd round of panning.
The frequencies of mutation (frame shift/stop codon mutations in the library region
or no detectable library insert at all) did not vary over the course of the panning exper-
iments and were even lower (144 clones sequenced, 4.1% of them were defective) than
the rates determined throughout the creation of the CPL19YS-2 library (7.6%). Due
to the relatively low number of experiments, it can not be concluded if this low rate is
due to a recombination of the original CPL19YS-2 library with clones that have been
completely verified for a correct sequence. After the 2nd panning round (see Figure 39),
most of the original kept parts of the recombined clones #1–#4 could still be found in the
sequences of the clones analyzed: From the CPL19YS-2-B library, all four different left
sequence parts could be detected, while for the CPL19YS-2-D library only two different
right sequence parts were found. Four specific clones were already found multiple times,
indicating enrichment of certain phagemids. A selection and enrichment had obviously
already happened in the two panning rounds, an enrichment that “early” in the panning
experiments had not been observed in the two panning experiments of the CPL19YS-2
library on CD28.
As it was also in the case of the panning of the CPL19YS-2 library on CD28 (sec-
tion 3.3.3.3), the modification of the immobilization procedure seems to have caused a
change in the preferred enrichment conditions — while the input for the two different
pannings in the 3rd panning round was the same phagemid population obtained from the
2nd round of panning, different clones were subsequently enriched. This effect is shown
in Figure 40 for the panning with the CPL19YS-2-B sublibrary and in Figure 41 for the
panning with the CPL19YS-2-D sublibrary on CD28.
After four rounds of panning, both sublibrary pannings yielded not just three or four
single specific clones (as with the pannings of the original CPL19YS-2 library on CD28,
compare section 3.3.3.3), but rather a multitude of different clones (with some of these
occurring more than once, see Figures 40 and 41).
The clones enriched were sorted in groups with different parts of the original recom-
bined sequences. The designations chosen for these groups were 1B-4B for the four differ-
ent original left sequence parts (for the recombined clones #1–#4) in the CPL19YS-2-B
library and 1D–4D for the four different original right sequence parts in the CPL19YS-
2-D library.
This result has to be analyzed under two different aspects — for one thing, this ex-
periment has been conducted to examine the contribution of the pre-selected sequences
to the binding to the CD28 target. If one half of a preselected sequence appears more
often after four rounds of enrichment than the other half, it is highly probable that it
contributes more to affinity than the other half which was less frequently enriched in the
parallel experiment.
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Another point is the screening for synergistic motifs by recombining the preselected
sequences with the original library — while one half of the pre-selected sequence gets
preferentially enriched over the other, the variable sequence part from the library (Fig-
ure 36) will be screened for motifs that contribute further affinity to the pre-selected
sequence halves, “enhancing” their binding properties.
If the “groups” of enriched clones shared the affinity/enrichment relevant motifs, that
could indicate that the actual conserved “half” of the recombined clones that is defining
the group designation was contributing most to the affinity — which was one point in
designing that experiment (see section 3.3.3.4).
Looking at the groups of sequences that were enriched, not at single clones, it is
obvious that different groups were preferentially enriched: In the 4th panning round of
the CPL19YS-2-B library, only 1 out of 24 clones belonged to group 1B, the other 23
clones were all from group 4B. This means that the left part of the original clone #4 was
predominantly enriched over the other groups.
In the panning of the CPL19YS-2-D library, clones from the groups 1D, 2D and 3D
were enriched finally (groups 1D and 3D for the panning on 4×proteinA beads, groups
2D and 3D for panning on 2×protein A beads and 2×streptavidin beads). No clone
belonging to group 4D could be found among the analyzed clones.
Checking all isolated clones from the 4th panning round, 43 of 44 sequences had an
even number of 2 cysteines, only one single clone (#228 in the panning of the CPL19YS-
2-B library) was found that just possessed the central fixed cysteine, without any more
cysteine in the flanking left or right sequence parts. As already discussed for the first two
panning experiments on CD28, the selection for paired cysteines indicates advantageous
properties for those clones (like a “rigidified” peptide structure or the “presentation” of
an amino acid motif between two cysteines), although this can not be confirmed without
direct comparison experiments or structural data.
A comparison of the enriched sequences does not show obvious similarities or consensus
sequences of more than one or two amino acids and therefore no definite motifs.
However, as already noted in section 3.3.3.3 from the pannings of the original CPL19YS-
2 library, the VYAD motif is part of the sequence in the two most enriched groups in
the pannings (group 4B, Figure 40 and group 1D in Figure 41). As in the first panning
experiments on CD28, in the panning of the sublibrary CPL19YS-2-D the group of clones
containing the VYAD motif was selected against in the 3rd/4th round of panning after
switching from proteinA beads to streptavidin beads. In the panning of the CPL19YS-
2-B library on CD28, the group of clones containing VYAD was still present after the
switch of the immobilization matrix. This could mean either that VYAD is not specific
for the proteinA matrix in combination with the target, or that the first two rounds
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of enrichment on proteinA beads already enriched this group of clones enough to stay
dominant after the change of the target immobilization method.
In the group of clones enriched from the CPL19YS-2-B library a weak consensus se-
quence can be assumed after four rounds of panning (Figure 40). This consensus sequence
is S(L/F)(L/F)(H/N/P)GGCAA, but has not appeared at any other position in the en-
richment. The loop length of the (potential) disulfide loop is seven /six amino acids,
enclosing mostly small amino acids .
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Figure 39: Sequences of single clones isolated after 2 rounds of panning the recom-
bined libraries CPL19YS-2-B and CPL19YS-2-D on CD28
“grouping” was done based on from which original clone the fixed sequence part was (B for
clones with the left parts kept, from the CPL19YS-2-B library, D for clones with the right parts
kept, from the CPL19YS-2-D library). Sequences isolated more than once are shown with their
frequencies of isolation.
100
3 Results and discussion
Figure 40: Sequences of single clones isolated after 3/4 rounds of panning the re-
combined library CPL19YS-2-B on CD28
“grouping” was done based on from which original clone the fixed sequence part was, B indicates
origin from the CPL19YS-2-B library. Sequences isolated more than once are shown with their
frequencies of isolation. A weak consensus sequence can be assumed in the sequences isolated
after four rounds of panning, especially in the last seven sequences. It starts after the central
fixed HC position and is S(L/F)(L/F)(H/N/P)GGCAA, but has not appeared at any other po-
sition in the enrichment. The loop length of the (potential) disulfide loop is mostly seven amino
acids, enclosing mostly small amino acids.
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Figure 41: Sequences of single clones isolated after 3/4 rounds of panning the re-
combined library CPL19YS-2-D on CD28
“grouping” was done based on from which original clone the fixed sequence part was, D indicates
origin from the CPL19YS-2-D library. Sequences isolated more than once are shown with their
frequencies of isolation.
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3.3.3.5 Conclusions from panning on CD28
The two independent panning experiments gave comparable results, although the isolated
clones did not show obvious similarities. Both independent pannings took about the same
number of panning rounds to enrich the clones finally perceived as dominant; the fact
that the sequences are not looking similar can not be explained finally — it remains
open if this is either due to an original library complexity that was too high to allow
reproducible enrichments: The original fraction of phages used for the first round of
screening in phage display needs to contain at least 104 clones of each presented peptide
in order to reproduce enrichments (from personal communication with John Collins).
The complexity used here, 4.2×108 definitely approached that limit, considering the
amounts of phage used in the initial panning rounds (2.3×1012). This result further
emphasized the considerations regarding the desired complexity of a primary library, as
discussed in secton 3.1.1.
None of the panning experiments on CD28 yielded any detectable enrichment of target-
unspecific motifs. While this eliminated the problem of having to determine which en-
riched candidates were matrix- and which were target-specific, the question arises why no
clones from the library were showing affinities to the immobilization material that was
common in some experiments (polystyrene Dynabeads and the recombinant proteinA
that was covalently coupled to the beads, in some pannings used in four consecutive
rounds). A minor point could be that the majority of motifs enriched on protein A
(according to Menendez and Scott, 2005) contained tryptophan, which is absent in the
library.
The two different immobilization methods used seemed to have an impact on the
preference on which clones were finally enriched. While this change of the immobilization
method for the target used for panning (section 3.3.3) had originally been implemented
to reduce the enrichment of target-unspecific phages, it also introduced a slight change
in the structure of the target itself, since the recombinant fusion protein used in the
first two panning rounds contained the amino acid residues 1–152 of CD28, and the
biotinylated fusion protein that was used partially in the rounds 3–4 contained only
amino acid residues 1–134.
This slight difference in the presented target was necessary due to the commercial
availability of the target, however, it also showed that the target structure had a clear
effect on the preference for certain clones. Were structural information about the iso-
lated clones available (see also section 3.4 for prediction algorithms inferring secondary
structure likelihood), which is not, one could try to relate the change in preference to
the change of target structure.
Right now the final proof remains to be given that the isolated clones actually ex-
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hibit affinity to the CD28 target, even without the surrounding structuring matrix the
phage surface might provide. The unsuccessful experiments to analyze target-peptide
interactions are presented in section 3.5.
3.3.3.6 Effect of recombination on the panning process
Due to time and material constraints, the panning on CD28 using the recombined clones
was only performed once, so the reproducibility of the outcome can not be evaluated.
The fact, however, that a strong enrichment was observed, implies at least that the two
recombined libraries are usable for screening.
Even though accurate measurement values were not possible (e.g. from Biacore exper-
iments, see section 3.5), the observed results indicate that the recombination of clones
isolated from a panning and ”backcrossed“ with the original library indeed was advanta-
geous for the affinity properties of clones in the library, since the output:input ratio of
phages went up earlier in the panning cycle using the recombined libraries than it did
for the original CPL19YS-2.
This does however not give information if the recombined clones are actually more
affine, or if the new sublibraries just have a greater portion of clones that express affinity
to the target (due to the motifs contributed by the clones enriched on CD28 before).
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3.3.4 Evaluation pannings on other targets
In addition to the pannings on the anti-p53 Ab-6 antibody and CD28, there were two
more panning experiments – on streptavidin coated beads Dynabeads M-280 Streptavidin,
Invitrogen, California) to select for clones specific to the streptavidin surface, and on the
M3.5 protein (a part of the M3 protein of group A streptococci, Dinkla et al., 2007,
2009), which was expressed as a GST (glutathione S-transferase) fusion protein and
immobilized on glutathione sepharose beads (Glutathione Sepharose 4 Fast Flow, GE
Healthcare, United Kingdom).
The panning of the CPL19YS-2 library on streptavidin beads was performed similarly
to the pannings on CD28 without anything immobilized on the beads, to get comparable
results and determine potential streptavidin specific sequence motifs in the library. The
panning on the GST-M3.5 fusion protein was performed on amounts of 10–80µg of target
in PBS, following the conditions stated by Dinkla et al. (2007).
The library was panned twice on both targets for four rounds, but no enrichment was
detected, neither an increase in the phage output:input ratio, nor any enrichment of
specific single clones. After four rounds, mainly clones had been enriched that contained
deletions in the library region, leading to no expression and presentation of fusion protein
at all.
The enrichment of clones encoding no (presentable) fusion protein at all is usually a
strong indication for no target-specific enrichment at all, since phagemid infected bacteria
without an encoded fusion protein have a slight growth advantage. The absence of any
increase in the phage output:input ratio after each panning round further supports that
conclusion, suggesting that the CPL19YS-2 library does not contain clones with high
affinities to both targets.
3.3.5 Evaluation panning on a polyclonal serum recognizing a specific
linear Pseudomonas peptide antigen
Since the panning of the CPL19YS-2 library on the antibody anti-p53 Ab-6 (section 3.3.2)
had only yielded a single clone with an expected motif enriched, another evaluation
panning on antibodies was conducted. This work was carried out by Juliane Lindner
and Jonas Kügler (Helmholtz Centre for Infection Research). The results are, however,
presented here, as they provide valuable data for the evaluation of the library with respect
to diversity and quality.
The panning target is a polyclonal mouse serum against a peptide from Pseudomonas
aeruginosa with the sequence CVAPTADEHFTTLFQATNPS. It was expected that re-
lated, perhaps overlapping motifs would be enriched during panning the CPL19YS-2
library.
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3.3.5.1 Panning conditions
The panning was performed as described in chapter 2.2.5.1, except for the washing con-
ditions, which were changed to ten times washing with PBS-T. The amount of target
immobilized for each panning was 50µL of serum, immobilized on 50µL of protein A
beads. Four rounds of panning were performed, the clones enriched after the fourth
round were analyzed by sequencing.
3.3.5.2 Analysis of isolated phages
After four rounds of panning, 32 clones were analyzed per sequencing. Of these, 2 were
“defective” in that they had a stop codon mutation in the library sequence, leading to
no expression of the peptide-pIII fusion (6.25% defective clones, in line with the other
pannings).
In contrast to the panning on the antibody anti-p53 Ab-6 (section 3.3.2), a large set
of different clones was enriched in this experiment, and all of them sharing a region of
sequence homology, allowing the proposal of a consensus sequence for the region probably
contributing the most to the affinity to the polyclonal antibodies (Figure 43a).
It can also be noted that a single clone, # 19 (Figure 43b), was enriched that contains
a motif of 10 aa length which is almost identical to a 9 aa stretch of the Pseudomonas
antigen with the exception of the red A position and the insertion of a D at the fourth
position. This clone’s sequence is the one that is closest to the Pseudomonas peptide
against which the polyclonal antibodies were generated.
The only position where no amino acid in the consensus sequence corresponds with a
respective amino acid in the Pseudomonas peptide is the glutamic acid in the marked
blue region, where only alanine, aspartic acid or leucine were found in the enriched clones
at this position. As no glutamic acid was intended to be encoded in the variable part of
the library, it would not be available for enrichment.
However, considering that aspartic acid has a similar hydrophilicity a positive charge
under the pH of the panning buffer, aspartic acid can be considered an acceptable sub-
stitution for glutamic acid at this position.
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Figure 42: Sequences of single clones isolated from the CPL19YS-2 library after 4
rounds of panning on a polyclonal antibody serum against the Pseudomonas peptide
CVAPTADEHFTTLFQATNPS
The amino acid sequences have been aligned with the Pseudomonas peptide sequence to allow
the recognition of a consensus sequence. Clones isolated more than once are shown with their
frequencies of isolation.
(a)
(b)
Figure 43: Motifs obtained from panning the CPL19YS-2 library on a polyclonal
antibody serum against a Pseudomonas peptide (a) Consensus sequence from 13 different
clones compared to the original Pseudomonas antigen (b) The clone 19 has a motif of 10 aa length
that is almost identical to a 9 aa stretch of the Pseudomonas antigen with the exception of the
red A position and the insertion of a D at the fourth position.
3.3.5.3 Conclusions from panning on a polyclonal serum recognizing a specific
Pseudomonas peptide
The results from this panning experiment complement the previous validation screening
of the CPL19YS-2 library on the anti-p53 Ab-6 antibody. They further confirm that
panning & selection is working. This is an independent validation of the quality of the
new library. In comparison to that previous panning, a variety of different clones was
enriched which all shared a long (7/8 aa) easily identifiable consensus sequence.
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This enrichment of clones with a similar or identical binding sequence (consensus
motif) with different flanking sequences is expected from a highly diverse library. This
supports the final (assumed) conclusions drawn after the panning on the anti-p53 Ab-6
antibody, stating that the lack of diversity in the obtained clones from that experiment
was rather due to too stringent washing conditions than to a lack of diversity in the
library. Previous uncertainty of library quality based on earlier experiments are thus
considered invalidated.
The statistical probability that a clone, randomly picked from the library, will contain
the enriched consensus sequence (Figure 43a) can be calculated estimated:
Averaging ten different possible amino acids per variable position, the positions 1(A),
2(P), 4(A), 5(D) and 7(H) would each contribute a 10% probability (only one defined
amino acid), while positions 3(T/S) and 8(F/L) would each give a 20% probability (two
defined amino acids from ten possible). These probabilities, multiplied by five as the
number of overall five possible positions that might hold the consensus due to limitations
in library composition, result in a probability of 5
105×52 = 2 × 10−6. Multiplied with
the (assumed) library complexity of 1.8 × 108 (section 3.2.2.3), one could expect about
360 different clones in the library expressing the consensus sequence. 12 clones have
been enriched dominantly in the panning when 32 clones have been analyzed after four
panning rounds, there may be more different clones present in lower concentrations.
Using an additional correction factor of 3 due to the (statistically low) sampling number
of just 32 clones sequenced (Collins, 1997), one comes to the final result that there would
be about 36 (=12× 3) clones enriched in the experiment, which means that ∼10% of 360
clones with the expected motifs got enriched in this screening.
It is noted that the epitopes isolated here from the CPL19YS-2 library are linear
motifs; 11 out of 12 enriched clones present that motif outside of a (postulated) disulfide
stabilized loop. While disulfide bridges confer stability in general, and in fact 10 out of
12 clones have an even number of cysteines, one would expect linear motifs to be enriched
when panning against polyclonal antibodies that were selected against a linear peptide.
Thus, this test did not validate the efficiency of the library for isolating complex motifs
with secondary structures, but the findings are consistent with the expected library
complexity, stability of the library and a reasonable efficiency of display.
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3.4 Computer analysis of secondary structure elements in
peptides from the library
It is generally expected that an enrichment of binding motifs is enhanced by the ligand
forming a secondary structure. Being able to characterize secondary structures formed
would therefore help to evaluate binding motifs. Since accurate predictions of the sec-
ondary structure are not possible based solely on the amino acid primary structure,
computer analysis methods are used that take known structures into account as well.
The prediction of the secondary structures used here was performed using the Phyre
system (Protein Homology/analogY Recognition Engine,
http://www.sbg.bio.ic.ac.uk/phyre/ – see also Bennett-Lovsey et al., 2008). The models
produced by Phyre are based on finding a sequence alignment to an already known struc-
ture, copying the coordinates and relabeling the residues according to the input sequence.
Different prediction algorithms are used to generate the final prediction sequence.
All work for entering the sequences to Phyre and retrieving the prediction results was
kindly done by Joachim Reichelt, Helmholtz Centre for Infection Research, department
of Structural Biology.
The prediction of secondary structures in peptides is difficult at best and should be
considered only as an indication of what might actually be a structural feature. Even with
proteins, which usually present a more fixed structure than flexible peptides, predictions
are usually only valid for 70–80% of all cases. The prediction algorithms do not take
(potential) disulfide bridges into account, although those could be added later manually
in predicted 3D models in many cases. The predicted sequences were not precise enough,
however, to make an addition of those disulfide bridges possible in most cases. This is
mainly due to difficulties in structure prediction of short peptides, further analysis would
require information on structure data e.g. by crystallization.
The information generated by Phyre in this analysis gives either
• C for a “random coil” formation of the respective amino acids,
• E for a straight “extended” structure of the amino acids, or
• H for a helical structure that the amino acids form.
The first comparison was for a number of ten clones randomly picked from the library,
compared to ten completely random peptides. The goal was to determine if certain
structural features were either dominant or preferred, or if any structural components
would show up at all.
As can be seen in Figure 44, the variable sequence part of peptides from the library
does not differ much from the fully randomized control sequences shown below. The
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fixed sequence parts in front and after the variable parts seem not to contribute to
other structural features, being just random coil elements that are shared amongst all
candidates from the library.
Especially for the last seven amino acids this is desirable, since those amino acids were
supposed to act as flexible linker and not be part of any potential interaction site.
Analyzing the peptides that have been enriched in the pannings on CD28 (Figure 45)
offers additional information: Without differentiating between different panning exper-
iments, it can be clearly seen that the occurrence of helical structures is significantly
less frequent (13%) than it was in the peptides picked randomly from the library (36%)
or the fully randomized peptides (50%). Since helices form rather rigid structures, this
is an indication that flexibility was required for the enriched peptides to attach to the
CD28 target.
The first seven peptides in Figure 45 were enriched independently, but still share a
few properties: A stretch in the middle of the peptide (5–11 aa) is always forming an
extended structure, which is flanked by a few random coil elements and in most cases
another extended structure to the left and to the right. The fixed positions to the left
and the right of the variable sequence parts are again random coil, as concluded already
from the random library peptides.
In the recombination experiment, the first four clones (61–83) had been recombined
with the original CPL19YS-2 library and the resulting new libraries been panned on
CD28 again, after which new clones were enriched (several of them shown in this figure,
sequences 217–240 from recombination with the left peptide part kept fixed, sequences
241–263 from recombination with the right peptide part kept fixed). Even considering
that the left or right part of the sequence was not just random, but taken from four dis-
tinct clones, the enriched peptides look surprisingly similar in their predicted secondary
structures: The majority of recombined enriched peptides was consisting of two closely
neighbored extended stretches of amino acids (a stretch in the center of the peptide of
again 5–11 aa, and another extended section of 5–6 amino acids).
The only five peptides breaking that pattern are the candidates 254–262, where Phyre
predicts potential helical structure elements. It can not be resolved finally if those are
just artifacts from small homologies found in the prediction process, but it is notable
that the only five peptides with helical structure element prediction have emerged in the
panning of the recombined CPL19YS-2-CD28D library on the CD28 (after the change in
immobilization method, indicated by the D4B, see section 3.3.3.1).
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3.5 Analysis of target-peptide interactions
3.5.1 Surface plasmon resonance affinity measurements
With several clones enriched in three different panning experiments, more data was
required on the actual absolute affinities of the encoded peptides to the CD28 target.
This data should be obtained by Biacore measurements (section 2.2.5.5), immobilizing
peptides on the surface of the sensor chip and using CD28 as analyte to determine the
affinity constants of the respective peptide to CD28.
The peptides required for the interaction studies could not be obtained directly from
the phagemid preparations (no pre-determined cleavage site available), and measure-
ments of the whole phagemid particles presenting the peptides would have influenced
the results potentially too much (due to possible interaction of phage surface and the
peptides; small changes in the valency of presentation that could have a huge impact on
the perceived avidity).
The peptides were synthesized chemically by Raimo Franke from the department of
Chemical Biology at the Helmholtz Centre for Infection Research, Germany. The syn-
thesis method was Fmoc/tert-butyl solid phase synthesis on a Multisyntech Syro peptide
synthesizer. The synthesis products were purified in a preparative HPLC (high perfor-
mance liquid chromatography) step and the fractions containing the expected molecule
mass were determined by LC-MS (liquid chromatography-mass spectrometry).
The synthesized peptides (Figure 46) lack an additional GELG-sequence on their N-
terminus. This region was constant in all peptides from the CPL19YS-2 library and not
specific for single enriched clones, therefore it was left out due to encountered difficulties
in the chemical synthesis. A C-terminal lysine was added after a constant linker region
SSPG. This lysine is biotinylated (ordered from Novabiochem) to allow immobilization
of the peptides on streptavidin, fixing the peptide similarly to the original fusion to the
pIII phage protein.
Problems encountered in the synthesis process, due to peptide length and aa compo-
sition, led to broad peaks in the chromatograms of HPLC and MS-LC. Aggregation is
a probable explanation, considering the hydrophobic sequence stretches in the synthe-
sized peptides. It was most probably also causing most of the synthesis attempts not to
succeed, in that analysis of synthesis products did often not show the expected product
mass at all.
Due to the limitations mentioned above, only 4 of originally 16 peptides specified were
finally synthesized.
To determine if the recombination process was yielding candidates with improved affin-
ity, recombined clones (#253, #254 and #261) were compared to a clone that had been
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enriched in the first panning (clone #75) and that had been used for the recombination.
This conferred a comparison of 13 variable amino acids on the amino-terminus side of
the peptide — all showing the same 13 amino acids plus a SSPG linker at the carboxy-
terminus. All had the potential for forming a single disulfide bridge within the variable
peptide.
With the sensor chip consisting of four flow cells, the first cell was left empty (with no
ligand coupled to the surface) as reference cells.
Peptides #75, #254 and #253 were picked for the measurements first (since there
were only three cells left for measurements and peptide #261 had the highest grade of
impurity from the synthesis).
The peptides were immobilized on the sensor chip as described in section 2.2.5.5 (see
Figure 48).
The injection of the CD28 analyte, however, did not yield any difference in relative
response (RU) for the flow cells with the immobilized peptides (fc2–fc4) from the con-
trol cell (fc1). The analyte was added first at a 100 nM, then at a 1µM concentration
(Figure 47).
Dissociation was detectable right after the injection of CD28 was ended, and the abrupt
drop was the same for all four measured cells, not significantly different from the reference
cell (with the reference cell giving the strongest signal). The dissociation did not follow a
characteristic dissociation curve as expected from strong interaction partners. The signal
did not return to the baseline, though, even after attempts to regenerate the sensor chip
surface with 1.5M NaCl, 3M NaCl and 10mM glycine (pH3) (see Figure 49). This
indicates that some molecules must have remained on the surface of the chip, regardless
of immobilized peptide in a flow cell or not.
Figure 46: Sequences of peptides synthesized for Biacore affinity measurements in
regard to CD28
The first peptide (#75) was isolated in the first panning experiments of the CPL19YS-2 library
on the CD28 target, while the other three peptides were enriched in a panning of the recombined
CPL19YS-2-D library on the CD28 target. They share the right sequence part with the peptide
#75 due to the recombination.
While the phage displayed peptides had an additional GELG-sequence on their N-terminus, this
region constant in all clones was left out due to synthesis difficulties. The C-terminal lysine added
after the constant linker region SSPG is biotinylated to allow immobilization of the peptides on
streptavidin, fixing the peptide similarly to the original fusion to the pIII phage protein. In the
library peptides, the pIII protein is fused to the SSPG linker after an additional TPDI sequence
(see p.59, Figure 16).
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Furthermore, after injection of the CD28 analyte solution into a flow cell, no additional
peptide could be immobilized on the streptavidin chip (data not shown here), even using
much larger amounts of peptides than in the initial immobilization step. The CD28
protein itself was ruled out as binding irreversibly to the surface, since the ”background
signal“ remaining after injection of CD28 was below 100 RU, while a molecule of a mass
of ∼42 kDa (mass of reduced monomer of the CD28/fc fusion) completely covering the
sensor chip surface would yield signals of several thousand RU.
While biotin, as a rather small molecule (244Da), could explain the shift in mass as
well as the inaccessibility of the surface to biotinylated peptides, the manufacturer of the
CD28/fc fusion denied remaining traces of biotin in the final preparation of the protein,
and the PBS buffer solution alone was not found to block the chip surface before.
The experiment was repeated with another sensor chip to verify the measurements,
giving similar results.
Injection of CD28 into the flow cells of a Biacore CM5 chip (same surface as the strep-
tavidin SA chip, just without the covalently bound streptavidin) resulted in a temporary
binding to the surface (as expected), and returned to the base line after injection. This
shows that the observed phenomenon of irreversible binding to the chip surface is depen-
dent on the streptavidin and its interaction with some substance in the CD28/fc solution,
although this substance could not be determined.
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Figure 47: Injection of CD28 analyte to measure the affinities of peptides immobi-
lized on a streptavidin SA Biacore chip
CD28 was injected into the four flow cells for 120 s, at a flow rate of 30µ. Two different concen-
trations of CD28 were used.
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Figure 48: Immobilization of three selected peptides on a streptavidin SA Biacore
chip
Three different peptides were immobilized on the Biacore chip in respective flow cells (fc2–fc4),
the first flow cell (fc1) was left empty as a reference cell. Peptide was added until RU values
between 150 and 300 were reached to allow for sensitive measurements later after adding of the
analyte.
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Figure 49: Attempts to regenerate the flow cells of a streptavidin SA Biacore chip
after injection of CD28
The flow cells on the Biacore chip used in the experiment in Figure 47 were attempted to
regenerate in three different steps after the affinity measurements that were conducted until
second 500. Regeneration of the chip surface was attempted by rinsing the flow cells twice for
one minute each at a flow rate of 30µL/min, using 1.5M NaCl, 3M NaCl and 10mM glycine
(pH3).
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3.5.2 Relative ranking of peptide affinity by phage ELISA
A phage ELISA experiment, comparing the affinity of defined amounts of different
phagemid particles presenting encoded peptides to the CD28 target, allows an estimation
of the relative ranking of the peptide candidates.
It still must be taken into account that differences in fusion protein expression levels,
potential differences in valency and the structural environment of the phage particle
surface can influence the results.
For the relative ranking, the clones selected in the Biacore measurements (clones #75,
#253, #254 and #261, section 3.5.1) were packaged into phagemid particles and the
tetracycline/kanamycin titers (amount of helper phage) as well as the tetracycline/ampicillin
titers (amount of phagemid particles) determined.
While a ratio of 1:10 to 1:5 was expected (and achieved with other packaged phagemid
particles), these packaged clones had much higher ratios of M13K07 helper phage to
phagemid particles of between 20:1 and 500:1. Their ratio of native pIII to fusion-protein
pIII was not known, but could be different from the ∼10% presentation value determined
in section 3.3.1 due to the observed difference in the ratio of helper phage to phagemid
particles.
In the actual ELISA measurements, ∼109 phage particles (from each clone) were in-
cubated with the immobilized CD28 target in separate microtiter wells as described in
section 2.2.5.6.
However, there was no observable difference at all between the amounts of phage
remaining bound to the microtiter plate wells after washing, be it M13K07 or a fraction
from the original CPL19YS-2 library (both as controls) or the four clones of interest
(clones #75, #253, #254 and #261).
Changes in washing stringency or repeating the experiment gave similar results of no
observable increased affinity of the phagemid particles encoding the enriched peptides.
3.5.3 Conclusions from affinity measurements
The enrichment experiments had shown results indicative of successful enrichment of high
affinity ligands; panning experiments from the literature using primarily monovalently
displayed peptides have never been found to enrich ligands with KD values worse than∼1500 nM.
Although the measurements were hindered by the observed unexpected irreversible
binding to the sensor chip surface after injection of the CD28 analyte solution, an affinity
value of better than 500 nM would have been noticeable using analyte concentrations of
up to 1µM. So while the measurement itself showed to be not optimized methodically,
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a high affinity interaction between the selected synthetic peptides and the CD28 target
protein could not be quantified.
Since both experiments that were performed to assess the affinities of the peptides did
not give any indication of high affinities, their implication of low affinity of the enriched
peptides toward CD28 should not be overlooked. But these implications are contradicting
the results of the panning enrichments, and both experiments could have been impaired
by several factors:
The plasmon resonance measurement was performed using synthetic peptides. While
it could not be guaranteed that these peptides would show the same “folding” (if it can
be expected from the peptides used here), the oxidative conditions used to allow for the
forming of intramolecular disulfide bridges could not be guaranteed to match the cell
environment as well. The purity of the synthetic peptides was also not as high as one
could have desired, although this was due to the difficult synthesis process which yielded
only minor amounts of peptide. The effects of by-products or substances potentially
remaining from the synthesis could also affect the peptides’ stability or their potential to
bind to the CD28 target molecule, and no information was available if the immobilization
procedure was presenting the peptides in a similar way to the conditions on the phage
surface.
By using the ELISA measurement, the use of synthetic peptides should be avoided by
measuring the affinity of peptides presented on the phage surface, matching the conditions
used in the panning (synthetic peptides could have been added competingly in a second
step if there had been detectable affinity of phagemid particles) and ruling out effects
of the synthesis process. The observed difficulties in packaging the specific clones of
interest were different from the conditions observed in the original panning experiments,
though, and could not be corrected by repeated packaging preparations. If expression
of the fusion peptide was impeded in these clones enriched specifically, it would explain
non-observable affinity in the ELISA measurement as well.
Experiments to re-clone just the peptide encoding sequence into an expression vector
appeared to be a good way to determine if the packaging problems were an effect of the
encoded peptides itself (potentially causing growth disadvantages to host cells, either
being toxic or inhibiting the metabolism) or acquired by mutation of a remote part of
the phagemid DNA. These experiments could not be conducted due to time limitations,
however, leaving the problems noticed, but unexplained.
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4.1 Rationales for designing a peptide library
The aim of this work was to establish and evaluate a phage displayed peptide library that
is suitable for the isolation and characterization of very high affinity ligands for variable
targets, thus not being tailored for specific purposes.
Starting with the design of the library, a phage displayed peptide library was chosen.
While today peptide libraries are mostly used for epitope mapping (e.g. Böttger and
Böttger, 2009; Uchiyama et al., 2005) and antibodies/antibody fragments are used for
the isolation of high affinity ligands especially for pharmaceutical targets (Dimitrov and
Marks, 2009), there have also been numerous successes to identify high affinity peptides,
e.g. a peptide with a KD of 68 nM to glycoprotein GPIα (Benard et al., 2008), the
model selection of a mRNA-displayed peptide binding to a monoclonal antibody against
human TP53 (KD=6nM) by Shiratori et al. (2009) or a p53 competing peptide for the
oncoprotein MDM2 (KD=3.4 nM) by Pazgier et al. (2009).
Although antibodies are used often as pharmaceutical candidates (Stockwin and Holmes,
2003), they later need to be trimmed down in size as far as possible to reduce immuno-
genicity (Irving et al., 2001), which leads more researchers towards peptides as pharma-
ceutic candidates (Ladner et al., 2004).
Peptides possess several more intrinsic advantages over antibodies as drug candidates,
including lower manufacturing costs (synthetic versus recombinant production, see Lad-
ner et al., 2004), a higher activity per mass (15–60-fold, assuming 75 kDa for one com-
bining site of an antibody and 10–50 amino acids), less chance of unintended interaction
with the immune system (assuming the peptide contains no known immune-system sig-
naling sequence, Ladner et al. (2004)), and better organ or tumor penetration (Graff and
Wittrup, 2003; Ruoslahti et al., 2005). Therefore, the small molecules obtained from
peptide libraries offer new approaches and are favored by the pharmaceutic industry if
available.
Considering these facts, the selection of a phage displayed peptide library was a viable
choice for the library format established in the course of this thesis.
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4.2 Covering complexity in library design
In the design of peptide libraries the potential complexity of a library is an important
quality criterium. However, the higher the potential complexity is, the lower is the
fraction of this complexity which it will be possible to cover in actually making the
library.
Even with new display technologies as e.g. in vitro-compartmentalization (section 1.2.1.4),
libraries are limited in size such that at the most only fully randomized 9- to 10-mers
could be adequately represented (Matsuura and Yomo, 2006).
An additional problem arises then in the efficiency of selection of individual clones
under panning conditions where maybe less than 10 displaying particles of an individual
clone are present in the initial challenge. With individual concentrations that low, es-
pecially when long washing steps are included, the retention of clones in the first round
becomes a “lottery” (Szardenings, 2003).
One response to this limitation could be deliberate reduction of the full complexity,
whereby a reduced repertoire choice is self-imposed, or just tailoring towards specific
targets, as with the ribonuclease inhibitor derived leucine-rich-repeat libraries of Stumpp
et al. (2003) or β-barrel scaffold libraries like the GFP-based libraries developed by Abedi
et al. (1998).
Reduction of complexity without reducing peptide length involves rational consider-
ations on similarity of structure between different amino acids. Such model concepts
should be confirmed experimentally. This was done e.g. done by Fellouse et al. (2004)
who created a synthetic library using a Fab framework with CDR diversity restricted
to four amino acid types (tyrosine, serine, alanine, aspartate), obtaining antibodies with
2–10 nM affinities to human vascular endothelial growth factor (VEGF). Further restric-
tion to just tyrosine and serine (Fellouse et al., 2005) still yielded antibodies with 60 nM
affinities to VEGF (see e.g. the review of Koide and Sidhu, 2009, for further details
on reduction of amino acid diversity). This concept has rarely been used for peptide
libraries (e.g. Larsson et al., 2002), but has never been tested thoroughly for peptide
libraries (Szardenings, 2003).
The approach of a deliberately limited complexity has been taken in the library design
described here, resulting in a reduced repertoire of amino acids at each position. These
are arranged in a set of four cassettes which can be recombined with each other either
during the process of creating the library or at any later stage. The potential complexity
of each cassette is below 108. The library was assessed with regard to its constitution
and expression of the fusion peptide, thus a library comprising > 2 × 108 clones should
carry all possible cassettes according to the library design (as in Figure 16, p.59).
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4.3 Recombination as a key feature of the CPL19YS-2
library
The CPL19YS-2 library consists of four cassettes that would yield a theoretical com-
plexity of 1.6×1025 when fully recombined. This represents a much higher potential
complexity than what is common in conventional peptide libraries.
While conventional phage libraries are limited in their maximal complexity due to the
above mentioned low concentrations per clone in the initial challenge round, the full
potential complexity of the CPL19YS-2 library is not available in a single panning round
as well. The amount of different clones that can be screened per panning round is still in
the 108 range, but new diversity can be generated easily between panning experiments,
adding new combinations from the pool of the potential 1.6×1025 candidates.
Recombination as a tool to add diversity and additional complexity has been postulated
already by Moore et al. (1997). Methods used to add library diversity like e.g. successive
rounds of point mutations (Yu and Smith, 1996), will increase the diversity linearly.
Recombination between already existing or induced mutations as already performed by
e.g. Stemmer (1994a,b), in contrast, will yield exponential potentiation of the existing
diversity.
While different DNA shuﬄing methods have been established since 1994, their require-
ment of ∼70% sequence homology at the recombination sites makes them only suitable
for larger proteins where low density mutations are reassorted, not mostly completely
randomized smaller peptide libraries where such a sequence fixation would cover a large
part of the supposedly variable sequence.
Shuﬄing cassettes in an ordered way by the method of Cosmix Plexing was shown to
be a feasible way to increase the complexity of the primary library and to generate new
variants, giving access to a highly complex, but still accessible library of peptides. As
already established by Collins et al. (2001), this method did not require the long homology
stretches used in other recombination technologies. The recombination process used was
not a one-time action but could be repeated as often as desired to generate new diversity.
The recombination technique Cosmix-Plexing can be used for three different purposes:
• Increase of library diversity: The clones from the primary CPL19YS-2 library
were recombined with themselves, generating ∼2.4×108 combinations in a single
enzyme restriction, religation and cloning step (Section 3.2.2.3). This procedure
was not observed to confer any bias on sequences recombined (section 3.2.2.5).
• Backcrossing of enriched clones with the CPL19YS-2 library: Cosmix-
Plexing can also be used to “backcross” enriched clones with a library to increase the
variety in defined cassettes, while keeping the enriched sequences of the remaining
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cassettes (Figure 12b). Using this approach, it is possible to screen the library
for sequences that are synergistic to the sequences in the kept cassettes. It can
also be analyzed which cassette(s) of an enriched peptide are contributing most to
enrichment by replacing specifically either one or another sequence part.
This method has been used with clones obtained from a panning on CD28 (sec-
tion 3.3.3.4). The newly generated sublibraries CPL19YS-2-CD28B and CPL19YS-
2-CD28D showed a much faster enrichment and earlier increase of the output:input
in the panning cycle than the original CPL19YS-2 library, indicating that the new
sublibraries possessed already higher target-specific affinities at the beginning of
the panning experiment. It was also notable that certain pre-selected cassettes
were enriched over others, giving leads for further analysis of interacting motifs.
• Recombination between enriched clones: Clones from preselected populations
(e.g. >104), as the clones obtained after 1–2 panning rounds, often contain several
different motifs that confer target specific affinity. If these clones are recombined
using Cosmix-Plexing, a new library with increased target-specific diversity (>108
clones) could be generated and be subjected to further panning rounds. This has
not been applied during this thesis, so further testing is required to confirm the
theoretical advantage of this technique.
The recombination process has been established and shown to be working without any
noticeable bias introduced by the recombination process.
4.4 Considerations for secondary structure in the
CPL19YS-2
Guided development of secondary structure in the CPL19YS-2
Working with peptide libraries to identify highly affine ligands, one encounters their
limits when the target requires more than just linear chains of amino acids. Linear
peptide motifs will be as they are most common in short peptide libraries (<8–12 aa, as
are the lengths of peptides in commonly used libraries — see e.g. Noy et al., 2008) or in
any clones that do not form stable secondary structure.
While it is possible to isolate short peptides that assume non-linear conformations at
least when bound to specific targets, as for example a hexamer mimicking a nicotinic
acetylcholine receptor site (by Balass et al., 1993), it is generally accepted that longer
peptides increase the chance to form secondary structures: The longer peptides get,
the more chance there is for intra-molecular stabilization in the form of hydrogen-bonds
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or hydrophobic sidechain interactions. These restrictions reduce entropy, and they also
restrict the available conformations a peptide may take. Longer peptides allow for further
stabilization by the potential for formation of alpha helices or beta sheets. These motifs
usually take at least ten to fifteen amino acids to form, which is already more than
most peptide libraries comprise. Short polypeptides generally do not exhibit much of
these secondary structure in solution, as the entropic cost associated with the folding
of the polypeptide chain is not compensated for by a sufficient increase in stabilizing
interactions (Hudgins and Jarrold, 1999).
These deliberations were taken into consideration in designing the CPL19YS-2 library,
in particular by generating a library with a variable display segment of 33 aa size which
has a strong preference to form disulfide bridges at different positions. The loops poten-
tially formed by these bridges can vary in length (between 4 and 8 aa length). It has
been reported by others that a constraining cysteine loop often requires optimization in
its loop length (Nagi and Regan, 1997). This variable element in the library should allow
selection of the ”optimized disulfide loop length“ already during the early screening steps.
Analyzing the clones from the CPL19YS-2 that were isolated either randomly or from
enrichments during different pannings, the observations of Kay et al. (1993) with respect
to counter-selection of unpaired cysteine residues selected against were not observed. The
randomly isolated clones, without any previous selection, showed a random distribution of
0, 1, 2 or 3 cysteines in addition to the fixed central cysteine. Although this distribution
was shifted towards more cysteines, due to an observed bias in the synthesis of the
oligonucleotides used to construct the library, there was no indication of a bias against
unpaired cysteines as observed by Kay et al. (1993). it should be noted that their phage-
displayed library presented the variable peptide on five copies of the phage pIII protein,
requiring correct folding and function (as pIII) of the hybrid protein. Our library is
preferentially monovalent, i.e. only one hybrid pIII protein is present on average per
two phage particles. In CPL19YS-2 there are still some four functional non-hybrid pIII
molecules available for functional attachment and injection of DNA from the phagemid
particles.
While the original library had a preference (∼50% of all clones) for peptides with
two cysteines, it is notable that the majority of clones enriched in different panning
experiments (56 out of 62 – 90.3%) possesses an even number of cysteines. This is
significantly higher than the library average and therefore strongly supports a positive
effect on enrichment from the formation of intramolecular disulfide bridges. It can not be
concluded at this point if this positive effect is due to enhanced rigidity of the peptide in
general, aggregating hydrophobic residues or stabilizing hydrogen bonds, or an improved
presentation of an amino acid motif in the disulfide ”loop“. In the two experiments
carried out with antibodies as targets (sections 3.3.2 and 3.3.5) where a linear motif
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was expected, the presumed disulfide bonds in enriched clones were always outside the
detected motif. These results support our arguments which put emphasis on the potential
for generating disulfide bridges. Such an approach had previously also been postulated
by e.g. McLafferty et al. (1993).
4.5 Application of the CPL19YS-2 library for various target
screenings
Peptide libraries used in the screening for affinity ligands are either tailored for spe-
cific purposes, by limiting their amino acid composition or by using defining struc-
tural/scaffold elements, or alternatively were in contrast conceived as “universal“ random
libraries without any structural bias (Clackson and Wells, 1994). Both approaches have
yielded successful enrichment of specific ligands on some of the examined targets where it
is noted that this required optimization of varying protocol parameters in the screening
process. It is also discussed that some targets may not be suitable for this methodology,
as there are proteins whose interaction sites would have a low maximal affinity to small
molecules (Cheng et al., 2007), which has been difficult to predict.
In the current work, different targets have been used to screen the CPL19YS-2 pep-
tide library for affinity candidates. While it was possible to confirm the display and
screenability on model targets (anti-p53 Ab-6 antibody, and later on by lab members on
antibodies from a polyclonal serum) by the isolation of candidates with expected epitopes,
other screening experiments could not enrich single phage clones at all (pannings on pure
streptavidin beads, pannings on a part of the M3 protein of group A streptococci).
That the unsuccessful panning on streptavidin beads enriched for no specific motif was
expected, as the library was designed to exclude the common streptavidin-binding HPQ
motif. The library does not contain the integrin binding RGD motif either to reduce the
potential of unspecific enrichment if the library is used for panning on eukaryote cells.
The unsuccessful screening on the M3 protein might well be due to the target being
unsuitable for a peptide library. The M3 protein is interacting with collagen at several
sites and remains in a flexible, extended state (Dinkla et al., 2007, 2009). This may
be disadvantageous for a screening of a peptide library where the candidates are not
large enough to be interacting with several collagen sites. M3 would not present a target
pocket which could be expected to strongly bind a peptide ligand.
The different pannings on CD28, either with the original CPL19YS-2 library or recom-
bined libraries to make use of the implemented recombination features, showed promising
results in the enrichment behavior which led to expectations of high affinities. As these
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were not confirmed in the peptide-target interaction analysis, it remains unclear if the
affinities were too low to be measured, leaving the enrichment results as potential arti-
facts of phage matrix mediated binding of the peptides to the target (as noted e.g. by
Webster, 1996), or if the correct affinity values could not be determined due to difficulties
in the chemical synthesis of the examined peptides.
The products obtained from chemical synthesis led to broad peaks in the chromatograms
of HPLC and MS-LC, instead of clearly defined peaks indicating pure products. Aggre-
gation due to partially hydrophobic sequences could explain the encountered problems
as well as incomplete synthesis that has been observed during the synthesis process.
The dependence on chemical synthesis in order to be able to characterize isolated
peptides outside of the phage context must be seen as a design flaw in a library that is
supposed to encode peptides which could not be easily provided by chemical synthesis.
Although high affinity ligands against many different targets have been obtained using
phage display libraries displaying antibodies (or -fragments), there have been many con-
siderations of how to improve these methods. Following the natural approach of shuﬄing
the heavy and light chains of antibodies, recombination has been used to increase library
complexity (de Haard et al., 1999; Griffiths et al., 1994; Marks et al., 1991; Sblattero
et al., 2001; Zhang et al., 2007). These different methods of ordered recombination have
been shown to be successful with antibodies, while recombination in peptides has not
been used to this extent, mostly due to required homologous sequence stretches. Using
Cosmix plexing (Collins et al., 2001) as recombination method, by including cycles of
recombination between selection the effective diversity can be considerably increased,
and the theoretical maximum diversity can be approached step by step. This approach
is equivalent to V gene shuﬄing, but carried out in parallel, rather than in series, as it
is performed in other methods (compare e.g. Sblattero et al., 2001).
4.6 Concluding remarks
In comparison to mutation strategies which allow linear increases in complexity, an ex-
ponential potentiation could be achieved by recombination between existing or induced
mutations present in a population (Moore et al., 1997). While it was not possible to
confirm here that this yielded higher affinity ligands than panning from the primary
CPL19YS-2 library (as no affinities were measurable for the isolates from the panning
on CD28), the process itself has been used to recombine enriched clones with the orig-
inal library at desired positions in the peptides. Sequencing of these clones confirmed
the enriched sequence parts as well as recombined sequence parts. Subsequent panning
experiments with these clones indicated strong preferences for several conserved parts
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of the original enriched sequences after recombination, allowing an easy mapping of se-
quences that conferred to positive selection. This could also be used as a tool to analyze
which part of a peptide contributes most to affinity selection easily.
Nevertheless, the general behavior of the library in the panning experiments, showing
increase in input:output ratios and generally observed enrichments of similar secondary
structure patterns after panning on CD28 show that the library is useable for panning
experiments requiring potentially complex ligand structures without prior tailoring of
the library.
Consequently, the general usability of the CPL19YS-2 library for screening has been
confirmed and is also being used in further screening experiments in our laboratory.
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In this work, a novel peptide library CPL19YS-2 was created, its quality was validated
and quantitatively assessed. The essential recombination features have been shown to be
easily available as tools to increase initial diversity of the library as well as for recombi-
nation later in/after a panning experiment.
With these results, a toolbox is accessible which allows the panning for medium length
(longer than in most peptide libraries) and complex peptide structures as ligands for
a broad range of possible binding partners. The absence of a preferential predefined
structure as well as having high complexity provide a ready-to-use technology for panning
on a wide range of targets.
Until now, the range of targets that have been chosen for panning does not yet al-
low conclusions as to the usefulness of generating ligands with more stable secondary
structures. Further experiments in our lab have shown that enrichment from the library
on targets different from the ones examined in this thesis showed better results, so the
full effect of recombination needs to be assayed on these targets, further characterizing
the impact this method could have on the affinity of selected peptides as is expected.
Similar recombination work conducted on antibodies has already shown advantages (e.g.
Sblattero et al., 2001), and its successful transferability to peptide libraries still needs
further validation.
A limitation of the CPL19YS-2 library seemed to be in the potential difficulties aris-
ing when enriched identified peptide motifs should be analyzed. In order to measure the
affinities of isolated motifs to their targets exactly, the ligand needs to be available with-
out any effects from neighboring sequences and the phage context. While short peptides
of less than ten amino acids can be synthesized chemically routinely, the peptide se-
quences from the CPL19YS-2 library presented large difficulties in the synthesis process,
prohibiting affinity measurements for most of them.
If the library was to be modified, the cloning of a DNA sequence encoding protease
cleavage site between the pIII protein of M13 and the encoded library would allow for
the production and purification of single clones just from phagemid infected E. coli cul-
tures rather than having to rely on chemical synthesis. The inclusion of an amber stop
codon (TAG) between the displayed-peptide gene and the pIII gene would be another
possibility. It would allow the production of the fusion protein for phage display in an
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amber -suppressor strain (e.g. XL1-Blue from Stratagene), while a transformation of the
phagemid into a non-suppressor E. coli strain could be used for expression and secretion
of the library peptide.
Better results from the first panning round might be achieved by using polyvalent dis-
play for just one round of panning (taking the low concentration of every single clone
in the first panning round into account), returning to monovalent presentation for the
following rounds, capturing potentially more of the medium- to high-affinity clones in
the initial panning round. This could be achieved by either switching of the packaging
system (e.g. Hyperphage from Rondot et al., 2001, which produces phage particles pre-
senting only fusion proteins), or by using cell based systems that eliminate the use of
helper phage completely. Such systems use bacterial cells for phage packaging that carry
different phage gene encoding plasmids, allowing control over the valency of presentation
(Chasteen et al., 2006), as used by Secco et al. (2009).
Taken together, this work gives access to a versatile peptide library of possible high
structural complexity and presents first steps in its further characterization.
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6.1 Summary
Phage display of peptides is a technique that is used to express and present peptides
as fusion proteins on the surface of a phage particle. These presenting particles are
in general used to select for peptides which can interact with a given target molecule.
The method is carried out most frequently in an empirical iterative affinity enrichment
procedure starting with libraries comprising large numbers of variants.
In this work, a phage display peptide library was created (”CPL19YS-2“), which should
possess the potential for formation of secondary structure in the library due to a length
of 33 amino acids for the encoded peptides. This should allow for higher affinities to
many various types of target molecules than that which is achieved by using common
libraries of shorter peptides.
The library was designed with respect to the Cosmix-plexing method, which allows
recombination of hyper-variable DNA regions. It uses type IIs restriction enzymes that
recognize a defined DNA sequence, but cut in a fixed distance from that sequence. The
enzyme can therefore bind outside of the hyper-variable region which encodes the library
diversity. This method can be applied to increase the diversity of the primary library,
but its main strength is to allow the recombination of different coding DNA cassettes
of peptides from preselected populations which already showed affinity to a particular
target, thus optimizing the binding capacities of these variants to this target.
The library was created using synthetic DNA and, together with a modified expression
vector, assessed for its constitution. Furthermore, the Cosmix-plexing recombination
method was validated and established for this library.
Expression and presentation of the library peptides were validated, and the suitability
of the CPL19YS-2 library for screening was confirmed in affinity selection experiments.
In a screening of the CPL19YS-2 library for ligands binding to CD28 (a T cell surface
protein), specific peptide variants were enriched and recombined using Cosmix-plexing.
Indications of high affinity to CD28 (and of higher affinities for the recombined variants)
could not be confirmed in BIAcore analysis.
The inability to obtain clear evidence of affinity of the synthetic peptides was assumed
to be due to difficulties in the chemical synthesis of such peptides which contained some
very hydrophobic stretches. Some candidates have still not been successfully synthesized
chemically.
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6.2 Zusammenfassung
Phage display von Peptiden stellt eine Technik dar, mit der Peptide an einem Ober-
flächenprotein eines Phagenpartikels als Fusionsproteine exprimiert und damit präsen-
tiert werden können. Diese präsentierenden Phagenpartikel werden im Allgemeinen
dazu verwendet, Peptide zu selektieren, die mit vorgegebenen Zielmolekülen interagieren.
Diese Methoden wird in den meisten Fällen in Affinitäts-Anreicherungen mit iterativen
Zyklen angewendet, wobei zu Beginn der Anreicherungen meist Bibliotheken mit einer
hohen Anzahl verschiedener Peptide eingesetzt werden.
In dieser Arbeit wurde eine Phage Display-Peptid-Bibliothek erstellt (”CPL19YS-2“),
die durch eine Peptid-Länge von 33Aminosäuren das Potential zur Ausbildung von
Sekundärstrukturen besitzen soll. Diese Eigenschaft soll höhere Affinitäten zu einer
Vielzahl verschiedener Zielmoleküle zulassen, als es bisher mit kürzeren Peptiden aus
gängigen Peptid-Bibliotheken möglich ist.
Die Bibliothek wurde mit Hinsicht auf die Methode des Cosmix-plexing entwickelt,
da diese die Rekombination in hypervariablen DNA-Regionen erlaubt. Sie verwendet
Restriktionsenzyme vom Typ IIs, die eine definierte DNA-Sequenz erkennen, aber in
einem festgelegten Abstand von dieser schneiden. Dadurch kann die Bindung eines Re-
striktionsenzyms außerhalb der hypervariablen Region stattfinden, innerhalb welcher die
Diversität der Bibliotheksstruktur kodiert ist. Mit Hilfe dieser Technik kann man die
Diversität der Ausgangsbibliothek steigern, ihr größerer Vorteil liegt aber darin, dass sie
die Rekombination verschiedener kodierender DNA-”Kassetten“ von Peptiden aus vorse-
lektierten Population erlaubt, die bereits eine Affinität für eine bestimmte Zieldomäne
besitzen. Dadurch kann die Affinität der Varianten für ihr Zielmolekül optimiert werden.
Die mittels synthetischer DNA erstelle Bibliothek wurde zusammen mit einem modi-
fizierten Expressionsvektor bzgl. ihrer Zusammensetzung untersucht und die Rekombi-
nationsmethode des Cosmix-plexing validiert und etabliert.
Die Expression und Präsentation der Peptide wurden validiert, und die Eignung der
CPL19YS-2 Bibliothek für Screenings wurde in Affinitätsanreicherungs-Experimenten
bestätigt.
In einem Screening der CPL19YS-2-Bibliothek auf Liganden für CD28, ein Ober-
flächenprotein von T-Zellen, wurden spezifische Peptide angereichert und mittels Cosmix-
plexing rekombiniert.
Die Hinweise darauf, dass diese Peptide hohe Affinitäten besitzen (und die rekom-
binierten Varianten höhere Affinitäten), konnten in BIAcore-Analysen nicht bestätigt
werden.
Die Schwierigkeiten beim Nachweis der Affinität der synthetischen Peptide liegen ver-
mutlich in Limitierungen bei der chemischen Synthese begründet, da diese Peptide einige
sehr hydrophobe Abschnitte aufweisen. Einige der Peptide konnten bisher noch nicht
chemisch synthetisiert werden.
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